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The 6th Young European Scientist Meeting - YES Meeting 2011 
is an international conference build up by a group of stu-
dents in Porto, Portugal. 
Since our first edition, in 2006, we have four main com-
ponents that include students’ presentations, world-class 
talks, interactive workshops and an interesting social pro-
gram that uncovers the beautiful region of Porto.
We received a record number of registrations, and this year, 
for the first time, we had more than 400 students attending 
our meeting from more than 30 countries. We were thrilled 
to know that so many students see in YES Meeting an op-
portunity to present their research, to attend unique talks 
and to make friends from so many backgrounds. This is, 
in fact, the central point for YES Meeting: to give students 
a stage to present, to discuss, to learn, to discover and to 
surprise themselves. In line with our goal of supporting 
students’ works, we formed a partnership with the Inter-
national Journal of Medical Students (IJMS), to publish the 
abstracts presented during the meeting as a supplement of 
the first number of IJMS. 
As part of the former YES Meeting Organizing Committee 
and as Editor of the International Journal of Medical Stu-
dents, I am proud of such a collaboration between two or-
ganizations that promote students’ research and science.
Another novelty of this year was the establishment of YES 
Meeting as an official partner of the International Fede-
ration of Students Association – IFMSA, one of the largest 
international students forums, representing more than 1.2 
million medical students. This was, of course, a great honor 
for us and expresses the good work we have been doing 
along the years. It also brings responsibility and we hope to 
keep up to the expectations.
YES Meeting has also increased the participation of stu-
dents from different scientific backgrounds, such as, Medi-
cine, Biology, Biochemistry, Engineering and Pharmacy, just 
to name some. This is, again, very exciting for us and we 
believe that sharing knowledge is essential for scientific 
progress. In a time of financial and social stress like the 
one we are facing now, these discussions and learning pro-
cesses can generate partnerships and join efforts that can 
make a difference.
Regarding the scientific program we had memorable talks 
in fields such as Integrins, Bone Marrow, Brain-Machine 
Interface, Ageing, Cardiovascular Medicine and NOTES (Na-
tural Orifice Translumenal Endoscopic Surgery). The inter-
vening speakers gave an enlightening perspective on great 
scientific advances and included Reinhard Fässler, Mikhail 
Lebedev, Rudi Westendorp, Mariela Jaskelioff, Mark Caul-
field, Vickas Patel, Gero Hütter and Robert A. Montgomery, 
among others. The workshops were highly anticipated and 
met the expectations with great opportunities for everyone 
to get “hands on” in many activities from surgical gestures 
to diagnostic medicine.
We also had first-class poster and oral presentations in 5 
main areas: Oncology & Molecular Biology, Neurosciences, 
Physiology & Immunology, Internal Medicine and Surgery. 
The Abstracts are included in this Supplement.
We encourage you to keep up with your research interests 
and projects and to submit them to IJMS. We also invite 
you to visit YES Meeting’s webpage at www.yesmeeting.org 
and to participate in future editions of this unforgettable 
scientific experience.
The 6th Young European Scientist Meeting 2011
Delfim Duarte1.
Figure 1. Delfim Duarte, President of the 6th Young European Scientist Meeting 2011 at Opening.
See photos of the YES Meeting on the next page.
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INTERNAL MEDICINE Session
PS 2  Airway-invasive inoperable Thyroid Carcinoma: An Interven-
tional Pulmonary approach to management in the Asian 
setting. 
Arjun Lakshmana Balaji1, Nayana Nagraj2, Abhinav Singla2.
1 Rajiv Gandhi University of Health Sciences & Fortis Hospita ls, Bangalore.
2 Rajiv Gandhi University of Health Sciences.
Aim: To evaluate clinically and to treat the patients with airway in-
vasive thyroid cancer using interventional pulmonary procedures. 
Introduction: Invasive thyroid cancer causing tracheal stenosis and 
obstruction is essentially managed by surgical methods. In patients 
who cannot be operated, or fail other methods, interventional pul-
monary (IP) procedures offer reasonable options. There is scant data 
from the Asian and Indian setting in this regard. In this study, we 
report an IP approach to such patients with airway-invasive thyroid 
cancer, who failed or were not candidates for conventional options. 
Methods: 10 consecutive patients, over 3.2 years, with primary 
airway-invasive thyroid cancer referred for IP treatment were in-
cluded. Clinical evaluation, CT imaging followed by bronchoscopy 
was done. Therapeutic modalities used included debulking using 
cauterization, balloon dilatation, and stenting. Thermoablation was 
done using APC and electrocautery. Periodic follow up was done, 
for recurrence. Results: 22 procedures were done in 10 patients (8 
males and 2 females) with invasive thyroid disease, causing stridor 
as the main symptom. The mean age of the patients was 44.9 years 
(13 - 75 years). Rigid bronchoscopy was done in 80% and flexible 
bronchoscopy was used in 20%. Debulking and dilatation was done 
in all the patients, and silicone stenting (Dumon stent, Novatech 
Corp) was done in 5 patients. Airway patency was achieved in all 
patients (100% immediate success rate). The mean survival postpro-
cedure was 23.1 months (2 - 38 months). There were no procedure 
related complications. One patient died 12 months post procedure 
due to non-stent related causes. In 1/10 patients, complete cure 
was achieved, and the stent was removed after 15 months. Another 
unique case was a 75 year male with papillary carcinoma, managed 
with recurrent (11) treatments over 3.2 years. Conclusions: IP proce-
dures in invasive thyroid carcinoma offer good options to patients 
who have exhausted all conventional options, to maintain quality of 
life, and possible longevity. This is one of the first series in an Asian 
and Indian setting, demonstrating the utility of IP in invasive thyroid 
Ca. Other unique features in this series are the use of APC and 
electrocautery with outcomes at par with reports using lasers. Our 
study also shows a significant survival advantage with IP methods. 
In staging systems such as described by SHIN, > SHIN stage 2 survival 
is 1.5 years, while patients in our series (SHIN 4) had a mean survival 
of about 2 years.
PS 46  Evaluat ion of correlat ion between severity of dry eye syn-
drome and patients with diabetes mellitus. 
 Kashkouli M, Amani A.
 Eye Research Center, Rasoul Akram Hospita l, Tehran University of Medi-
cal Sciences. 
Aim: To assign the severity of dry eye syndrome in diabetic patients 
Introduction Diabetes is one of the most common systemic disea-
ses. Dry eye syndrome is one of the eye involvements in diabetic 
patients. Evaluation of correlation between dry eye syndrome and 
diabetic retinopathy in patients with non insulin-dependent was the 
aim of this study. Methods: In this study two hundreds eyes from 
100 diabetic patients (non insulin dependent) were selected and 
evaluated for dry eye syndrome. The patients then were divided into 
four group: Group 1: patients without diabetic retinopathy; Group 
2: patients with non proliferative diabetic retinopathy; Group 3 : 
patients with proliferative retinopathy Group; 4: patients with pro-
liferative diabetic retinopathy undergone PRP. All the patients were 
examined for Schirmer test, TBUT, staining the cornea with flourecein 
and then allocated in different group based on the severity of dry 
eye .Collected data were analyzed by X2 and Kendle- taue tests using 
SPSS software. Results: Prevalence of dry eye syndrome in patients 
in group 1 was 48% in group 2, 3 and 4 were 52%, 60% and 80% 
respectively. Conclusions: Dry eye syndrome is a complication of 
diabetes mellitus and its severity correlates with severity of diabetic 
retinopathy.
PS 52 ATTITUDES OF MEDICAL STUDENTS TOWARDS PSYCHIATRIC PA-
TIENTS. 
Vanja H.
Medical Faculty, University of Novi Sad.
Aim: To examine the attitudes towards psychiatric patients among 
first and fifth year medical students of Medical Faculty Novi Sad and 
to assess the differences in attitudes caused by duration of medical 
education. Introduction: Negative attitudes towards psychiatric pa-
tients are very spread in society. Among others, physicians also have 
the negative attitudes. Methods: Data were obtained using question-
naire which consisted of 27 questions. 127 first year and 74 fifth year 
medical students took part in the survey. We compared the attitudes 
between the two groups and also of fifth year medical students 
which have some family member who is treated for some psychiatric 
disorder, with those who do not have. Results: Fifth year students 
have generally more favourable attitudes. Greatest difference was in 
the attitudes in areas students met during their faculty education, 
such as therapy and psychiatric hospitals. The difference was less 
and statistically insignificant in social and personal attitudes. Sta-
tistically significant differences were found between the two groups 
of fifth year students. The group of students with family member 
treated for some psychiatric disorder had less negative attitudes. 
They also had more stances towards psychiatric disorders, and their 
responses were more uniform. Conclusion: Although there is a po-
sitive difference between first and fifth medical students’ attitudes 
towards psychiatric patients there is a plenty of possible improve-
ment in their education, in order to reduce stigma. Further research 
should be done on attitudes towards specific mental disorders. 
PS 68  T2* magnetic resonance imaging of the liver in thalassemic 
patients in Iran. 
Zamani F1, Razmjou S1, Akhlaghpoor Sh2, Eslami SM1, Azarke-
yvan A3, Amiri A1.
1 Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, 
Tehran University of Medical Sciences.
2 Department of Computed Tomography, Noor Medical Imaging Center.
3 Research Center of Iranian Blood Transfusion Organization.
Aim: To investigate the accuracy of T2*-weighted magnetic resonan-
ce imaging (MRI T2*) in the evaluation of iron overload in beta-
thalassemia major patients. Introduction: Conventional treatment 
of beta-thalassemia major requires regular blood transfusions to 
maintain pretransfusion hemoglobin level above 90 g/L. A major 
drawback of this treatment is transfusion siderosis, which, in asso-
ciation with the increased intestinal iron absorption, apoptosis of the 
erythroid precursors and peripheral hemolysis, leads to inexorable 
iron accumulation in various organs such as the heart, liver and 
endocrine organs. The assessment of body iron is still dependent 
upon indirect measurements, such as levels of serum ferritin, as well 
as direct measurements of the liver iron content. Serum ferritin has 
been widely used as a surrogate marker but it represents only 1% of 
the total iron pool, and as an acute phase protein, it is not specific 
because the levels can be raised in inflammation (e.g. hepatitis) and 
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liver damage. Liver iron concentration measured by needle biopsy 
is the gold standard for evaluation of siderosis. However, it is an 
invasive technique which is not easily repeated and its accuracy is 
greatly affected by hepatic inflammation-fibrosis and uneven iron 
distribution. More recently, biomagnetic susceptometry and magne-
tic resonance imaging (MRI) have been validated for measuring iron 
overload, and these techniques have great merit in being noninva-
sive. Biomagnetic susceptometry is a non-invasive, well calibrated 
and validated method as a quantitative measurement technique, 
but it has limited clinical value because of its high cost and technical 
demands. MRI has been considered a potential method for assessing 
tissue iron overload, as iron accumulation in various organs causes a 
significant reduction in signal intensity stemming from a decrease in 
the T2 relaxation time. Methods: In this cross-sectional study, 210 pa-
tients with beta-thalassemia major having regular blood transfusions 
were consecutively enrolled. Serum ferritin levels were measured, 
and all patients underwent MRI T2* of the liver. Liver biopsy was 
performed in 53 patients at an interval of no longer than 3 mo after 
the MRIT2* in each patient. The amount of iron was assessed in 
both MRI T2* and liver biopsy specimens of each patient. Results: 
Patients’ ages ranged from 8 to 54 years with a mean of 24.59 ± 
8.5 years. Mean serum ferritin level was 1906 ± 1644 ng/mL. Liver 
biopsy showed a moderate negative correlation with liver MRI T2* (r 
= -0.573, P = 0.000) and a low positive correlation with ferritin level (r 
= 0.350, P = 0.001). Serum ferritin levels showed a moderate negative 
correlation with liver MRI T2* values (r = -0.586, P = 0.000). Conclu-
sions: Our study suggests that MRI T2* is a non-invasive, safe and 
reliable method for detecting iron load in patients with iron overload.
PS 99  VITAMIN D RECEPTOR POLYMOR PHISM IN PORTUGUESE PA-
TIENTS WITH SYSTEMIC LUPUS ERY THEMATOSUS. 
Santos G1, Marinho A2, Carvalho C1, Bettencourt A1, Costa PP1, 
Almeida I1, Vasconcelos C1,2, Silva BM1.
1 UMIB, Instituição de Ciências Biomédicas Abel Salazar - UPorto.
2 UIC - CHP Unidade de Imunologia Clínica do Centro Hospitalar do Porto 
- Hospita l de Santo António.
Aim: To determine whether VDR gene polymorphisms are related to 
the susceptibility to SLE, severity and activity of the disease in the 
Portuguese population. Introduction: Systemic Lupus Erythematosus 
(SLE) is an autoimmune disease with a large variation in clinical 
presentation - acute versus indolent - and associated syndromes: 
non severe pattern, cutaneous and articular versus nephritic, cere-
bral, etc. An explanation for this heterogeneity can be framed in the 
setting of the so called “mosaic of autoimmunity”, in which genetic 
and environmental factors are generally acknowledged as playing a 
role in the onset of autoimmune disease. Genetic and environmental 
factors are generally acknowledged as playing a role in the onset of 
SLE. Vitamin D is a steroidal hormone that in addition to its role in 
calcium homeostasis, has been shown to possess immunomodula-
tory effects through the Vitamin D Receptor (VDR). Several studies 
have demonstrated a higher prevalence of vitamin D deficiency in 
SLE patients and a possible mechanism for its influence in the disea-
se was already proposed (Figure 1). In humans, multiple polymor-
phisms of the VDR gene have been identified, some of them with 
functional impact. The relationship between SLE and polymorphisms 
in the VDR gene has been already subjected to scrutiny [1]. Further 
studies are necessary to better understand the risks and benefits 
of vitamin D supplementation in the prevention and treatment of 
autoimmune diseases and its real impact in daily clinical practice. 
Methods: A sample of 181 SLE patients (according to the ACR criteria) 
with Northern Portuguese descent, were studied and compared with 
181 ethnically-matched controls (Control Population). SLE clinical 
and laboratory manifestations were also evaluated. Genotyping of 
the FokI polymorphism of the VDR gene was performed using Taq-
Man® allelic discrimination assay. Differences in frequencies were 
evaluated using the Chi-Square test and Fisher’s exact test. Analyses 
were done with SPSS v.18 software. Significant levels were set at 
p<0.05 and confidence intervals (CI) were given at 95%. Results: No 
statistically significant differences, between patients and controls, 
for the VDR FokI genotype frequencies were found. However, we 
could identify an association with disease activity. The genotype ff 
of the FokI polymorphism was significantly less frequent in patients 
with SLEDAI ï³4(n=79) than in patients with SLEDAI <4(n=74) (6.3% vs. 
21.6%, corrected p [p(c)] = 0.009). Conclusions: We provide for the 
first data suggesting that the ff VDR FokI genotype reduces disease 
activity. Our findings are in agreement with previously published re-
sults that associated a more active immune system with the FF VDR 
genotype [2]. The discrepancies reported for this association, may be 
explained by the fact that VDR signalling, although contributing to 
the outcome of immune response, can be overruled by more potent 
immune pathways.
PS 129  Pscribe: a unique e-learning program to practice pharmaco-
therapy. 
Brebenel I, Van Doorn A.B.D., De Waard-Siebinga I, De Graeff 
P.A.
Department of Clinical Medicine - University Medical Center Groningen.
Aim: E-learning is gaining importance in academics, especially in 
medical education1. In this study, we estimated the number of 
academic e-learning programs, later specified as medical and 
pharmacological e-learning programs. Introduction: Prescription 
errors are frequently made mistakes by physicians with potential 
serious health issues for the patient. It is estimated that up to 500 
errors are made per 1000 patient hours. In order to prevent these 
mistakes, the University of Groningen has developed an e-learning 
program in collaboration with the University Medical Center Gro-
ningen to teach students to prescribe drugs; it is called Pscribe. 
This web-based e-learning program teaches proper prescribing in a 
case-oriented manner based on the World Health Organization 6-step 
(WHO 6-step). To estimate the potential benefits and use of Pscribe 
in medical education, we estimated the number of available medical 
e-learning programs. Methods: First, we estimated the total number 
of academic e-learning programs ([universities] x [estimated facul-
ties/university] x [estimated programs/faculty]), medical e-learning 
programs ([medical schools] x [estimate programs/medical school]) 
and pharmacotherapy e-learning programs ([medical schools] / [me-
dical courses]). We took many factors into account to make these 
estimates as accurate as possible. Second, we estimated the num-
ber of web-based e-learning programs that teach medical students 
prescribing through case-based exercises, like Pscribe. Criteria we 
used to match other programs to Pscribe are: inspiration by the 
WHO 6-step, possibility to create cases in a user-friendly way and 
datatracking; a function that might be useful for research purposes. 
Results: We estimate academic e-learning programs between 50.000-
150.000 programs (8.547 x 6 x 1 or 3), medical e-learning between 
20.000-40.000 programs (2.081 x 10 or 20) and pharmacotherapy e-
learning between 1.000-2.500 programs (20.000 or 40.000 / 22). When 
we added the specified searching terms we found 3 other programs, 
i.e. Dynamisch Patiënt Simulator developed by the University of 
Leiden and the Leiden University Medical Center, The National Pres-
cribing Curriculum developed by the University of South Australia 
and ‘Signposts for good prescribing’, a program developed by the 
British National Health Service. Although these programs have similar 
functions as are available in Pscribe, none of the programs had all 
these functions integrated in one program. Further, data-tracking 
was not available in the studied programs. Conclusions: Although 
several other e-learning programs are available to teach students 
how to prescribe drugs that might resemble Pscribe, we were not 
able to find another program that combines the different functions 
including the data-tracking function. Hence, we conclude that the 
pharmacotherapy e-learning program Pscribe has unique features 
that cannot be found in other programs. Implementing it in medical 
education might reduce the number of prescription errors made by 
future physicians.
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in west of Iran, and 3 girls, mean age of 15±3.08, referred to the 
clinic of Kermanshah University of Medical Sciences with history of 
favism and hemolytic anemia. An age and sex matched group of 
healthy individuals, 95 males and 15 females with the mean age of 
16.19±2.17, from the Kermanshah Province of Iran were selected and 
along with G6PD individuals were studied for factor V Leiden muta-
tion. Healthy individuals consisted of school boys and blood donors. 
All of G6PD individuals and controls were not consanguineous. DNA 
was extracted by phenol chloroform method. The activity of glucose-
6-phosphate dehydrogenase was determined using the fluorescent 
spot test. G6PD mutations were identified by a combination of PCR-
RFLP technique, single strand conformation polymorphism (SSCP) 
analysis and DNA sequencing. The factor V Leiden was detected 
by PCR-RFLP method using MnlI restriction enzymes, as previously 
described . Chi-square test is used for matching the variants and 
we utilized SPSS.V.12 for statistical application. Results: Among G6PD 
deficient individuals there were 3 males carrier of factor V G1691A 
giving the prevalence of 5% and allele frequency of 2.5%. Factor V 
G1691A mutation was detected as heterozygous in 3 males out of 
110 healthy individuals indicating the prevalence of 2.7% and allele 
frequency of 1.3%. No homozygous factor V G1691A and was found. 
Overall comparing to the healthy individual the differences were not 
statistically significant. Conclusions: Compared with those without 
the mutation of factor V Leiden, heterozygous carriers have a 7-fold 
increased risk of venous thrombosis; homozygous individuals have 
a risk that is increased up to 100-fold. It has been indicated that the 
G6PD deficiency could be connected to the venous thrombosis. In the 
present study, the prevalence of factor V Leiden in G6PD individuals 
tended to be higher compared to controls (5% vs. 2.7%) but, the di-
fference was not statistically significant. Briefly, our finding indicates 
that the prevalence of factor V Leiden in G6PD deficient individuals 
is not statistically different compared to normal subjects and G6PD 
deficiency is not associated with this thrombophilic mutation in 
Western Iran.
PS 162  NOWADAYS ENTEROSCOPY IN DIAGNOSIS OF SMALL BOWEL 
CROHN’S DISEASE. 
Ivanova EV1, Ivanova EV1, Kadnikova UA2, Fedorov ED1.
1 Moscow University Hospital, Russian Federation.
2 Faculty of Fundamental Medicine, Lomonosov Moscow State University, 
Russian Federation.
Aim: The aim of the study is to evaluate the diagnostic capabili-
ties of videocapsule endoscopy (VCE), single- and double-balloon 
enteroscopy in diagnosis of small bowel Crohn’s disease. Introduc-
tion: Crohn’s disease is a chronic disease which is predominantly 
observed in the developed countries and may affect any part of the 
gastrointestinal tract from mouth to anus. Up to 30% of patients 
diagnosed with Crohn’s disease have only small-bowel involvement 
(Bourreille A. et al., 2009). The modern endoscopic techniques of 
the small-bowel imaging such as videocapsule and balloon-assisted 
enteroscopy (BAE) allow to visualize any part of small bowel mucosa 
and play a significant role in patients with suspicion on Crohn’s 
disease. Methods: From V.2003 to V.2011 we observed 52 pts. with 
suspected small bowel Crohn’s disease; 8 (15,4%) of them were 
operated urgently because of complications: bleeding (2), secondary 
appendicitis (4), perforation (1), bowel obstruction (1). Another 44 
pts (m-23, f-21, ranged from 15-72 years, mean age 37,5±12,0 years) 
underwent complex examination including 19 VCE and 50 balloon-
assisted enteroscopies (from which 8 interventions as a follow-up) 
for the last 3,5 years. VCE was performed in 32 pts. (incl. 7 after 
VCE); there were 22 peroral examinations in 21 pts, 28 transrectal in 
21 pts and both of them in 10 pts. Results: Typical Crohn’s disease 
appearances (ulcers, pseudopolyps, edema, mucosal hyperemia, 
scars, pseudostrictures or strictures) were found in 15 (34,1%) pts 
(incl. 4 pts after VCE) from 44 who were examined endoscopically. In 
8 pts we`ve revealed stenosis, in 4 of them we`ve passed through 
the ileocecal valve stenosis by bouginage with the enteroscope and 
were able to examine superior area (up to 35 cm of ileum). Beyond 
the stenosis area we took target biopsy. In all Crohn’s disease was 
confirmed histologically in 5 (33,3%) pts. We haven`t found any 
PS 149  Accuracy of D-dimer/fibrinogen ratio to predict developing of 
pulmonary thromboembolismin patients admitted to inten-
sive care units. 
S. Hajsadeghi1, S.R. Jafarian Kerman2, M. Khojandi3, H. Vaferi4, 
R. Ramezani5, N. Movasseghi Jourshari6, S.A.J. Mousavi7, H.R. 
Pouraliakbar8.
1 Assistant professor, Cardiologist, Rasoul-e-Akram Hospital, Tehran Uni-
versity of Medical Sciences, Tehran, Iran.
2 Medical Intern, Head of Cardiology Field, Medical Students Research 
Committee, Tehran University of Medical Sciences, Tehran, Iran.
3 Medical Intern, Medical Students Research Committee, Tehran Universi-
ty of Medical Sciences, Tehran, Iran.
4 Medical Student, Medical Students Research Committee, Tehran Univer-
sity of Medical Sciences, Tehran, Iran.
5 Medical Student, Medical Students Research Committee, Tehran Univer-
sity of Medical Sciences, Tehran, Iran.
Aim: The aim of this study is to evaluate Ddimer/fibrinogen ratio 
(DDFR) in ICU patients as a rule-in diagnostic test for patients 
presenting symptoms and signs of PTE. Introduction: Pulmonary 
thromboembolism (PTE) has been known as the third cause of car-
diovascular related deaths. PTE can increase D-dimer and decrease 
fibrinogen levels .But in settings such as Intensive Care Units (ICU) 
and other long-term and critically ill hospitalized patients, several 
factors can influence D-Dimer and fibrinogen concentrations that 
make them unreliable to diagnose PTE. The aim of this study is 
to evaluate the accuracy of D-dimer/fibrinogen ratio (DDFR) in ICU 
patients presenting symptoms and signs of PTE. Methods: Critically 
ill patients admitted to ICU that were suspected to PTE were included 
and then the definite diagnosis was established either by Angio-
graphy or CT- Angiography. D-dimer and fibrinogen was measured 
before treatment and other parameters were extracted from medical 
records. Patients with drug history of anti-coagulants, oral contra-
ceptive, and previous history of PTE were excluded. Suitable analytic 
tests were performed by SPSS software. Results: Thirty-seven PTE 
and 33 non-PTE subjects were included. Mean value of D-dimer and 
fibrinogen was 3.97±3.22 μg/ml and 560.6±197.3 mg/dl, respectively. 
Significant higher values was seen in D-dimer (4.65±3.46 vs. 2.25±2.55 
ug/ml,p=0.006) and DDFR (0.913±0.716 vs. 483±0.440 x 103,p=0.003) 
in PTE patients. ROC analysis showed 70.3% sensitivity and 70.1% 
specificity with D-dimer value of 2.43 ug/ml, (AUC=0.714,p=0.002); in 
contrast, DDFR had 70.3% sensitivity and 61.6% specificity with value 
of 0.417x103, (AUC=0.710,p=0.004), considered as the best cut-points. 
In backward stepwise regression analysis, DDRF (OR= 0.72,p=0.025), 
gender(OR=0.76,p=0.049) and WBC (OR=1.11,p=0.373) were modeled. 
(p= 0.029,R2=0.577). Conclusions: Cut-points for D-dimer<0.4 and 
DDFR>0.25 x 103 can be used as fairly reliable test to rule-out and 
rule-in PTE in these patients. Thus, with use of D-dimer and DDFR 
some patients may no longer need any other expensive diagnostic 
tests such as angiography to confirm or rule-out PTE; though is not 
accurate enough and more studies are recommended.
PS 150  The study of association between factor V leiden mutation 
and G6PD deficiency. 
Mozafari H, Heidarpour A, Rahimi Z.
Faculty of Medicine, University of Kermanshah.
Aim: Regarding to the moderate prevalence of Factor V Leiden mu-
tation and relatively high prevalence of G6PD deficiency in Western 
Iran, the aim of the present study was to assess the prevalence 
of these thrombophilic mutations among G6PD deficient individuals 
from this area. Introduction: G6PD (Glucose 6-phosphat dehydro-
genase) deficiency is the most common erythrocyte enzymopathy 
in humans, estimated to affect 400 million individuals worldwide. 
Factor V Leiden is a variant of human factor V that causes a hyper-
coagulability disorder. And it is clinically important genetic mutation 
associated with increased susceptibility to venous thrombosis.The 
factor V Leiden gene variant is caused by a single point mutation 
at nt1691, leading to the replacement of arginine at position 506 
in the activated protein C (APC) cleavage site of factor Va by glu-
tamine. Methods: In this cross-sectional study,G6PD deficient indi-
viduals consisted of 57 school boys randomly selected from 6 high 
schools located in 3 educational areas of Kermanshah ,a province 
International Journal of Medical Studentswww.ijms.info   •   2013  |  Vol 1  |  Suppl 1  s9
Abstracts
endoscopic signs of Crohn’s disease in 17 pts. (no abnormalities 
found-6, enteritis-9, celiac disease-1, NSAID-ulcers - 1). Conservative 
treatment has been applied in 10 (66,7%) pts., including 1 pt, who 
underwent polypectomy because of polyp enlargement. Surgical in-
tervention - in 5 (33,3%) pts. because of persisting clinical picture 
of bowel obstruction. There was a capsule retention in 2 (10,5%) 
pts. In 1 case the capsule was extracted using a polypectomy snare 
through the enteroscope perorally by laparoscopically assisted BE; 
in the second case the patient was operated on because of severe 
extended (15cm) stricture up to 6 mm. No side effects during diag-
nostic BE were observed. It was one complication - bleeding in 1 
patient on the 4-th day after polypectomy of Crohn’s induced polyp 
in ileum that was successfully stopped using argon plasma coagu-
lation. Conclusions: The use of the new enteroscopic techniques 
substantially improves the diagnosis of small bowel Crohn’s disease 
and allows to determine a proper treatment of this disease in time. 
This technology might unfortunately also bring complications, such 
as videocapsule retention and bleeding after polypectomy. BAE can 
be a useful method in VC retention cases to avoid operation and to 
provide
minimally invasive treatment.
PS 169  Can Type D personality contribute to cardiovascular risk in 
Major Depressive patients? 
Maksimovic A.
Faculty of Medicine, University of Belgrade.
Aim: The aim of our study was to investigate possible role of Type 
D personality as a risk factor for cardiovascular morbidity in MD pa-
tients compared to healthy subjects. Introduction: Type D personality 
is defined as the joint tendency towards negative affection and so-
cial inhibition. Large body of evidence consistently shows strong co-
rrelation between Type D personality and morbidity of cardiovascular 
diseases. On the other hand, Major depression (MD) is associated 
to various comorbid cardiovascular disorders, as well as Type D per-
sonality. Methods: Our investigation included 60 MD outpatients in 
remission and 55 mentally healthy controls. The Type D personality 
was measured by self-rating 14-item scale. Demographic and clinical 
data were obtained by interviewing the subjects and reviewing their 
medical records. Statistical analyses were performed using SPSS for 
Windows v. 13.0. Results: Nearly 2/3 of subjects were females in both 
study groups. MD patients and controls were age-matched (48.17 ± 
9.55 vs. 42.17 ± 7.25, respectively). The prevalence of Type D per-
sonality was high in both patients and controls (81.7% vs. 77.6%, 
respectively), without statistically significant difference among study 
groups (X2=0.28, p> 0.05). Cardiovascular morbidity was significantly 
more prevalent in MD patients compared to healthy controls (X2= 
30.73, p< 0.001). 56.7% of MD group had cardiovascular morbidity 
in contrast to 6.1% of controls. The predictive value of male gender, 
MD and the Type D personality for a cardiovascular risk was analy-
zed. The overall predictive model was statistically significant (X2 = 
25.348, p <0.001), and it explained 26.6 to 35.7% chance for a person 
to develop a cardiovascular condition. However, the only significant 
predictor of cardiovascular risk was the presence of Major depres-
sion (Exp B = 28.93, p<0.01). Conclusions: This was the first study 
exploring Type D personality in MD patients. Our results showed 
surprisingly high prevalence of Type D personality in both groups. 
Previous studies in general population indicate approximately 20% of 
Type D’s. In contrast to other findings, Type D was not related to risk 
for cardiovascular morbidity itself. Our study suggests that Type D 
personality contributes to cardiovascular morbidity in approximately 
1/3 male MD patients.
PS 180  Actions of immunomodulat ors of two pharmacological 
groups on eradication and factors of specific and non-speci-
fic immune resista nce in Helicobacter Pylori induced peptic 
ulcer disease. 
Kughan G, Kuzin VB, Dugina VV.
Faculty of General Medicine, Nizhny Novgorod State Medical Academy.
Aim: 1. To investigate the influence of immunomodulators Licopid®(a 
synthetic bacterial preparation) and Derinat®(a preparation of nu-
cleic acid) in combination with antihelicobacter “quadro-scheme” 
therapy(QST) on efficiency of eradication in patients with peptic ulcer 
disease(PUD)caused by HP. 2. To reveal interrelation of changes of in-
tensity of specific immunity(levels of Immunoglobulins and popula-
tion T-lymphocytes) and non-specific immunity(lysozyme activity in 
saliva and gastric juice) for the given group of patients. Introduction: 
Appearance of widespread antibiotic-resistant H. Pylori(HP) strains 
and suppression of immune system by exo- and endogenous factors 
causes more difficulty in HP eradication using standard schemes of 
treatment. This research is conducted to study efficiency of immu-
nomodulators combined with eradication therapy on efficiency of 
eradication of HP and improvement of immune system. Methods: 1. 
This research is carried out on 70 patients within the age range of 20-
55 years with PUD of stomach caused by HP. 2. Depending on types of 
received therapy, three groups of patients have been allocated:-(a) 
Group A(control group) consisting of 20 patients receiving “quadro-
scheme” therapy(QST) consisting of bismuth colloidal subcitrate, 
omeprazole, amoxicillin and furazolidon. (b) Group B of 25 patients 
receiving QST with Licopid® (c) Group C of 25 patients receiving QST 
with Derinat® 3. Before and six weeks after application of prepara-
tions, the histomorphological tests of biopsy material taken endos-
copically from stomach, blood immune test and nephelometric test 
of saliva and gastric juice from patients are done. Results: Six weeks 
after treatment, bacterial contamination test reveals that absence of 
HP is essentially higher in Group B(94.8%) and C(95.3%) compared 
to Group A(73.7%). Coccal/Resistive forms of HP are absent in Group 
B and C whereas present in Group A(10.5%). Blood immune test 
revealed that levels of CD-3, -4 and -8 T-lymphocytes and Immunog-
lobulin A, M and G are increased in Group B and C, more pronounced 
for Group C. In contrast, their levels are decreased in control Group 
A. The maximal authentic increase of lyzosymal activity in saliva is 
observed in Group C(on 12.3 % compared to initial level) whereas in 
Group B its activity reliably increases(8.1%). Activity of lysozyme in 
gastric juice increased 7.4 % for Derinat® and 3.6 % at application 
Licopid®. In Group A, the lowest activity of lysozyme in saliva and 
gastric juice is marked. Conclusions: Application of immunomodula-
tors on background of QST leads to increased eradication of HP and 
improved factors of specific and non-specific immune resistance, 
more pronounced at application Derinat®.
PS 183  STUDY OF I/D POLYMORPHISM OF ANGIOTENSINE CONVERTING 
ENZYME (ACE) IN CHRONIC HEPATITIS C: INFECTION, PROGRES-
SION AND RESPONSE TO THERAPY. 
Boleto G2, Correia R2, Marinho C2,3, Serejo F1, Bicho M2,3, Baldia 
C2, Ferreira J2.
1 Gastroenterology and Hepatology Department, Instituto de Medicina 
Molecular.
2 Laboratory of Genetics, Center of Metabolism and Endocrinology, Lisbon 
Medical School.
3 Instituto de Investigação Bento da Rocha Cabral, Lisbon, Portugal.
Aim: To evaluate the association between ACE polymorphism and 
chronic hepatitis C (CHC) severity and response to antiviral thera-
py. Introduction: Angiotensin-II (AT-II) seems to play an important 
role in liver fibrogenesis through hepatic stellate cell proliferation 
and TGF-β1 up-regulation via AT-II type 1 receptor in vitro. Inhibiting 
the action of AT-II,results in a decrease of blood markers of hepatic 
fibrosis, TGF-β1 levels and hepatic fibrosis in NASH. The regulation 
of ACE (Angiotensin Converting Enzyme) activity by ACE I/D polymor-
phism in intron 16 is well-established, being the D allele associated 
with a higher serum ACE activity. Methods: Population samples: 127 
CHC patients (38 females and 89 males - 50.2±12.3 and 43.4±10.3 
years) and 643 controls (171 females and 472 males - 45.6±12.1 and 
51.3±15.4 years). Exclusion criteria: alcohol intake ≥ 40 g / day and 
metabolic disease. Liver fibrosis has been evaluated by biopsy and/
or FibroScan (Peter Scheuer score) and steatosis (Brunt score) be-
fore and after treatment. Patients were divided in different groups 
according to fibrosis (0-1 vs 2-4); steatosis (0 vs 1-2 vs 3-4) and 
treatment response (sustained responder vs non-responders). ACE 
I/D polymorphism was evaluated by PCR. All statistical analysis were 
done using SPSS 16.0 and the significant level established for p<0.05. 
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Results: Genotype DD was significantly more prevalent among CHC 
patients compared to controls (72.4% vs 44.3%; OR=3.299, 95% CI 
[2.171-5.015]; p=0.000). After treatment the stage of liver fibrosis 
was associated with ACE I/D polymorphism with a higher frequency 
of ID and II carriers among patients with fibrosis 2 to 4 (48.5% vs 
20.7%; OR=3.608, 95% CI [1.167-11.151]; p=0,044). No differences were 
found between steatosis groups and responders vs non-responders. 
Conclusions: Genotype DD was significantly more prevalent among 
CHC patients but ACE I allele may be a risk factor for liver fibrosis 
progression.
PS 183  Antibiotic resistance of Escherichia coli strains isolated from 
healthy food animals and tab water samples in Greece. 
Syrri G, Petridou E, Delfaki A, Christogiorgou Chr, Tzimotoudis 
N, Bramis G, Giadinis N, Filioussis G.
Faculty of Veterinary Medicine, Aristotle University of Thessaloniki Gree-
ce.
Aim: The aim of our study was to investigate the antibiotic resistance 
of E. coli strains isolated from healthy food animals and from tab 
water samples in Greece. Introduction: In many European countries 
antibiotics are continuously added to animal feeds to promote 
growth and increase feed efficacy. Many retrospective studies pro-
ved that the introduction of an antibiotic in a farm increases not 
only the level of resistance of pathogenic, but also of commensal 
bacterial species. Studies on the transfer of commensal resistant 
bacteria from animals to human mainly concern Escherichia coli (E. 
coli). The latter is a symbiotic inhabitant of the intestine in all food 
animal species and it is also considered as the main indicator of 
fecal pollution in the microbiological surveillance of drinking water. 
Methods: Sixty five E. coli strains yielded from stools of healthy food 
animals were included in the study. The strains were categorized as 
follows: 19 from calves, 11 from birds, 19 from swine, and 16 from 
sheep. The sampling was performed directly from the rectum of the 
animals. Additionally 33 E. coli isolates cultured from tab water sam-
ples were also included in the study. Disc diffusion method was used 
to determine susceptibility to the following antibacterials: Penicillin 
(6μg), amoxicillin (25μg), tetracycline (30μg), spreptomycin (10μg), 
gentamycin (10μg), trimethoprime/ sulfamethoxazole (1,29/23,75μg), 
cefixime (5μg), ceptiofur (30μg), enrofloxacin (5μg), and chloramphe-
nicol (30μg). Individual colonies were suspended in normal saline 
to 0.5 McFarland and using sterile swabs the suspensions were 
inoculated on Muller Hinton agar for 24 hr. E. coli ATCC 25922 was 
used as control strain. Breakpoints were determined according to 
EUCAST guidelines. Results: The 65 isolates of animal origin exhibited 
high resistances to 8 antibacterials. In details all 65 isolates were 
resistant to penicillin 42 were resistant to tetracycline, 27 to chloram-
phenicol, 39 to trimethoprim/sulfamethoxazole, 48 to streptomycin, 
42 to amoxicillin, 23 to enrofloxacin and 22 to gentamycin. Twelve 
tetracycline resistant strains carried the tetracycline resistance gene 
tet(B). In contrast low resistances were observed to cephalosporin 
(7 to cefixime and 5 to ceptiofur respectively ). Isolates from swine 
stools exhibited the highest antibiotic resistances. Briefly all 19 iso-
lates were resistant to tetracycline, trimethoprim/sulfamethoxazole, 
streptomycin, and amoxicillin while 9 of 19 to enrofloxacin 15 of 
19 to chloramphenicol, and 9 of 19 to gentamycin. The antibiotic 
profiles of the 33 E coli strains isolated from tab water samples were 
completely different. Resistances were observed only in 6 isolates 
to tetracycline and in 4 isolates to streptomycin. Conclusions: Food 
animals and tab water could be the vectors for the transmission of 
different bacteria to humans. Therefore we strongly support that the 
exposed resistances should be considered for further investigation.
International Journal of Medical Studentswww.ijms.info   •   2013  |  Vol 1  |  Suppl 1  s11
Abstracts
NEUROSCIENCES Session
PS 5  Gamma knife treatment of growing Vestibular Schwannoma: 
Tumor control - A prospective study. 
 Varughese JK1, Wentzel-Larsen T2, Pedersen P-H3, Lund-
Johansen M4.
1 Institute of Surgical Sciences, University of Bergen, Norway.
2 Department of Neurosurgery, Haukeland University Hospital, Bergen, 
Norway.
3 Institute of Surgical Sciences, University of Bergen, Norway.
4 Department of Neurosurgery, Haukeland University Hospital, Bergen, 
Norway.
Aim: In this study we wish to detail the success rate of GKRS, by 
comparing growth rates before and after GKRS treatment, and finding 
the proportion of tumors that get a successful treatment (defined as 
a negative or zero post-treatment growth rate). Introduction: Vesti-
bular schwannoma (VS) is a benign tumor that arises in the eighth 
cranial nerve, giving symptoms of hearing loss, tinnitus, and vertigo. 
In general, it is a slow-growing tumor that in some cases even shows 
spontaneous regression. When and how to treat is debated, but in 
some centers, newly diagnosed small tumors are subject to con-
servative treatment, i.e. serial MRI scans without active treatment. 
In cases where the tumor has shown rapid growth in serial scans, 
or has become relatively large, treatment is usually offered. Two 
primary treatment methods prevail: microsurgery, where the tumor 
is physically removed; and gamma-knife radiosurgery (GKRS), where 
a gamma ray radiation dose is delivered to the tumor. This radiation 
dose, in theory, causes tumor growth arrest. Methods: Between 2000 
and 2006, 347 patients were diagnosed with VS. From these, 159 
(46%) received treatment by the end of 2007, while the remaining 
190 (54%) were treated conservatively. A total of 41 (22%) of these 
conservatively treated patients later received GKRS treatment due 
to growth of the tumor, as detected by the serial MRI scans. These 
41 patients were included in the study, and were followed for a 
minimum of two years after treatment. The tumor volume on both 
pre-treatment and posttreatment images were measured, and mixed 
effects models were used to analyze the growth rates before and 
after treatment. We also conducted a logistic regression analysis to 
determine whether the age of the patient or the growth rate before 
treatment are related to achieving successful treatment. Results: A 
mean pre-treatment growth rate corresponding to a volume doubling 
time (VDT) of 1.38 years was found, and a post-treatment VDT of 
-19.6 years. While the post-treatment growth rate is not significant, 
the difference in growth rate compared to the pre-treatment period 
is. A tumor control rate of 65% was found. Neither age nor growth 
rate was related to tumor control, with p-values >0.079. However, we 
do find that a tumor of volume 2.0 cm3 has 11.43 times the odds of 
tumor control as that of an otherwise identical tumor with a volume 
of 1.0 cm3. Conclusions: We found a lower tumor control rate for 
GKRS treatment of VS than previously reported. This finding is likely 
because other studies have included patients that had no growth 
potential, while our study includes only patients who have had 
previously documented growth. Larger tumors have a significantly 
greater odds of tumor control than smaller tumors. Details will be 
presented at the conference.
PS 20  Brain Derived Neurotrophic Factor (BDNF) impairs recovery of 
synaptic transmission after hypoxia, by a mechanism depen-
dent on glutamate NMDA receptors. 
Afonso F Oliveira1,2, Joaquim A Ribeiro1,2, Ana M Sebastião1,2.
1 Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Uni-
versidade de Lisboa, Lisboa, Portugal.
2 Unidade de Neurociências, Instituto de Medicina Molecular, Universida-
de de Lisboa, Lisboa, Portugal.
Aim: Access the role of NMDA receptors upon the noxious effects 
of the neurotrophin BDNF on synaptic transmission after hypoxia. 
Introduction: The pathology of stroke is dependent on the molecular 
events that determine neuron death or neuron survival. Brain De-
rived Neurothrophic Factor (BDNF), a member of the neurotrophin 
family, has been pointed out as an essential factor for the regulation 
of neuronal survival, differentiation, and cell death events. In addi-
tion to these long-lasting actions, BDNF has been shown to have 
presynaptic regulatory effects as well as postsynaptic regulatory 
actions. Relevant to our work is the ability of BDNF to selectively 
and rapidly enhance phosphorylation of NMDA receptors thus raising 
their opening probability and opening frequency. An ongoing project 
at our unit has shown that in hypoxic conditions BDNF impairs reco-
very of synaptic transmission on reoxygenation. This observation led 
us to investigate if the BDNF-induced impairment on the recovery of 
synaptic transmission after hypoxia is related to the activation of the 
NMDA component of the glutamatergic response, which is known to 
be involved in neuronal damage as a consequence of ischemic or 
hypoxic episodes. Methods: Field-excitatory post-synaptic potentials 
(fEP SP) were recorded from the CA1 area of hippocampal slices, 
taken from male Wistar rats (4-6 weeks old), in a recording chamber 
for submerged slices and continuously superfused with gassed ba-
thing solution at 32º. Drugs were added to the superfusion solution 
and hypoxia was induced by changing to an equivalent solution 
equilibrated with 95% N2 plus 5% CO 2. An hypoxic period of 90 min 
was used, followed by a reoxygenation period of 30 min. The neu-
roprotective effect of adenosine was prevented in all experimental 
conditions by adding DPCP X (50nM), an adenosine A1 receptor an-
tagonist. AP-V(50μM), a NM DA receptor antagonist was also present 
to prevent NM DA receptor activation. In test slices, BDNF (20ng/ml) 
was added to the bathing solution for at least 20 min before hypoxia, 
being present up to the end of the recording period. Recovery from 
hypoxia in slices in the absence (control) and presence (test) of 
BDNF was compared. The data are expressed as mean ± SEM and 
mean differences were evaluated by unpaired t-test. Values of p < 
0.05 were considered to represent statistically significant differences. 
Results: In control conditions, i.e. when only DPCPX and APV were 
present, the mean fEPSP slope measured at the end of reoxygenation 
was 98.01 ± 3.692% of baseline values, (N=8). When BDNF was added, 
mean fEP SP slope measured at the end of reoxygenation was 102.6 
± 5.792 % of baseline values (N=10). Statistical Analysis of mean fEP 
SP slope at the end of reoxygenation in BDNF and control conditions 
showed no statistically significant differences (P = 0,5336), sugges-
ting that the impairment of recovery from hypoxia caused by BDNF 
requires activation of NMDA receptors. Conclusions: NMDA receptor 
antagonism prevents the noxious effects of BDNF upon synaptic 
transmission after hypoxia, thus implying NMDA receptors in the 
underlying mechanism of BDNF action.
PS 29  Influence of sex steroids on the neurochemical organization 
of the lateral posterior parvicellular division of the hypotha-
lamic paraventricular nucleus
Coelho S, Silva S.M.
 Anatomy Department, Faculty of Medicine, University of Porto.
Aim: This study aims to examine if there are sex differencs in the 
neurochemical phenotype of one of the pre-autonomic divisions of 
the hypothalamic paraventricular nucleus (PVN) that might contribu-
te for the sexually dimorphic activity of the adrenal cortex. Introduc-
tion: It is well established that sex streoids influence the production 
of glucocorticoids by modulating the activity of the key elements 
of the hypothalamic-pituitary-adrenal axis (HP A axis). Females are 
known to produce more corticosterone than males, both in basal 
and in stress conditions, and this discrepancy is usually associated 
to sex-related features of the HPA axis. However, there is clinical and 
preclinical evidence of dissociation of adrenocorticotrophic hormone 
(ACTH) and glucocorticoid production, particularly during disease, 
which suggests that the activity of the adrenal cortex is regulated 
by factors, other than ACTH produced by the pituitary gland. The la-
teral posterior parvicellular division of the PVN (PVNlp) is one of the 
autonomic-related descending projections and its neurons express 
receptors for sex steroids. We will focus on this PVN division in or-
der to find out if its neurons display gender-related differences that 
might influence the apparent dimorphic physiology of the adrenal 
cortex. Methods: Six-month-old male and female Wistar rats were 
maintained throughout the experiment under standard laboratory 
conditions. Solid diet and water were available ad libitum until the 
day of sacrifice. Fifteen days before the end of the experiment, half 
of the males and of the females were submitted to gonadectomy 
under deep anesthesia. Thirteen days later, the four groups - intact 
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males (n=6), intact females (n=6), orchidectomized males (n=6) and 
ovariectomized females (n=6) - were stereotaxically injected in the 
lateral ventricle with colchicine. After perfusion, the hypothalami 
were processed for immunocytochemistry. The total number of neu-
rons immunoreactive for corticotrophin-releasing hormone (CRH), 
vasopressin (VP) and oxytocin (OXT) in the PVNlp was estimated 
using the optical fractionators method. Data were analyzed by using 
a 2-way analysis of variance with sex and gonadectomy as the inde-
pendent variables. Whenever significant effects were detected, the 
Tukey HSD post hoc test was performed. Results: There were no sex 
differences in the total number of VP and OXT neurons. However, 
and in contrast to OXT neurons, the number of VP neurons was 
significantly reduced in gonadectomized males and females. The 
total number of CRH neurons was sexually dimorphic, with males 
containing approximately twice the number in females. The number 
of CRH neurons was significantly reduced by gonadectomy in males, 
but not in females. Conclusions: These results clearly show that the 
neurochemistry of the PVNlp differs between male and female rats, 
and that these sex differences are dependent on the circulating le-
vels of sex steroid hormones. This indicates that the PVNlp might 
play a significant role in the establishment of the sexually dimorphic 
pattern that might characterize corticosterone production.
PS 77  Influence of sex steroid hormones in the aging process of 
the female hippocampal CA1 region
M. E. Couto, S. I. Sá, M. J. Marques, N. Lukoyanov, M. D. 
Madeira
Department of Anatomy, Faculty of Medicine, University of Porto.
Aim: This study aims to examine if the loss of regular estrous cycli-
city plays a role in the establishment of the structural changes in 
the hippocampal CA1 region during aging. Introduction: Cognitive 
functions progressively decline in aging and hormone replacement 
therapy seems to improve memory and to reduce the risk of demen-
tia in postmenopausal women. In rodents, beginning in middle age 
(9-12 months), estrous cycles begin to become irregular, and this 
transitional process is comparable with the menopausal transition 
in women. However, an important distinction is that the the loss of 
reproductive cycles in middle-aged rats does not occur with conco-
mitant decline in estradiol concentrations but, instead, they become 
acyclic and have chronically high estradiol concentrations. Therefore, 
we tested the hypothesis that long-term repeated administration of 
estradiol and progesterone might prevent the decline of cognitive 
functions and the associated changes in the morphology of hippo-
campal neurons. For this purpose, we focused on the CA1 hippocam-
pal region because its neurons are recognized targets for estrogens. 
Methods: Wistar female rats were allocated to the following groups: 
i) Adult group: control rats killed at 6 months; ii) Intact old group 
(“old”): after sham-ovariectomy at 12 months of age, rats received 
no further treatment; iii) Ovariectomized group (”OVX”): after ova-
riectomy at 12 months of age, rats received no further treatment; iv) 
Hormone replacement group (“HR”): after ovariectomy at 12 months, 
rats received a weekly s.c. injection of 10 μg 17beta-estradiol in 
100 μl sesame oil followed, 48 h later, by 500 μg progesterone in 
100 μl sesame oil. At the end of the experiments (6 or 24 months), 
spatial learning and spatial memory were evaluated using the Morris 
water maze. Then, rats were anesthetized and perfused. After being 
isolated, the hipoccampal formations were Golgi impregnated. The 
dendritic trees of CA1 pyramidal cells were drawn and the dendritic 
branching density, number of dendrites per cell, total dendritic leng-
th and mean length of the terminal segments estimated. Results: 
All old female rats showed impaired spatial learning and memory. 
In old rats there was a trend towards an elongation of the dendritic 
trees compared to adult, OVX and HR rats. In addition, the number of 
dendritic branches in the proximal part of the apical trees and in the 
distal part of the basal arborizations was higher in old females than 
in the remaining groups. Conclusions: These results demonstrate 
that the presence of persistently high circulating levels of estrogens 
in old females is a determining factor for the development of age-
related changes in hippocampal CA1 pyramidal cells.
PS 79  Investigation into the T-lymphocyte response following Abe-
ta42 immunisation in human Alzheimer’s disease
Matthew Cheaveau1, Elina Zotova1, James Nicoll1,2, Delphine 
Boche1
1 Division of Clinical Neurosciences, University of Southampton, UK.
2 Department of Cellular Pathology, Southampton University Hospitals 
NHS Trust, UK.
Aim: To investigate whether the (i) meningoencephalitis and (ii) 
pathological modifications following immunisation are CD4+ T-lym-
phocyte mediated. Introduction: Alzheimer’s disease (AD) is a neu-
rodegenerative disease associated with cognitive impairment and is 
characterised pathologically by amyloid-beta (Abeta) and tau protein 
deposits within the brain. The amyloid hypothesis places abnormal 
aggregation of Abeta at an early point in the pathogenesis of the 
disease, upstream of tau aggregation. Given the escalating social and 
economic burden of AD, an immunisation strategy has been develo-
ped to stimulate the clearance of Abeta deposits, with the ultimate 
aim being to improve cognitive function. Despite promising animal 
studies demonstrating Abeta removal and cognitive improvement, a 
human clinical trial was terminated because of a meningoencepha-
litis side-effect that was suspected to be T-lymphocyte mediated. 
Preliminary data indicates that CD8+ T-lymphocytes do not mediate 
the meningoencephalitis or the pathological modification following 
Abeta1-42 immunisation; however the role of CD4+ T-lymphocytes is 
unknown. Methods: CD3 (marker of CD4+ and CD8+ T-lymphocytes) 
immunohistochemistry was performed on formalinfixed paraffin-
embedded sections from 28 control unimmunised (cAD) and 16 
immunised AD (iAD) cases (AN1792, Elan Pharmaceuticals) in the 
medial frontal gyrus, superior middle temporal gyrus and inferior 
parietal lobule. T-lymphocytes were manually quantified with the 
location of T-lymphocytes being noted in areas of white matter, grey 
matter (including perivascular or parenchymal) and the meninges. 
Statistical analysis was performed using SPSS, and data compared 
to CD8+ T-lymphocytes and other pathological features previously 
obtained. Results: Analysis reveals no significant difference in the 
number of CD3+ T-lymphocytes between cAD and iAD cases. The CD3+ 
T-lymphocyte count in our meningoencephalitis case exceeds the 
respective upper quartiles for all anatomical areas in both cAD and 
iAD cases. In cAD cases, grey matter CD3+ T-lymphocyte number is 
significantly correlated with phosphorylated tau load (P=0.01). This 
correlation disappears after immunisation. Instead, grey matter CD3+ 
T-lymphocyte number was significantly correlated with a microglial 
marker of inflammation (P=0.007). Conclusions: TIn relation to the 
previous CD8 data, we can conclude that (i) CD4+ T-lymphocytes are 
involved in the meningoencephalitis side-effect and, (ii) T-lympho-
cytes are not implicated in the pathological modification following 
immunisation. The precise role of T-lymphocytes will determine if fu-
ture therapies circumvent or exploit this adaptive immune response.
PS 101  Impact of neonatal administration of a neurotrophic-factor 
enriched diet on rat development
Caetano AP
Faculty of Medicine, University of Lisbon.
Aim: To evaluate the effect of several diets enriched with neuro-
trophic factors on prosaposin, BDNF and TrkB receptor levels in the 
hypothalamus of mice. Introduction: Neurotrophins (NTs) such as 
Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), 
NT-3 and NT-4 have an important role in pre- and post-natal brain 
development. Neurotrophin receptors include two different types 
- the p75 and the Tropomyosin-Kinase (TrkA, TrkB and TrkC)(Hefti, 
1997-Annu Rev Pharmacol Toxicol 37:239). BDNF in particular, through 
activation of TrkB receptors has been shown to have a key role in 
the central nervous system (CN S) development, neuronal homeos-
tasis and cerebral processes related to synaptic plasticity, such as 
long-term potentiation (Tyler et al., 2002-Learn Mem 9:224; Yamada 
et al., 2002-Life Sci 70:735). In fact, changes in BDNF expression du-
ring development are associated with impaired brain development 
(Nishigori et al., 2008-Reprod Sci 15:895). Prosaposin, is another mo-
lecule with neurotrophic properties, essential for human neuronal 
cell survival, differentiation and maintenance, particularly in early 
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phases of brain development (Sikora et al., 2006-Acta Neuropathol 
113:163). It has been described that the level of maturation of CN S 
in newborn rats in the first weeks of life is similar to a premature 
newborn human between 20-40 weeks post conception (Clancy et 
al., 2007-Neurotoxicology 28:931). Given that, neurotrophic factors 
and its receptors expression are crucial to the development of CNS. 
Since most of premature newborn human are fed with supplemented 
milk, we proposed to investigate the consequences of oral supple-
mentation with different milk fractions, chosen by their neurotrophic 
properties, in the neonatal period on the hypothalamic levels of 
prosaposin, BDNF and its receptors. Methods: Sprague Dawley male 
rats were fed with different diets (water, 1, 2, 3) through a pipette 
from postnatal day (PN D) 2 through PN D10, 13, 15, 18, 21, 28, or 36. 
The rats were killed and the hypothalamus isolated, disrupted with 
a Teflon pestle in 0.32M sucrose-Tris pH 7.5 and supplemented with 
protease inhibitors. SDS-PAGE (12%), was used to separate proteins, 
which were transferred to nitrocellulose membranes. After blocking 
with 5% milk solution, blots were incubated overnight at 4ºC with 
primary antibodies for the proteins of interest. The membranes were 
incubated with secondary antibodies conjugated with horseradish 
peroxidase for 1h at room temperature. The proteins were detected 
using Super Signal substrate. Results: In hypothalamus taken from 
animals fed with water, there was a 2.2 fold increase in TrkB-FL levels 
from PN D13 to PN D28 and from PN D15 to PN D28 (n=4, p<0.01). 
Hypothalamus from PN D13 rats fed with diet 1 show a significant 
increase in BDNF levels (1.6 fold, n=6, p<0.05) and a slight increase in 
TrkB-FL receptor and prosaposine levels. Conclusions: We show that 
there are age-related changes in TrkB-FL receptor levels in the studied 
PNDs. We also demonstrated that an oral diet is able to significantly 
increase BDNF levels and slightly increase TrkBFL receptor and pro-
saposine levels. Since it is classically established that neurotrophins 
do not cross the blood-brain barrier, the present work demonstrates 
that peripherally administered substances can modulate the levels 
of neurotrophins in CNS. This evidence opens new perspectives on 
possible strategies to increase neurotrophins in the CNS.
PS 116  Effects of caffeine on startle reflex and prepulse inhibition 
(PPI) in the rats grouped by baseline PPI levels
Efendioglu E1, Oral S2,Uslu G2,Goktalay G2
1 Faculty of Medicine, Uludag University. Bursa,Turkey.
2 Department of Medical Pharmacology, Faculty of Medicine. Bursa,Turkey.
Aim: The purpose of this study is to investigate the role of caffeine, 
a widely used dopamine agonist and adenosine antagonist, on sen-
sorimotor gating mechanism through a cross-species measurement 
termed prepulse inhibiton (PPI) in Sprague-Dawley rats. Introduction: 
The answer of an organism to a reflex-eliciting startle stimulus (pul-
se) is inhibited when it is preceded by a weaker stimulus (prepulse). 
This is termed prepulse inhibiton (PPI) and is a measurement of sen-
sorimotor gating in central nervous system. This measurement has 
been found to be impaired in several neurological and psychiatric 
disorders, including schizophrenia, bipolar disorder, obsessive com-
pulsive disorder and nocturnal enuresis. Direct or indirect agonists 
of dopaminergic system are widely used to generate decreases in 
PPI which can be reversed with antipsychotics. Since PPI level is also 
related to cognitive functionality of brain, not only antipsychotics but 
also widely used chemicals are analyzed as we intake them excessi-
vely on regular basis of our life. Caffeine is, surely, one of the most 
taken chemical which exists in coffee, tea, soda, chocolate etc. Even 
though we consume caffeine with lots of beverage and food today, 
prior studies which examine the relation of caffeine intake and PPI 
level were not so common and systematic in literature. Methods: All 
procedures used in this study were approved by the Local Ethical 
Committee. Twenty-four male adult (3-4 months) Sprague-Dawley 
rats were used in this study. Animals were handled and habituated 
to laboratory before starting the experiments. After that their ba-
seline levels were measured. Rats have been grouped into as low, 
moderate and high groups according to their baseline PPI values 
at 78 dB prepulse stimuli. Following that caffeine (10 mg/kg) was 
administered subcutaneously to high and low groups. Right after the 
injection animals were placed to the Acoustic Startle Reflex System 
(SR-Lab, CA, USA). Startle magnitudes, PPI values and habituation 
responses were recorded during the study. Results: The caffeine ad-
ministration did not make any significant effect on startle magnitude 
in both low and high group (p> 0.05). Caffeine had no effect on 
PPI in low group, however in the high group caffeine decreased PPI 
levels at 74 and 78 dB’s of the two prepulse stimuli values (p<0.05). 
When the inter stimulus interval (ISI) between pre-pulse and pulse 
stimuli was decreased to 50 or increased to 500 ms, caffeine made 
no change in the low inhibition group, but it increased the PPI of the 
high inhibition group. When habituation responses were compared, 
caffeine did not make any significant effect on both low and high in-
hibitory groups. Conclusions: This study shows that the rats grouped 
by baseline PPI values give different responses to caffeine.
PS 117  Investigating the Role of Microglia in Gliomas Using an in 
vitro Model
Billingham C, Powell M, Gatherer M, Nicoll J, Boche D.
Division of Clinical Neurosciences, School of Medicine, University of 
Southampton, United Kingdom
Aim: The aim of this study is to characterise an organotypic model of 
glioma using rat hippocampal slices, and to investigate the immune 
profile of this model. Introduction: Malignant gliomas are a heteroge-
nous group of primary brain tumours, associated with a particularly 
poor prognosis. The role played by microglia in this condition is 
not fully understood, and has been the focus of recent research. 
Organotypic modelling has proven to be a useful in vitro tool to 
represent complex in vivo environments. Methods: Rat hippocampal 
slices were prepared and after 7 days, rat C6 tumour cells added to 
one group of theslice cultures. The trauma of the addition of cells 
was replicated in the sham group by the addition of cell free media, 
and a third group consisted of the control slices, to which nothing 
was added. At different time-points (D1, D3, D5 and D7), the cultures 
were stopped and immunohistochemistry undertaken on fixed slices 
using Iba1 (marker of microglia), CD68 (marker of microglial phago-
cytosis), and Ki67 (marker of proliferation). At the same time-points, 
RNA extraction, reverse transcription and gene amplification was per-
formed to detect cytokines (IL1β, IL6, IL10, TNFα and TGFβ). Results: 
We reproduced an in vitro model of brain tumour, and have shown 
an increase in Iba1+ microglia associated with glioma cells (p=0.001). 
In addition the phagocytic activity of microglia, as determined by 
the ratio CD68:Iba1 (%), was significantly increased in the glioma 
model over the time of the experiment and compared with control 
groups (p<0.001). An increase in cell proliferation in the glioma group 
was observed at all time-points using the marker Ki67 (p<0.001). We 
also observed that the levels of mRNA of pro-inflammatory cytokines 
IL1β, IL6 and TNFalfa were reduced in the tumour group relative to 
control groups (p=<0 .001). The levels of mRNA of TGFβ were found 
to be significantly higher than control on days 3 and 7 (p=0.001 and 
p=0.038 respectively). Conclusions: In our organotypic model of brain 
tumour, we have observed that glioma cell proliferation is associated 
with proliferation of microglia, an increase in microglia phagocytic 
activity, and a cytokine profile which overall is anti-inflammatory. 
Thus our model supports the role of microglia promoting tumour 
growth, and is suitable for further investigation and manipulation of 
the role of microglia in glioma.
PS 137  The effects of Abeta42 immunisation on microglia and neuro-
inflammation in human Alzheimer’s disease
Bharambe V, Boche D, Zotova E, Nicoll JAR.
Division of Clincial Neurosciences, School of Medicine, University of 
Southampton, UK.
Aim: To investigate the effects of Abeta42 immunisation on microglial 
activation and the consequences this has for neuroinflammation in 
the immunised AD brain. This will be done using Iba-1; a protein that 
has proven itself in animal and human studies to be a reliable and 
specific marker of microglia. Introduction: Alzheimer’s disease (AD) 
is the leading cause of dementia worldwide and affects 35 million 
people. For over a century its pathogenesis and the factors involved 
in its inexorable progression have remained enigmatic. Although 
senile plaques and tau pathology are regarded as disease hallmarks, 
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clearance of some of these features following immunisation does 
not alter cognitive decline or mortality. Therefore other pathological 
features have come to the forefront. Microglial activation evoked by 
amyloid-beta (Abeta) has been implicated as the trigger for neuroin-
flammation. Evidence suggests that this inflammation is detrimental 
and contributes to the neurodegenerative process. Interestingly, stu-
dies following immunisation with Abeta42 have proposed a beneficial 
role for microglia in the clearance of the very plaques that activated 
them. Methods: Immunostaining against Iba-1 was performed in 11 
immunised AD cases (iAD - AN1792, Elan Pharmaceuticals) and 28 
unimmunised AD (cAD) cases. This was quantified by two methods 
(manual and computer analysis) and correlated with previous patho-
logical data from the laboratory. Results: 1. Iba -1 protein load (%) 
is significantl y lower in iAD vs . cAD cas es (p=0.002). 2. There is no 
significant difference in the number of Iba-1 positive cells between 
iAD and cAD groups (p=0.435). 
PS 163  Effect of hemopressin peptide fragments on G-protein activa-
tion in rat membrane homogenate
Szlávicz E1, Tömböly C2, Bojnik E2, Benyhe S2, Borsodi A2
1 Faculty of Medicine, Szeged.
2 Biological Research Centre, Hungarian Academy of Sciences, Szeged.
Aim: Here we describe the detailed in vitro biochemical characteri-
zation of hemopressins towards opioid and cannabinoid receptors 
using receptor binding and G-protein activation assays performed in 
rat brain membrane. Introduction: The endogenous ligands of can-
nabinoid (CB) receptors are of lipid origin. A possible nonapeptide 
ligand for CB1 cannabinoid receptors was suggested from rodent 
brain or adipose tissue named as hemopressin with PVNFKFLSH se-
quence (Dale et al., 2005.). Hemopressin was shown to be selective 
ligand to CB1 cannabinoid receptors. This peptide derived from the 
alfa-chain of hemoglobin, also has a hipotensive effect, and inhibits 
peripheral hyperalgesic responses. Methods: Hemopressin nonapep-
tide and its C-terminally truncated heptapeptide fragment (PVNFKFL) 
were synthesized by solid phase peptide synthesis. Results: Using of 
opioid radioprobes revealed no binding affinity towards this system, 
while GTPïS assay, which mesures the agonist mediated G-protein 
activation, has demonstrated that hemopressins could activate 
the G-proteins. The stimulatory effect was inhibited by the specific 
cannabinoid receptor antagonist AM251, but not by the opioid re-
ceptor antagonist Naloxone. Conclusions: Our results indicate that 
hemopressins selectively interact with G-proteins coupled to the CB1 
cannabinoid receptors.
PS 171  Synergistic roles of the proteasome and mitochondria in 
alpha-synuclein oligomerization: implications in Parkinson’s 
disease
D. Martins Branco1,2, A. Raquel Esteves1, Daniela M. Arduino1, 
Catarina R. Oliveira1,2, Cristina Januário2 , Sandra M. Cardoso1,2
1 Center for Neurosciences and Cell biology, University of Coimbra.
2 Faculty of Medicine, University of Coimbra.
Aim: The main goal of this work is to study the involvement of mi-
tochondrial deregulation in the Ubiquitin-Proteasome System (UP 
S) impairment in different Parkinson´s Disease (PD) models.  We 
will also evaluate the interplay between UPS and mitochondria in 
ubiquitin dependent alpha-synuclein clearance. Introduction: PD is 
the most common progressive neurodegenerative movement disor-
der, characterized by the selective loss of nigrostriatal dopaminergic 
neurons and the presence of intracellular insoluble proteinaceous 
inclusions, known as Lewy Bodies (LBs). Although PD etiopathogene-
sis remains elusive, the leading hypothesis for the death of specific 
groups of neurons establishes that mitochondrial dysfunction, UPS 
impairment, and protein ologomerization are major events that act 
synergistically causing this devastating disease. Methods: To charac-
terize this process we used three different PD cell models: SH-SY5Y 
ndufa2 knockdown (KD) cells, PD cybrids and peripheral blood cells 
(PBC) of patients with diagnostic of PD. Each one was compared with 
the correspondent cellular control: SH-SY5Y cells, control cybrids and 
PBC of individuals who does not suffer of PD. For each model we 
proceed to study the mitochondrial electron transport chain (ETC) 
complex I activity, determined with NADH-ubiquinone oxidoreductase 
activity assay; measure 20S and 26S proteasome chymotrysin-like 
activity, using fluorimetric proteasomal activity analysis; and quan-
tify ubiquitination and alpha-synuclein aggregation by Western Blot 
(WB). The first two cell models were incubated with lactacystin to 
work as a negative control of proteasomal function. Incubation with 
NDUFA antibody was used to quantify, by WB, NDUFA protein KD in 
SH-SY5Y ndufa2 KD cells. MTT reduction test was used to measure 
the cell viability. Results: Our data show that: mitochondrial ETC 
complex I activity was reduced in the three PD models used, as 
in SH-SY5Y cells treated with lactacystin; there was no significant 
reduction of 26S proteasome chymotrysin-like activity in the three 
PD models, but there was a surprising increase of 20S activity, 
transversal to the three models; SH-SY5Y ndufa2 KD cells and PD 
patient’s lymphocytes shown a leaning to increased ubiquitination 
and alpha-synuclein oligomerization. Lactacystin concentration used 
does not affect cell viability. Conclusions: Our results suggest that 
mitochondrial dysfunction, transversal to these three chronic PD 
models, upregulate UPS function in an AT P independent manner. 
Mitochondrial dysfunction, through reduction of AT P synthesis and 
increase of ROS production, may increase protein missfolding and 
affect the ATP dependent degradation process of UPS, that is also 
the most susceptible to oxidative stress, resulting in ubiquitinated 
species accumulation. As a possible cell response, 20S proteasome 
chymotrysin-like activity seems to be up-regulated which could 
mean a mechanism of protein aggregation rescue, even if it does not 
stop alpha-synuclein oligomerization as shown in this work results. 
In the other way, inhibition of UPS in SH-SY5Y cells proved to impair 
mitochondrial function. These results suggest that the cross-talk 
between mitochondria and proteasome is likely to be a two ways 
dead-road inside the cell. This line of investigation together with the 
study of other protein quality control systems, as autophagy, may 
open a new window to PD therapeutics.
PS 185  Effect of the amyloid-beta peptide in GABA release from hi-
ppocampal synaptosomes: modulation by BDNF
Sara Parreira*, Sofia R. Lérias*, Sandra Vaz, Maria José Dió-
genes, Joaquim Alexandre Ribeiro, Ana Maria Sebastião *co-
first author
Institute of Pharmacology and Neurosciences, Faculty of Medicine, Uni-
versity of Lisbon; Neurosciences Unit, Instituto de Medicina Molecular, 
University of Lisbon.
Aim: To determine the effect of amyloid-beta (Abeta) peptides in 
gamma-aminobutyric acid (GABA) release from rat hippocampal sy-
naptosomes and how it is modulated by brain-derived neurotrophic 
factor (BDNF). Introduction: Alzheimer’s disease (AD) is the main 
cause of dementia in the elderly, and the hippocampus is one of the 
most vulnerable brain regions (1). While the cause of AD is uncertain, 
several lines of evidence suggest Abeta peptides as having a causal 
role in its pathogenesis (2). Recent findings support a key role for 
GABAergic dysfunction in AD (1); however, the effect of Abeta upon 
GABA release in the hippocampus still remains unclear. BDNF is an 
endogenous glycoprotein from the neurotrophin family which affects 
neuronal growth, survival and differentiation (3). It also plays a role 
in synaptic plasticity and neuronal protection (4). BDNF inhibits GABA 
release from isolated hippocampal nerve terminals (synaptosomes) 
(3), but its influence on Abeta-induced dysfunction has not yet been 
elucidated. Methods: Rat hippocampus slices were incubated for 
60min with or without Abeta (25μM) and the synaptosomal fraction 
was obtained and incubated with [3H] GABA. Synaptosomes were 
layered over GF/C filters and superfused with artificial cerebrospinal 
fluid. At the 5th (S1) and 29th (S2) minutes, synaptosomes were sti-
mulated with K+ (15mM). When testing for the effect of BDNF (20ng/
ml), it was applied before the 2nd stimulation period. The eluent 
was collected in 2min fractions for liquid scintillation counting, as 
were the filters at the end of each experiment. BDNF effects were 
calculated as changes in S2/S1 ratios as compared with controls (no 
BDNF added) in the same synaptosomal batch. Abeta effect was cal-
culated as changes in S1 area as compared with controls (no Abeta 
International Journal of Medical Studentswww.ijms.info   •   2013  |  Vol 1  |  Suppl 1  s15
Abstracts
incubation). Experiments were only considered for further analysis 
if the S2/S1 ratio in the absence of BDNF was between 0.8 and 1.2. 
Data is presented as mean±SEM for n experiments. The significance 
of the differences was calculated with the Students’ T-test.. Results: 
The amount of GABA released during S1 from synaptosomes prepared 
from slices incubated with Abeta (1.69±0.19, n=18) was not signi-
ficantly different (p>0.05) from that obtained in control conditions 
(1.54±0.13, n=14). BDNF decreased GABA release by 26.8±8.1% (n=5) 
in control conditions and by 21.1±2.6% in synaptosomes prepared 
from slices incubated with Abeta. Both BDNF-induced decreases were 
significantly different (p<0.05), but there was no significant differen-
ce between the decrease in control conditions and the decrease in 
synaptosomes prepared from slices incubated with Abeta (p>0.05). 
Conclusions: As reported in the past (Canas et al, 2004 [3]) and now 
seen by us, BDNF significantly decreases GABA release from synap-
tosomes prepared from hippocampal slices. Abeta treatment did not 
affect GABA release as well as it did not influence the inhibitory 
effect of BDNF.
PS 192 Effects of the antioxidant treatment with EGCG in the nora-
drenergic neurons of the A5 and A7 during Diabetes 
João Silva1,2, André Miranda1,2, Patrícia Pereira-Terra2,3, Diogo 
Raposo2, 
Carla Morgado2,3, Isaura Tavares2,3
1 Escola de Ciências da Saúde, University of Minho.
2 Institute of Histology and Embryology, Faculty of Medicine of University 
of Porto.
3 IBMC, University of Porto.
Aim: Evaluate the effects of antioxidant treatment with Epigalloca-
thechin Gallate (EGCG), a potent antioxidant present in green tea, 
in the noradrenergic neurons of the A5 and A7 pontine cell groups 
in STZ-diabetic rats and in behavioral pain responses. Introduction: 
Diabetic neuropathy is a common complication of diabetes, which 
is accompanied by changes at the central and peripheral nervous 
system and altered pain sensations, namely chronic pain. Streptozo-
tocin (STZ)-diabetic rats were shown to present neuronal hyperacti-
vity at the spinal dorsal horn along with decrease in the numbers of 
noradrenergic neurons of the A5 and A7 pontine cell groups. Noradre-
nergic neurons from A5 and A7 project to the spinal dorsal horn and 
modulate nociceptive transmission by releasing noradrenaline and, 
accordingly, diabetic rats present lower levels of noradrenaline and 
higher behavioral responses to pain. The mechanisms underlying 
the decrease in the numbers of noradrenergic neurons in the brains-
tem during diabetes remain unclear. Since preliminary data shows 
that diabetes induces oxidative stress damage in neurons of those 
areas, we designed a study to evaluate the effects of antioxidant 
treatment with Epigallocathechin Gallate (EGCG), a potent antioxi-
dant present in green tea, in the noradrenergic neurons of the A5 
and A7 pontine cell groups in STZ-diabetic rats and in behavioral 
pain responses. Methods: Diabetes was induced by intraperitoneal 
injection of Streptozotocin (STZ) in male Wistar rats. A group of STZ 
rats was submitted to a ten week treatment with EGCG, administered 
in aqueous solution (2g/l; STZ+EGCG) since the third day after the 
induction of Diabetes. The other experimental groups were kept with 
normal ingestion of water during the same period (STZ+water and 
CTR). The behavioral responses to pain were evaluated before and in 
the end of the treatment, using the paw pressure test and the Von 
Frey test to determine mechanical hiperalgesia and tactile allodynia, 
respectively. In the end of this treatment, the animals were sacrifi-
ced by vascular perfusion. Noradrenergic neurons were identified by 
immunoreactions against Tyrosine Hydroxylase(TH), involved in the 
synthesis of noradrenaline, in transversal sections of the brainstem. 
The immunoreactive neurons were quantified separately in A5 and 
A7 of each experimental group. Data was compared with ANO VA 
followed by Tukey’s post hoc test for multiple comparisons. Results: 
Rats treated with EGCG had hiperglicemia during all the experimen-
tal period and the treatment with EGCG didn’t affect the values of 
glicemia. Mechanical hiperalgesia and tactile allodynia was observed 
in the non treated STZ rats. STZ rats treated with EGCG shown less 
severe mechanical hiperalgesia and normal tactile sensitivity. Occu-
rred severe loss of noradrenergic neurons in the A5 and A7 of the 
non-treated STZ rats, in contrast with the STZ rats treated with EGCG 
where this lost was prevented. Conclusions: This study demonstrates 
that the antioxidant treatment with EGCG prevents loss of noradre-
nergic neurons in the A5 and A7 during diabetes, therefore contri-
buting to an improvement of the behavioural responses to pain. 
The increase of antioxidant ingestion or its supplementation can be 
presented as preventive measures to neurodegenerative processes 
that affect noradrenergic neurons of the brainstem involved in pain 
modulation and, consequently, to changes in the painful sensitivity 
during diabetes.
 
PS 196 Antioxidant treatment of diabetic animals with EGCG pre-
vents painful diabetic neuropathy and loss of serotoninergic 
brainstem neurons involved in descending modulation
André Miranda1,2, João Silva1,2, Patrícia Pereira-Terra2,3, Diogo 
Raposo2, Carla Morgado2,3, Isaura Tavares2,3
1 School of Health Sciences, University of Minho.
2 Department of Experimental Biology, Faculty of Medicine of Porto, Uni-
versity of Porto.
3 IBMC, University of Porto.
Aim: This study aimed to evaluate the effects of the antioxidant 
treatment with Epigallocatechin gallate (EGCG) on behavioral pain 
responses and on serotoninergic neuronal population of the RVM in 
streptozotocin (STZ)-diabetic rats. Introduction: Diabetes is accom-
panied by several complications which may include painful diabetic 
neuropathy. It is responsible for spontaneous pain, mechanical 
hyperalgesia and tactile allodynia and affects more than 25% of dia-
betic patients with neuropathy. Previous findings showed that during 
diabetes the numbers of serotoninergic neurons in the rostroven-
tromedial medulla (RVM) decrease probably due to oxidative stress 
and neuronal death. Since serotoninergic RVM neurons are involved 
in descending nociceptive modulation, it is likely that this accounts 
for painful diabetic neuropathy. Methods: Diabetes was induced in 
male Wistar rats (250-300g) by an intraperitoneal injection of STZ. 
Control rats (CTR) received only the vehicle solution. Three days later, 
a group of STZ rats started a treatment with an aqueous solution 
of EGCG (2g/l; STZ+EGCG) during 10 weeks while the remaining ex-
perimental groups were given water (STZ+water and CTR). Before 
onset of treatment and at its completion, behavioral evaluation was 
performed using the paw pressure test and the dynamic plantar aes-
thesiometer for determination of mechanical hyperalgesia and tactile 
allodynia, respectively. RVM serotoninergic neurons were identified 
by immunohistochemistry against tryptophan hydroxylase (TpH), the 
rate-limiting enzyme in serotonin synthesis. The number of immu-
norreactive neurons for TpH (TpH-IR) was counted in RVM, which en-
compasses the raphe magnus nucleus and the gigantocellular pars 
alpha area. Means were compared by One-Way Analysis of Variance 
(ANO VA) followed by Tukey post hoc test for multiple comparisons. 
Results: STZ rats showed hyperglycaemia three days after injection 
and EGCG treatment had no effects on the hyperglycaemic condition. 
Treatment with EGCG prevented tactile allodynia and mechanical hy-
peralgesia detected in untreated STZ rats, along with the decrease in 
the number of TpH-IR neurons at the RVM. Conclusions: The results 
of the present study show that EGCG treatment prevents serotoni-
nergic neuronal loss in the RVM in diabetes, which may explain the 
benefits of this treatment in behavioural response to pain. This study 
suggests that antioxidants may prevent the pathophysiological chan-
ges of serotoninergic descending pain modulation pathways during 
diabetes, giving rise to new perspectives on the development of the-
rapeutic strategies for the treatment of painful diabetic neuropathy.
PS 203 Apoptosis upregulation in multiorgan lesions in tuberous 
sclerosis
Jaroslaw Jozwiak, Pawel Wlodarski, Wieslawa Grajkowska, 
Ryszard Galus
Medical University of Warsaw
Aim: The aim of this study was to confirm whether apoptosis upregu-
lation is characteristic to all types of TS-associated lesions. Introduc-
tion: Tuberous sclerosis (TS) is a disorder manifesting with formation 
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of benign tumors or hamartomas in numerous organ systems: e.g. 
heart, brain, skin, lungs etc. The disease is known to be caused by 
the mutation in one of two tumor-suppressor genes: TSC1 or TSC2, 
encoding hamartin or tuberin, respectively. In our recent studies 
we found that apoptosis may be upregulated in tumors forming in 
the progression of TS. Methods: We used samples characteristic for 
tumors or lesions occurring in TS: cardiac rhabdomyomas, subepen-
dymal giant cell astrocytomas (SEGA), subependymal nodules, renal 
angyomyolipoma and ungula fibromas. As positive control served 
samples of healthy tissue from respective organs. We evaluated 
the protein lysates by Western Blotting, using antibodies raised 
against apoptosis-related proteins, i.e. Bax and Bcl-2. Results: We 
demonstrated strong Bax expression in all evaluated samples, but 
not in healthy tissue controls. At the same time, Bcl-2 levels were 
not significantly altered. Equal protein loading was confirmed with 
tubulin staining. Conclusions: Proapoptotic events are sometimes 
found in specific types of tumors. Interestingly, however, all five 
types of lesions characteristic for TS show intensified apoptosis. This 
is unusual, since some of these lesions, e.g. ungual fibromas, are 
rather treated as benign tissue architecture disorders and do not 
form tumors. Also, some of these lesions, i.e. cardiac rhabdomyo-
mas, subside spontaneously, while others, like SEGA, tend to grow 
with age and can finally transform into tumors requiring surgical 
intervention. Why apoptosis seems to outweigh proliferative proces-
ses in some TS-associated lesions, while it succumbs in others is a 
matter of debate.
PS 205  Tumorogenesis pathways in focal cortical dysplasia II B.
Monika Siedlecka, Jaroslaw Jozwiak, Stanislaw Szlufik, Wies-
lawa Grajkowska.
Medical University of Warsaw.
Aim: The aim of this study was to evaluate activation of protein 
kinase B/Akt and extracellular signalregulated kinase (Erk) pathways 
in FCD II B and compare these results with activation of tumoroge-
nic pathways in TS. Introduction: Focal cortical dysplasia (FCD) is 
a benign form of brain cortex deformation, belonging to the group 
of neuronal migration disorders occurring in the developing en-
cephalon. Histopathologic image is characterized by aberrated brain 
cortex architecture. Clinically, the most frequent symptoms include 
drug-refractory epilepsy. From among four types of FCD, type IIB is 
the most advanced one, characterized by the presence of dysmor-
phic or immature neurons and balloon cells, called Taylor cells. The 
presence of the latter type is also typical for tumors occurring in 
tuberous sclerosis (TS), thus it is sometimes assumed that FCD IIB 
may be a local form of TS. Methods: We used samples of FCD II 
B, subependymal giant-cell astrocytomas (SEGA) and subependymal 
nodule (SEN), which is another brain lesion characteristic for TS. The 
research was performed by Western Blot method, using antibodies 
specific for phosphorylated kinases of Akt and Erk pathways. Brain 
samples excised during lobotomy were used as negative control. 
Results: Activation of the following proteins has been demonstra-
ted: Erk, eIF4E; S6K1; Akt; GSK3ï¢; PDK1; MEK; RSK1. Also, we showed 
increased expression of cyclinD1 in tumor samples. Conclusions: 
OProteins phosphorylated in FCD IIB samples point to activation of 
Akt and Erk pathways. Also, activation of the above pathways in 
lesions occurring in TS, i.e. SEGA and SEN, has been demonstrated. 
Our results confirm similarity between FCD II B and TS.
PS 217 L-DOPA UPTAKE IN A CELLULAR MODEL OF DOPAMINERGIC NEU-
RONS
E. Magalhães-Ribeiro1, A. Leitão-Rocha1, M. P. Serrão1, E. 
Moura1,2, M. A.      Vieira-Coelho1,2
1 Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Univer-
sidade do Porto, Porto, Portugal.
2 Departamento de Neurofarmacologia, Instituto de Biologia Molecular e 
Celular, Porto, Portugal.
Aim: To characterize the transporter involved in L-DOPA uptake in 
these cells. Introduction: L-3,4-dihydroxyphenylalanine (L-DOP A) is 
the immediate product of the rate-limiting step in catecholamine 
biosynthesis and the precursor of all the endogenous catechola-
mines. Treatment with L-DOPA remains to date the most effective 
treatment for the slowness of movement, increased muscle tone 
and tremor, that are typical of Parkinson’s disease (PD). The human 
neuroblastoma cell line SH-SY5Y has been widely used as a cellu-
lar model of dopaminergic neurons for PD research. In this study 
we investigated the transporter involved in L-DOPA uptake in these 
cells. Methods: L-DOPA levels in SH-SY5Y cells were evaluated by high 
performance liquid chromatography with electrochemical detection. 
Results are presented as arithmetic mean ± standard error mean. 
Results: SH-SY5Y cells take up L-DOPA in a time dependent (linear 
until 6 min) and concentration dependent (2.5-2500 μM) manner. 
Non-linear analysis of the saturation curves for L-DOPA revealed a 
KM (μM) of 570 ± 97 and a Vmax (nmol/mg protein/6 min) of 611 ± 
34. The uptake of L-DOPA (2.5 μM) was reduced by the inhibitor of 
the L-type amino acid transporters 2-aminobicyclo-(2,2,1)-heptane-2-
carboxylic acid (BCH , 0.1-1000 μM) (IC 50 = 47 ± 2 nM; Emax = 24 ± 
10 % control uptake) and by neutralamino acids (1 mM), but not by 
the inhibitor of the A-type amino acid transporters N-(methylamino)-
isobutyric acid (MeAIB, 0.1-1000 μM), nor by the acidic and basic 
amino acids (1 mM). L-DOPA uptake (2.5 μM) was unaltered by lowe-
ring the pH from 7.4 to 6.2. In the absence of Na+ there was a 20% 
reduction in the Vmax values for L-DOPA uptake. Accumulation of 
L-DOPA in SH-SY5Y cells was largely inhibited by the L-isomers of the 
small and large neutral amino acids (alanine, serine, threonine, cys-
teine, leucine, isoleucine, phenylalanine, methionine, and tyrosine), 
histidine, tryptophan, valine, asparagine and glutamine. Whereas 
the amino acids glycine, proline and the basic amino acid arginine 
also produced an inhibition of L-DOPA uptake, albeit minor, the basic 
amino acids lysine and cystine, and acidic amino acids aspartate and 
glutamate, did not inhibit the uptake of L-DOPA. Conclusions: L-DOPA 
uptake in SH-SY5Y cells was sensitive to inhibition by BCH, but not 
to MeAIB, and was moresensitive to inhibition by neutral than to 
basic or acidic amino acids. Although most of L-DOPA was entering 
the cells in a Na+-independent manner, a minor component of L-DOP 
A uptake (25%) was found to require extracellular Na+. In general, 
these findings support the view that L-DOP A may be transported by 
systems B0 (Na+-dependent) and L (Na+-independent). The fraction 
of L-DOP A that is handled through system L is through a high-affinity 
(KM values in the μM range) and pH-insensitive transport, which are 
characteristic of the LAT1.
PS 224 Addressing cell proliferation in the subependymal zone in 
the experimental autoimmune encephalomyelitis murine 
model of multiple sclerosis
Alberto Silva, Ana M. Falcao, Sandro Mesquita, Joana A. Pal-
ha, Fernanda Marques, João Sousa.
Life and Health Sciences Research Institute (IC VS), School of Health 
Sciences, University of Minho, Campus Gualtar -PT Government Associate 
Laboratory, Braga /Guimarães, Portugal.
Aim: To address whether current treatment for multiple sclerosis, 
namely with natalizumab, influences cell proliferation in the sube-
pendymal zone (SEZ), in the experimental autoimmune encepha-
lomyelitis murine model of multiple sclerosis (EAE). Introduction: The 
subependymal zone (SEZ) is one of the major sites of neurogenesis 
in the adult brain. While thesecells usually migrate through the 
rostral migratory stream towards the olfactory bulb, they can also 
bemobilized to other brain regions and differentiate into various cell 
types. Such seems to be the case in EAE where cells originating from 
the SEZ have been shown to originate oligodendrocytes that may 
regenerate damaged neurons. Methods: EAE was induced in female 
SJL mice. All mice were weighed and scored daily for the appearance 
and severity of the symptoms. Treatment with natalizumab (5mg/
Kg), a humanized monoclonal antibody used as therapeutic appro-
ach to multiple sclerosis (MS) that blocks the passage of T and B 
cells from the immune system to the brain parenchyma start when 
the first sympthoms appeared. The control group received control rat 
IgG (control for the treatment). A control group for the EAE induction 
was also performed. Animals were sacrificed when symptoms were 
reverted in the treatment group, brains frozen and cut in 20 μm 
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slices for immunohistochemistry against Ki-67, a cellular proliferation 
marker. Sterological analysis was performed in the SEZ to determine 
proliferation and ectopic migration. Results: Present data show that 
natalizumab successfully reverted the EAE phenotype. Preliminary 
data suggest that the group induced with EAE and injected with IgG 
(that mimics a normal onset of the disease) showed a decreased 
number of Ki-67+ cells in the SEZ but showed an increase of its 
number in SEZ vicinity. Treatment with natalizumab leads to an in-
crease in the proliferation rate of the SEZ and a decrease in the non-
tangential migration of the cells from the SEZ comparatively with the 
IgG injected group. Conclusions: CNS lesions, as MS, modulate cell 
proliferation in the SEZ. We used a EAE relapse and remission model 
and the modulation of SEZ proliferation seems to be different from 
the already described EAE chronic models. It was also observed an 
increase in cell proliferation in the vicinity of SEZ, which may occur 
in order to repair the damaged foci. Finally, Natalizumab seems to 
increase cell proliferation in SEZ but slightly decreases in the vicinity.
PS 230 The antioxidant treatment with EGCG prevents pain and oxi-
dative stress damage at the spinal cord of STZ-diabetic rats
Raposo D., Pereira-Terra P., Morgado C., Tavares I.
Department of Experimental Biology, Faculty of Medicine and IBMC, Uni-
versity of Porto.
Aim: This study aimed to evaluate the effects of the treatment with 
Epigallocatechin Gallate (EGCG), a potent antioxidant present in 
green tea, at the behavioral pain responses and oxidative stress 
damage at the spinal cord of STZ-diabetic rats. Introduction: Diabetic 
neuropathy is a common complication underlying type I diabetes 
mellitus. Painful diabetic neuropathy - which is characterized by 
spontaneous pain, mechanical hyperalgesia and tactile allodynia - is 
a major disabling problem. The spinal dorsal horn is an important 
pain transmission relay and was shown to be affected during dia-
betes. Spinal nociceptive neurons were shown to be hyperactiva-
ted in STZ-diabetic rats, which seems to contribute to altered pain 
sensations. The mechanisms underlying spinal impairments remain 
unclear. Nevertheless it is likely that oxidative stress contributes 
to that impairment, based on previous findings showing increased 
oxidative stress damage at the spinal dorsal horn in STZ-diabetic 
rats and its reversal by an antioxidant treatment with alpha-lipoic 
acid, along with amelioration of pain responses. Methods: Diabetes 
was induced by intraperitoneal injection of STZ (60 mg/dl) in male 
Wistar rats. Control animals (CTR) received the vehicle solution. 
Three days post-injection one STZ-diabetic group started to receive 
EC GC (2g/L; STZ+EGCG) in the drinking water and the other main-
tained the normal water consumption (STZ+H2O) during 10 weeks. 
Mechanical hyperalgesia and tactile allodynia were behaviourally 
evaluated by Randall-Sellito and dynamic plantar aesthesiometer, 
respectively, before diabetes induction, at 4 weeks post-injection 
and in the end of the treatment. Then, the animals were sacrificed 
and spinal cords were removed. Spinal sections were immunoreac-
ted against 8-hydroxy-2’-deoxyguanosine (8-OH -dG), the marker of 
oxidative stress damage. The expression of 8-OH -dG was quantified 
by densitometry in 10 randomly taken spinal sections from the L4-L5 
segment. Means were compared by ANOVA followed by the Tukey 
post hoc test for multiple comparisons. Results: STZ rats developed 
hyperglycemia, which was maintained until the end of the experi-
ments and was not affected by treatment with EGCG. The paw with-
drawal thresholds evaluated by Randall-Sellito test were significantly 
lower in STZ+H2O than in CTR and STZ+EGCG rats. Moreover, STZ+H2O 
rats developed tactile allodynia, which was not detected in CTR and 
STZ+EGCG rats. Expression of 8-OH –dG was significantly higher in 
STZ+H2O than in CTR and STZ+EGCG rats. Conclusions: These findings 
show that the treatment with EGCG prevents the oxidative stress 
damage at the spinal dorsal horn of STZ-diabetic rats. Moreover, it 
ameliorated the mechanical hyperalgesia and prevented the develo-
pment of tactile allodynia, which is likely to be in part mediated by 
its spinal effects. The pain-related molecular and functional effects of 
EGCG at the spinal dorsal horn during diabetes will be studied in the 
future. Antioxidant treatment with EGCG should be, then, considered 
for the treatment of diabetic neuropathy.
PS 260 The involvement of nitric oxide in the antinociception indu-
ced by sucrose in mice
Shahlaee A, Farahanchi A, Javadi S, Dehpour AR.
 Faculty of Medicine, University of Tehran.
Aim: In the present study we examined the modulation of tail-flick 
response by long term sucrose ingestion in mice and evaluated 
the possible involvement of L-arginine-NO pathway in this effect. 
The involvement of opioid receptors in sucrose analgesia was also 
examined. Introduction: Sweet-substance-induced analgesia has wi-
dely been studied, and the investigation of the neurotransmitters 
involved in this antinociceptive process is an important way for un-
derstanding the involvement of the neural system in controlling this 
kind of antinociception. Sucrose is a naturally occurring sweetener 
with analgesic effects in newborns. In systematic reviews, single 
doses of sucrose have been reported to reduce pain in newborns 
undergoing commonly performed medical procedures. National and 
international pain management guidelines promote the widespread 
use of sucrose. Sucrose has also shown to provoke analgesic effects 
when ingested for a relatively long period of time (14 days). This 
analgesic effect is dependent on the number of days of sucrose 
intake. Although not fully understood, the mechanism of action 
is thought to involve activation of the endogenous opioid system 
through taste. It has been suggested that there is a role for nitric 
oxide (NO) pathway on modulation of pain and inflammation in anim 
als and humans. However, both inhibitory and promotive actions 
of NO in nociception and pain have been reported. Methods: Male 
albino mice were randomly distributed into six groups of ten. The 
groups received tap water, tap water along with daily intraperitoneal 
injections of naltrexone (20mg/kg), tap water along with daily injec-
tions of N-nitro-L-arginine methyl ester (L-NAME) (10mg/kg), sucrose, 
sucrose along with daily injections of naltrexone, and sucrose along 
with daily injections of L-NAME respectively for 12 days. Baseline tail 
flick latencies (TFLs) were taken prior to starting treatment. After 12 
days of treatment, TFL measurement was repeated and the mean 
values were calculated and compared. Results: The group receiving 
sucrose showed significant (p<0.001) antinociception compared to 
those receiving tap water alone or along with L-NAME or naltrexo-
ne. Administration of L-NAME with sucrose had no significant effect 
on sucrose antinociception. The group receiving sucrose along with 
naltrexone had %13 lower TFLs in comparison with those receiving 
sucrose alone (p<0.05). However, the former group also showed %15 
higher values compared to the control group (p<0.05). There was 
no significant difference between groups receiving tap water alone 
or along with L-NAME or naltrexone. Conclusions: Sucrose ingestion 
showed marked analgesia in mice which was partially inhibited by 
opioid receptor antagonist but unmodified by the nitric oxide syn-
thase inhibitor. Our findings support the hypothesis that sucrose 
may facilitate the release of endogenous opioid peptides that may 
ultimately be responsible for the observed antinociceptive effect. 
Contrary to previously studied pain models, the NO-cGMP had no role 
in the thermal hyperalgesia induced by the tail flick test. Based on 
our findings we recommend further studies on the involvement of 
NO in nociception in other animal and pain models.
PS 262  Could we use cortical connectivity analysis to monitor the 
anesthetic depth? A preliminary study.
Calin Alexandru, Radulescu Ana-Maria, Pavel Bogdan, 
Zagrean Leon
Center for Excellence in Neuroscience, University of Medicine and Phar-
macy “Carol Davila”, Bucharest, Romania.
Aim: This preliminary study aims to explore the possibility of mo-
nitoring the anesthetic depth by analyzing the dynamics of cortical 
connectivity by means of electroencephalography. Introduction: 
Cortical connectivity is considered to be one of the most sensitive 
parameters that assess neural function. In this study we evaluated 
the changes in cortical connectivity induced by nociceptive stimu-
lation during anesthesia in rats. Methods: In this experiment we 
used 5 Wistar rats of approximately 250-300g each. We induced and 
maintained anesthesia with chloral hydrate. The depth of anesthesia 
was estimated with the frontal median frequency (MEF). We main-
International Journal of Medical Students www.ijms.info   •   2013  |  Vol 1  |  Suppl 1 s18
IJMS
International Journal of 
Medical Students Abstracts
tained a basal ME F of 2 Hz. During the experiment we acquired the 
cortical electric activity through chronically implanted electrodes at 
the dura mater level. We used Biopac MP 150 systems for data acqui-
sition from 2 montages on each side (frontal and parietal on both 
hemispheres). After a baseline recording of 5 minutes, we applied 
a nociceptive stimulus by mechanically clamping the left hind leg 
for a 1 minute timeframe. Afterwards, the electroencephalographic 
signal corresponding to the right hemisphere was analyzed. The 
cortical connectivity was assessed using the fronto-parietal index of 
ME F (ratio of the median frequencies) and the Pearson coefficient 
between the frontal and parietal electrocorticographic montages.The 
experiment was approved by the Ethic Committee of “Carol Davila” 
University of Medicine and Pharmacy. Results: For the baseline re-
cordings, the fronto-parietal correlation calculated with the Pearson 
coefficient was 0.3 +/- 0.03 and the fronto-parietal index was 0.76 +/- 
0.06. During the timeframe corresponding to the nociceptive stimu-
lus the Pearson coefficient was 0.29 +/- 0.02 and the fronto-parietal 
index was 0.8 +/- 0.03. Comparison between these results show no 
statistical significance using the Student T-test (p>0.05). Conclusions: 
Our results show no significant change in cortical connectivity during 
nociceptive stimulation. Additional experiments should be carried 
through for further conclusive results.
PS 269 Prrxl1 Transcriptional Activity is Modulated by Phosphoryla-
tion.
Soares dos Reis R, Pessoa AS, Falcão M, Matos M, Monteiro 
CB, Monteiro FA, Reguenga C, Lima D.
Departamento de Biologia Experimental, Faculdade de Medicina, Univer-
sidade do Porto, Portugal; IBMC Instituto de Biologia Molecular e Celular, 
Universidade do Porto, Portugal.
Aim: To further characterize the nature and sites of Prrxl1 post-trans-
lational modifications and their impact on its function. Introduction: 
The establishment of synaptic connections between the PNS and 
CNS is a well-researched theme, and many molecules have been 
identified as guidance factors for the correct synapse. Prrxl1 is a 
homeodomain transcription factor essential for the connectivity and 
survival of nociceptive neurons in the mouse embryo dorsal root 
ganglion (DRG) and spinal cord (SC). Prrxl1-/- mice display abnorma-
lities in the spatio-temporal patterning of nociceptive afferent pro-
jections to the SC dorsal horn (dSC), defects in the development of 
dSC neurons and post-natal death of DRG small neurons (1,2). Prrxl1 
displays a multiple band pattern on western-blots (WB) (3), which 
is abrogated by incubation with a phosphatase. Methods: Mice were 
dissected and nuclear extracts of DRG and dSC of mouse embryos 
(from embryonic day E12.5 to post-natal day P14) were prepared 
using a Triton-sucrose buffer and analysed by WB. This time-course 
analysis was further completed by 2D-electrophoresis of embryonic 
and post-natal dSC extracts. Furthermore, nuclei of ND7/23 cells (a 
DRG-derived cell-line with nociceptive properties) and embryonic dSC 
were incubated with a Ga3+ Immobilized metal ion affinity chroma-
tography resin, with affinity for phosphopeptides. Constructs corres-
ponding to truncated versions of Prrxl1 were generated by molecular 
cloning, and their WB band pattern, transcriptional activity and DNA-
binding activity were assessed by luciferase-reporter assays and by a 
modified ELISA. CN Br Chemical cleavage of recombinant protein was 
performed to enhance this analysis. Moreover, site-directed mutage-
nesis was performed for an evolutionarily conserved putative phos-
phorylation site which was subjected to the same analysis. Results: 
Prrxl1 is highly phosphorylated and its phosphorylation state varies 
in a time and tissue specific manner. Phosphorylation seems to 
occur throughout the protein, clustering in the N-terminus (encom-
passing the DNA-binding domain) and in the C-terminus (containing 
a conserved putative regulatory domain). Analysis of evolutionary 
conserved sites has revealed a phosphorylation site in the homedo-
main, whose mutation impairs transcriptional activation and DNA-
binding. Luciferase reporter assays of truncated versions of Prrxl1 
have identified the N-terminus as sufficient for the DNA-binding and 
transcriptional activity of Prrxl1. Conclusions: Altogether, our results 
show that Prrxl1 is phosphorylated at multiple sites. Moreover, these 
phosphorylations probably play a fundamental role in the regulation 
of Prrxl1 transcriptional activity in nociceptive neurons.
PS 278 Modulation of BDNF effect on glutamate release in Synap-
tosomes by amyloid-beta peptide.
Carla Guerreiro1, Carla Ferreira1, Sandra Vaz2, Maria J. Dióge-
nes1,2, Joaquim Ribeiro1,2, Ana Sebastião1,2.
1 Institute of Pharmacology and Neurosciences, Faculty of Medicine, Uni-
versity of Lisbon.
2 Unit of Neuroscience, Institute of Molecular Medicine, University of Lis-
bon.
Aim: To study of the effect of the amyloid-beta (Abeta) peptide in 
glutamate release from rat hippocampal presynaptic terminals (sy-
naptosomes) and how amyloid-beta peptide modulate brain-derived 
neurothrophic factor (BDNF) effect on glutamate release in synap-
tosomes. Introduction: Accumulation of amyloid-beta peptides is a 
constant feature associated with the Alzheimer’s disease (AD). These 
peptides form aggregates and lead to degeneration of neurons in 
the neocortex, enthorhinal cortex and hippocampus, which use glu-
tamate as a neurotransmitter. It has been proposed that a sustained 
increase in extracellular glutamate levels may be associated with the 
cognitive deficits and loss of neurons observed. Also, studies with 
hippocampus slices showed that Abeta peptide inhibits the uptake 
of glutamate and increases its extracellular levels (Kabogo et al., 
2010). BDNF is an important neurotrophin for regulation of neuronal 
survival and differentiation. BDNF is also implicated in the modu-
lation of synaptic transmission and plasticity. This neurotrophin is 
found decreased in AD (Peng et al., 2005), which leads to wondering 
if its action is modulated by the presence of Abeta. Methods: Slices 
were obtained from Wistar rat hippocampus: half were incubated 
for 1 hour with ï¢-amyloid 25-35 (25μM) and the remaining were the 
control experiment. They were then homogenized and centrifuged.
The precipitate of the last centrifugation was resuspended in a Per-
coll solution and centrifuged. Then the supernatant was centrifuged 
two times with KHR solution. The synaptosomes were incubated with 
0.2 mM [3H]-glutamate for 5 min and then distributed in perfusion 
chambers with glass microfiber filters. After 20 minutes washout 
samples were collected during 40 minutes with 2 minutes intervals. 
The synaptosomes were stimulated for 2 minutes with a concentra-
ted solution of K+ added in min 5 (stimulation period, S1) and 29 
(stimulation period, S2), to induce an increased release of glutamate. 
20 ng/mL of BDNF (brain derived neurotrofic factor) were added in 
the 9th minute and its effect was quantified by the percentage chan-
ge in the ratio S2/S1. Results: In synaptosomes with Abeta, the ratio 
S2/S1 (93.5%) decreased when compared to the control situation. 
Analyzing only S1 (without-the effect of BDNF), in the presence of 
Abeta there is a decrease of glutamate release. BDNF increased glu-
tamate release by 21.2±4.5% (n=4) in control conditions and by 13.9 
± 20.9%(n=4) in synaptosomes prepared from slices incubated with 
Abeta (p<0.05 as compared with control). Conclusions: Regarding the 
effect of amyloid-beta protein in the release of glutamate, incubation 
of slices with amyloid-beta protein did not significantly alter the 
release of glutamate by synaptosomes. Given that the uptake inhi-
bitors do not increase the release of glutamate in the superfusion 
technique this result was to be expected. Clarifying this relationship 
might be useful for a better understanding of the pathophysiology of 
AD and thus contribute to new therapeutic approaches. BDNF causes 
a smaller increase in the glutamate release in synaptosomes of sli-
ces with Abeta, when compared to slices with no Abeta. Therefore, 
this may indicate that Abeta might have a modulator effect of the 
BDNF effect.
PS 292 Mapping glycine receptor (GlyR) and glycine transporters 
(GlyT1 and GlyT2) in primary cortical astrocytes.
Coelho D1, Figueiredo I1, Valente C1,2.
1 Faculty of Medicine & 2 Institute of Pharmacology and Neurosciences 
and Neurosciences Unit, Institute of Molecular Medicine, University of 
Lisbon, Portugal.
Aim: Investigate the expression and subcellular localization of glyci-
ne receptor (GlyR) and transporters (GlyT1 and GlyT2) in astrocytes, 
derived from the cerebral cortex. Evaluate developmental changes, 
at mRNA and protein levels, between astrocytes at 10, 18 and 24 days 
in vitro (DIV). Introduction: GABA and Glycine are the main inhibitory 
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neurotransmitters in the central nervous system (CN S). Glycine-me-
diated neurotransmission, although well established at the caudal 
regions of the CNS, has been disregarded in the brain. However, in 
recent years neuronal glycine receptor (GlyR) expression was found 
in several brain regions, including hippocampus and cortex. GlyR 
form pentameric channels permeable to chloride ions. Neuronal 
GlyR is composed by subunits α (1-3) and β, but little information 
about glial GlyR is available. Other important elements of glycine-
mediated synaptic activity are the glycine transporters (GlyT), which 
ensure glycine removal from the synaptic cleft. GlyT1 is located at 
the cellular membrane of glial cells, while GlyT2 is mostly present 
in glycinergic terminals. Given that glycine-mediated transmission 
is considered a potential alternative therapeutic target for the 
treatment of epilepsy, it is crucial to better understand the compo-
nents of glycinergic transmission in the brain, in both neuronal and 
non neural cells. Methods: Primary astrocytic cultures were prepared 
from P0-P2 Sprague-Dawley pups. To assess mRNA expression of GlyR 
subunits, total RNA was extracted, reverse transcribed and amplified 
with specific primers for α1, α2, α3 and beta transcripts. Quantifi-
cation, relative to transcript expression at 10 DIV, was performed 
with Pfafll’s equation by normalization with an internal control gene, 
β-actin. Immunofluorescence studies were performed by plating the 
astrocytes in PDL-coated coverslips. At 10, 18 and 24 DIV cells were 
fixed (4% paraformaldehyde), permeabilized (0.1% Triton X-100, 0.1% 
gelatin in PBS), blocked (0.25% gelatin in PBS) and incubated with 
the primary and with the fluorescent-labelled secondary antibodies. 
Astrocytes were immunolabelled with Glial Fibrillary Acidic Protein 
(GFAP) and GlyR or GlyT. Nuclei were stained with DAPI (1:15000) 
and autofluorescence was removed by a brief incubation in 100 mM 
CuSO4. Images were acquired on an inverted confocal laser scanning 
microscope. Results: The qPC R results indicate that only GlyRα2 and 
GlyRβ subunit transcripts are present in astrocytes. At the protein 
level, immunofluorescence studies at the different developmental 
stages show that astrocytes express GlyRα2 mainly in the cell body. 
Double immunolabelling of astrocytes with GFAP and GlyT confirmed 
GlyT1 and GlyT2 expression and revealed developmental changes in 
their subcellular localization. At 10 DIV both transporters are mostly 
confined to the cell body, while at 18 and 24 DIV they can be found 
in the cell membrane and in many astrocytic processes. Conclusions: 
This study confirms the presence of GlyR in cortical astrocytes, both 
at mRNA and protein levels. It also shows a developmental regulated 
subcellular localization of GlyT. This knowledge is important to pro-
mote further investigation on the functional meaning of astrocytic 
GlyR and GlyT during both physiological and pathological processes.
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ONCOLOGY & MOLECULAR BIOLOGY Session
PS 45 Heterologous Expression of Plasmodium falciparum IMPDH in 
E. coli.
Ang J.
Faculty of Life Sciences, University of Manchester.
Aim: The study aims to investigate the heterologous expression of 
Plasmodium falciparum IMPDH in E.coli in the hope of obtaining a 
sufficient protein expression level that can be used for inhibitors 
screening. The hypothesis of the investigation is that the uptake 
of Plasmodium falciparum Inosine Monophosphate Dehydrogenase 
(IMPDH) gene into E.coli will lead to significant production levels of 
the parasite’s IMPDH enzyme. Introduction: Malaria is a widespread 
vector-borne infectious disease that is caused by the parasite Plas-
modium spp. Currently, there are a variety of anti-malarial drugs in 
clinical-use. Despite the availability of a wide range of anti-malaria 
drugs, the rapid development of drug resistance among parasites 
means that there is always a need of better anti-malaria drugs. 
Therefore, continuous research has been done by scientists to iden-
tify new malaria drug targets that allow the development of better 
anti-malaria therapies. One of the potential malaria drug targets 
is the parasite’s IMPDH enzyme. IMPDH is essential for Guanosine 
Monophosphate (GMP) synthesis and subsequently the synthesis 
of Guanosine Triphosphate (GTP). Inhibition of IMPDH via an inhibi-
tor can cause disruption of intracellular biochemical reactions and 
this will eventually lead to death of the parasite. Methods: Electro-
transformation of pET-46 plasmid containing His-tagged Plasmodium 
falciparum IMPDH gene was done on E.coli strain BL21 DE3 Codon 
Plus which contains DE3 prophage that carries a T7 polymerase ex-
pression cassette, as well as LacI operon. The bacteria was then 
grow in culture and was induced with IPTG to allow the production 
of Plasmodium falciparum Inosine Monophosphate Dehydrogenase. 
Gravity-flow chromatography was then used to purified the proteins 
presence in the culture. The purified protein fractions were analy-
sed using SDS-PAGE and the activity of the enzyme was analysed 
using fluorescence spectrometer. The experiment was repeated in 
E.coli strain Rosetta P-Lysate DE3 and E.coli strain JMP 109 DE3. The 
influence of different post-induction incubation temperature on the 
production of Plasmodium falciparum IMPDH was also investigated. 
Dot-Blot analysis, PCR and GFP purification were set up as control 
experiment. Results: SDS-PAGE analysis showed no significant 
indications that were able to prove the presence of Plasmodium 
falciparum IMPDH enzyme. In addition, Fluorescence spectrometer 
assays also demonstrated inconsistent and negligible enzyme acti-
vity. Conclusions: From the investigation, it can be concluded that 
the Plasmodium falciparum IMPDH gene does not express well in 
E.coli. The results were not sufficient to indicate the presence of 
Plasmodium falciparum IMPDH. In the control experiments, small 
amount of expressions were present albeit inconsistent. The study 
also proved E.coli to be an incompatible model organism for he-
terologous expression of Plasmodium falciparum IMPDH. Without a 
well-match expression system, Plasmodium falciparum IMPDH could 
not be evaluated as a suitable research target for potential drugs. 
Future investigations of alternative expression systems such as yeast 
may enable the identification of a suitable heterologous expression 
system for the Plasmodium falciparum IMPDH enzyme, facilitating 
the development of IMPDH as a tractable drug target.
PS 49 Studies on the putative involvement of an effect in metabolic 
substrate cellular uptake in the anticarcinogenic effect of 
clotrimazole at the intestinal epithelial level.
Gregório I, Gonçalves P, Araújo JR, Martel FC.
Department of Biochemistry (U38-FCT), Faculty of Medicine, University of 
Porto, Portugal.
Aim: The aim of this study was to investigate: (a) the anticarcino-
genic effect of clotrimazole (CTZ) on tumoral and non-tumoral in-
testinal epithelial cell lines (Caco-2 and IEC-6 cells, respectively), 
by investigating its effect upon cell proliferation, viability and 
differentiation, alone or in conjunction with an inhibitor of mito-
chondrial oxidative phosphorylation (rhodamine123), and (b) the 
possibility of inhibition of the apical uptake of glucose or butyrate 
as a mechanism contributing to the anticarcinogenic effect of CTZ 
in Caco-2 cells. Introduction: Colorectal cancer is one of the most 
common solid tumours worldwide. Butyrate (BT) is one of the main 
end products of anaerobic bacterial fermentation of dietary fibre in 
the human colon and is an important metabolic substrate in normal 
colonic epithelial cells. BT becomes less essential for growth of neo-
plastic cells, which show an increase in the rate of glucose uptake 
and glycolysis, producing excessive lactic acid. CTZ is an antifungal 
drug that has demonstrated anticancer activity by inducing detach-
ment of some glycolytic enzymes from cytoskeleton, thus inhibiting 
glycolysis. Methods: The effect of CTZ on cell proliferation, viability 
and differentiation, 3H-deoxyglucose (3H-DG), 3H-Omethyl-glucose 
(3H-OMG) and 14C-butyrate (14C-BT) uptake and mRNA expression 
levels of glucose transporters was assessed. Results: In Caco-2 cells, 
CTZ showed anticarcinogenic activity, decreasing cellular viability and 
proliferation, and increasing cell differentiation. The effect of CTZ 
upon cell proliferation and viability was greatly potentiated in the 
presence of rhodamine123. In IEC-6 cells, CTZ also decreased cellular 
viability and proliferation, but increased cellular DNA synthesis rate 
and had no effect on cell differentiation. Exposure of Caco-2 cells to 
CTZ (10 μM) for 1 and 7 days increased (by 20-30%) the uptake of the 
glucose analogs 3H-deoxyglucose (3H-DG) and 3H-O-methylglucose 
(3H-OMG), respectively, but had no effect on the uptake of 14C-BT. 
The effect of CTZ upon 3H-DG and 3H-OMG uptake showed concen-
tration-dependency and was maximal at 10 μM. CTZ did not alter 
the pharmacological characteristics of 3H-DG and 3H-OMG transport, 
but produced significant changes at the level of mRNA expression of 
facilitative glucose transporter 2 (GLUT2) and Na+-dependent glucose 
co-transporter (SGLT 1). Conclusions: CTZ exhibits anticarcinogenic 
effect both in tumoral (Caco-2) and non-tumoral (IEC-6) intestinal 
epithelial cell lines. In Caco-2 cells, the anticarcinogenic effect of 
CTZ was strongly potentiated by inhibition of oxidative phosphoryla-
tion. Moreover, stimulation of glucose membrane uptake might be a 
compensation mechanism in response to the inhibition of glycolysis 
induced by CTZ.
PS 94 PgP modulators may mediate Imatinib Resistance in Chronic 
myeloid Leukemia.
Alves R1,2, Fonseca AR1,2, Gonçalves AC2,3,4, Alves V5, Abrantes 
AM4,6, Botelho MF4,6, Sarmento-Ribeiro AB2,4,7.
1 Master Student, Faculty of Science and Technology, University of Coim-
bra.
2 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
3 PhD. Student, Faculty of Medicine, University of Coimbra.
4 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra.
5 Immunology Institute, Faculty of Medicine, University of Coimbra. 
6 Biophysics Service, IBILI - Institute of Biomedical Research in Light and 
Image.
Aim: The aim of this study is evaluated the potential therapeutic of 
Reversin 205 in overcoming the resistance to Imatinib. Introduction: 
Chronic myeloid leukaemia (CML) is a mieloproliferative disorder 
characterized by the presence of the BCR-ABL gene fusion, which 
encodes an oncoprotein with a deregulated tyrosine kinase activity. 
This molecular event contributes to the enhancement in cellular 
proliferation and resistance to apoptosis, becoming the main the-
rapeutic target of the disease. In fact, the first-line treatment is 
Imatinib, a specific tyrosine kinase inhibitor that blocks the BCR-ABL 
tyrosine kinase activity. Although the good results with Imatinib, the 
development of drug resistance is a reality and can be mediated 
by different pathways, besides the BCR-ABL mutations, like the in-
crease in expression of drug efflux ABC (ATP biding Cassette family) 
transporters. Since Imatinib is a substrate for P-glycoprotein (PgP) 
and ABCG2 (BCRP) transporters, decreasing their actions may induce 
drug accumulation in cancer cells. Reversin 205 is a PgP modulator 
and can be a new approach to overcome resistance to Imatinib. 
Methods: For this purpose, we used a CML cell line, the K562 cells, 
and generated two sub-cell lines resistant to Imatinib the K562-RC 
and K562-RD cells. To obtain these resistant cells, K562 cells were 
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exposed to the drug following two strategies: by continuous expo-
sure of increasing concentrations of Imatinib (K562-RC) and by dis-
continuous exposure, with interchanged mediums with and without 
Imatinib (K562-RD). The half maximal inhibitory concentration (IC50) 
of K562 sensitive cells for Imatinib is 75nM, whereas for K562-RC 
cells this value is increased to the double (150nM) and in the case of 
K562-RD cells this value is 250nM. To evaluate the effect of Reversin 
205 on cell viability, all the different cell lines treated in absence and 
presence different concentrations of the drug, were analysed by the 
Resazurin Assay. Cell death was determined by optical microscopy 
(May-Grunwald staining), by flow cytometry (FC) using the Annexin 
V and Propidium Iodide double staining and by the expression levels 
of the activated caspase 3. The functionality of PgP was assessed 
using radiosensitizer (99mTc Sestamibi) kinetic studies. Drug efflux 
transporters expression levels, namely PgP and BCRP, was evaluated 
by FC using monoclonal antibodies. Results: We observe in K562-RD 
and K562-RC resistant cells an increase in PgP expression compared 
with the sensitive cell line, which may contribute to the resistance 
to Imatinib. However, K562-RC has a higher expression than K562-RD. 
The alterations in expression were followed with a higher radiosensi-
tizer profile. On the other hand, and concordantly with these results, 
we found that the IC50 at 24 hours of exposure to Reversin 205 
was 25μM to K562, 20 μM to K562-RD and 15 μM to K562-RC. This 
compound induced cell dead by apoptosis in a time- and dose- de-
pendent manner, confirmed by morphological analysis and by the 
increase in Caspase 3 expression. Conclusions: In conclusion, our 
results show that PgP expression may be involved in imatinib resis-
tance which may be circumventing by the PgP modulator Reversin 
205, suggesting that this compound could be used as a new potential 
approach in the treatment of resistant and sensitive CML.
PS 97 Immunophenotype features of blasts in patients with acute 
myeloblastic leukemia.
Jasmina Randjelovic, Vladan Milosevic.
Faculty of Medicine, University of Nis, Serbia.
Aim: The aim of this study was to evaluate the correlation between 
immunophenotipic findings and morphological subtype of leukemia 
according to FAB classification. Introduction: Acute myeloblastic leu-
kemia (AML) represents a clonal expansion of immature myeloid 
cells in a bone marrow. Clinical feature of AML is the consequence of 
impaired hematopoesis, and it is expressed like anemic, infectious 
or hemorrhagic syndrome. With the usage of monoclonal antibodies, 
specific for particular antigens on surface of the blasts, it is possible 
to identify the cell type that is prevalent in the malignant population. 
Methods: In the aim of this study, we have examined 30 patients of 
both sexes (7 females and 23 males) mean age 55.33 ï‚± 9.49 years, 
treated in a period between February and November of year 2010, at 
the Department of Hematology, Clinical Center of Nis. The diagnosis 
was made after bone marrow puncture and findings of more than 
30% of the immature elements in myelogram. At the same time, 
the samples were also taken for immunophenotyping. Results are 
shown as a percentage of positive cells on a specific CD antigen, 
and a comparative analysis in relation to FAB subtype is performed. 
Results: The highest value of CD34 was detected in AML M0, signi-
ficantly higher than in M1 (p <0.05), M2 (p<0.01), also as in M3, M4 
and M5 (p <0.001). The highest value of CD33 was detected in AML 
M1, significantly higher than in M0 (p <0.05). The highest value of 
CD14 was observed in AML M5, significantly higher than M0 and M3 
(p <0.05). Conclusions: Immunophenotyping is a valuable method 
for differentiation of certain cell types in AML, especially in cases 
of poorly differentiated forms, or with nonspecific cytochemical fea-
tures. The greatest expression of CD34 was found in M0, with the 
primitive progenitors. High expression of CD33 was found in subtype 
M1 and M2-M5 subtypes. CD13, as a “clean” myeloid marker was 
highly exposed in all myeloid subtypes, with maximum expression 
in M3, on the promyelocytes. CD14 was highly positive in the M5 and 
M4 subtypes, with the dominant population of monoblast.
PS 135 Characterizing a TET-repressible ErbB2-expressing fibroblast 
line as a possible model for testing ErbB2 targeted therapies.
Gabor Toth, Duarte Lisboa, Gyorgy Vereb.
Department of Biophysics and Cell Biology, Medical and Health Science 
Center, University of Debrecen.
Aim: Our objective was to characterize an ErbB2 expressing cell line 
that can serve as a model for antitumor therapies to better unders-
tand the keys of successful therapy in animal models. We’ve inves-
tigated the SADR cell line which is a derivative of NIH3T3 fibroblasts 
stably transfected with the ErbB2 gene under the negative control 
of tetracycline. Introduction: ErbB2 is a receptor tyrosine kinase 
underlying bad prognosis in several human malignancies. Trastuzu-
mab, a humanized anti-ErbB2 antibody, is a specific targeted therapy 
against these tumors, with a history of both success and a high rate 
of therapy resistance. Methods: We studied the sensitivity of SADR 
cells to short (5 minutes) and long (3 days) trastuzumab (0.1 mg/ml) 
treatment in terms of proliferation, cell cycle, ErbB2 expression and 
phosphorylation, apoptosis, and cell morphology in native and in 
ErbB2-deprived (tetracycline treated) SADR cells. As in initial experi-
ments we found a drift in the rate of proliferation inhibition, we also 
examined how the parameters in question changed during the aging 
of the cell line: experiments were made with cells from 3rd, 10th and 
20th passages. Proliferation was assessed both from mitochondrial 
activity (MTT assay) and from cell culture impedance (xCELLigence 
system). DNA, ErbB1, pErbB2 and Annexin V were fluorescently labe-
led and measured in flow cytometry. For further characterization, we 
also assessed mRNA expression using a whole mouse genome chip. 
Results: The proliferation rate upon ErbB2 deprivation by tetracycline 
decreased at all passages, coherent with the proliferation advantage 
from excess ErbB2. In these cells, trastuzumab did not decrease the 
proliferation further, nor did it affect the cell cycle, thus confirming 
specific trastuzumab action targeting ErbB2. In native SADR cells 
not treated with tetracycline, trastuzumab caused a G1-block that 
was correlated with the passage number, also enhanced short term 
ErbB2 phosphorylation, and decreased ErbB2 expression in the long 
run. While in the earliest passage minimal effects were observed 
upon trastuzumab treatment, by the 20th passage all ErbB2-related 
effects have manifested. Apoptotic rate was low (under 1%), and 
treatment did not alter that. Long term trastuzumab treatment 
decreased the focus formation and increased spreading. The mRNA 
expression showed that both trastuzumab treatment and ErbB2 de-
privation increase the expression of genes with antiangiogenic effect 
(thrombospondin, adamts5, connective tissue growth factor) and 
downregulate the level of those enhancing cell adhesion and focus 
formation. These confirm the observed morphological changes and 
the in vivo inhibition of tumor progression as well. Conclusions: The 
SADR cells appear to be not only a therapy target model, but also 
a model of addiction to the ErbB2 oncogene at the cellular level. 
The experiments also draw attention to the stability problems of 
transfected cellular systems.
PS 138 RNAi INDUCED DOWN-REGULATION OF FLT 3 EXPRESSION IN 
ACUTE MYELOID LEUKEMIA AND INCREASE SENSITIVITY TO the 
PROTEASOME INHIBITOR MG262.
Fonseca AR1,2, Alves R1,2, Gonçalves AC2,3,5, Alves V5,6, Silva L4, 
Moreira JN, Sarmento-Ribeiro AB2,5.
1 Master Student, Faculty of Science and Technology, University of Coim-
bra.
2 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
3 PhD. Student, Faculty of Medicine, University of Coimbra.
4 PhD. Student, Centre for Neuroscience and Cell Biology (CNC), Universi-
ty of Coimbra.
5 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra. 
6 Immunology Institute, Faculty of Medicine, University of Coimbra. 
Aim: The aim of this study was to analyze the efficacy of a siRNA 
anti-FLT3 in monotherapy and in combination with the proteasome 
inhibitor (PI), MG262, in hematologic malignancies,particularly in 
AML. Introduction: Acute Myelogenous leukemia (AML) is one of 
the most common type of hematological malignancies, which is 
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characterized by the block in cell differentiation, increase in cell 
proliferation and accumulation of hematopoietic immature cells of 
the myeloid lineage in bone marrow and peripheral blood. FMS-like 
tyrosine kinase 3 (FLT 3) is a tyrosine kinase (RTK) receptor involved 
in the survival, proliferation and differentiation of hematopoietic 
stem cells. Constitutively activation of FLT 3 has been reported in 
approximately 30% of AML. This aberrant activation is responsible 
for predicting poor clinical outcome and may constitue a new the-
rapeutic approach in this leukemia. Methods: For this purpose, we 
used an acute promyelocytic leukemia cell line, the HL-60 cells. The 
cells were culture in the absence and presence of 100 nM of the 
siRNA anti-FLT 3, delivered to cells by cationic liposomes, and/or with 
MG262 ranging from 1 nM to 100 nM. To evaluate the effect of siRNA-
FLT 3 and MG262 on cell viability and proliferation, Resazurin and 
the Trypan Blue exclusion were used. Cell death was determined by 
optical microscopy (May-Grunwald staining) and by flow cytometry 
(FC) using the Annexin V and Propidium Iodide double staining and 
the activated caspase 3 expression levels. We also analyzed FLT 3 
expression using an antibody anti-FLT 3 by FC. Results: Ours results 
show in cells treated with 100nM of siRNA-FLT 3, after 24 hours of 
transfection, about 10% of cell death and 60% of grow inhibition. On 
the other hand we found that the half maximal inhibitory concen-
tration (IC50) at 48 hours of exposure to MG262 was approximately 
25 nM. However, when we combine the RNAsi-FLT 3 with 5 nM of 
MG262, we observe an increase in the antiproliferative effect and 
in the percentage of cell death (80% and 45%, respectively), which 
suggest that RNAsi may increase the sensitivity to the proteasome 
inhibitor MG262. Besides that, the cytotoxic effect is mediated mainly 
by apoptosis in a time-and dose-dependent manner. Conclusions: 
In conclusion, our results suggest that there is a synergistic effect 
between siRNA-FLT 3 and MG262, demonstrating that the inhibition of 
multiple pathways becomes more efficient, illustrating the potential 
benefit of new combined targeted therapeutic approaches for AML 
treatment.
PS 142 QUANTIFICATIO OF SURVIVIN-IMMUNOPOSITIVE CELL OF LYMPH 
FOLLICLES IN DIFFERENT TYPE OC CHRONIC TONSILLITIS.
Ivana Mitic, Ilija Velickov, Mihajlo Lazarevic.
Faculty of Medicine, University of Nis, Serbia.
Aim: The aim of this paper was to show possible differences in the 
intensity of expression of this marker in the both CHT and RT by 
measuring numeral areal density of survivin-immunopositive cells in 
the germinative centers and the mantle zones of the lymph follicles 
in the chronic tonsillitis. Introduction: Chronic inflammations are 
frequent pathological states of the palatine tonsils. Specific entities 
are chronic hypertrophic tonsillitis (CHT) and recurrent tonsillitis 
(RT). During the inflammation in the lymph tissue are expressed 
many both pro- and anti-apoptotic factors, amongst which is survi-
vin. Molecular mechanisms by which surviving acts are not so well 
known, but his role in the inhibition of apoptosis is known. Methods: 
Material consisted of tonsils taken after tonsillectomy from patients 
of both sexes, age between 10 and 29 years: 5 tonsils with RT and 5 
tonsils with CHT. 5μm thick serial paraffin tissue slices were stained 
on hematoxylin-eosin and immunohystochemicall metod LSAB+/
HRP with aplication of the antibody for survivin. Determination of 
numerical areal density (NA) of survivn-immunopositive cells, that 
is, average nummber of cells on 1mm2 tissue, in the lymph follicles 
of tonsils: germinative centres and mantle zones. The digital pictures 
were taken with Olympus BX-50. For the quantification of the cells 
program Image J was used. Results: By comprising the NA of survivin-
immunopositive cells in the germinative centers and mantle zones of 
the lymph follicles of the tonsils with CHT and RT we found out that 
there is a statistically important difference in their number in the 
mantle zones, while there is no such difference in cell count found 
in the germinative centers. Conclusions: Survivin is expressed in the 
mantle zones and the germinative centers of the lymph follicles in 
the RT and CHT. Difference in the number of these cells in the mantle 
zones in RT and CHT might indicate that there is a different type 
of mechanism of expression of the secondary immune response in 
these two conditions.
PS 143 Significance of histopathological examination in diagnostics 
of chronical periapical lesions.
Sandra Pjevac, Sinisa Mirkovic, Dusan Lalosevic.
Medical Faculty, University of Novi Sad, Serbia.
Aim: Determine histopathological diagnosis of chronical periapical 
lesions, compare them with clinical diagnosis and classify them 
by size. Introduction: Preliminary diagnosis of chronical periapical 
lesions is determined by clinical symptoms and radiographs, but 
for definitive diagnosis histopathological examination is necessary. 
Methods: The examination included 34 patients with chronical pe-
riapical lesions diagnosed by clinical examination and radiographs. 
Removed chronical periapical lesions are processed by classical 
histological technique and histologicaly analyzed using hematoxylin 
& eosin stain. Results: By histological analysis is found that 53% 
of chronical periapical lesions are periapical granulomas and 47% 
radicular cysts. 70% of lesions were size < 9 mm, 18% 9 to 20 mm and 
12% > 20 mm. After histopathological examination is determined that 
in 26% of all cases the clinical diagnosis were wrong. Conclusions: 
Statistically significant difference between clinical and histopatholo-
gical diagnosis was confirmed.
PS 147 Effects of Chelidonium majus ethanolic extracts on viability 
and proliferation of different cell types in vitro.
Vladan Milosevic1, Sanja Stojanovic2, Stevo Najman2, Ana Mil-
tojevic3, Jasmina Randjelovic1, Jelena Najdanovic2.
1 Faculty of Medicine, University of Nis, Serbia.
2 Institute of Biology and Human genetics, Faculty of Medicine, University 
of Nis, Serbia.
3 Department of Chemistry, Faculty of Science and Mathematics, Univer-
sity of Nis, Serbia.
Aim: The aim of this study was to examine the effects of Chelidonium 
majus extracts on cell viability and proliferation of two different cell 
lines Hela and MDCK, respectively. Introduction: Chelidonium majus 
is the plant from the family Papaveraceae and its use in traditional 
medicine has been known since an ancient times. This plant is very 
rich in alkaloids and the most present are isoquinoline alkaloids 
such as sanguinarine, chelidonine, chelerythrine, berberine and 
coptisine. Other components that are isolated from this plant are 
flavonoids and phenolic acids. Extract of this plant and its com-
ponents have several important pharmacological activities such as 
antiviral, antimicrobial, anti-inflammatory and antitumor activity. 
Methods: Two different ethanolic extracts of aerial parts of the plant 
C. majus were examined, one prepared by Soxhlet apparatus and the 
other one by ultrasonic procedure. They were diluted in the culture 
media IMDM (Iscove’s Modified Eagle Medium) and examined in the 
following effective concentrations: 10 mcg/ml, 20 mcg/ml, 50 mcg/
ml, 100 mcg/ml and 250 mcg/ml, for each type of extraction. The 
cells were seeded into the 96 well plates and cultivated for 24h in 
Dulbecco’s Modified Eagle Medium (DMEM) at 37 °C in humidified 
5% CO2 atmosphere. Cells were incubated with extracts for 24h in 
the viability assay and 72h in the proliferation assay. Cells only with 
medium were used as a control. After an incubation period MTT test 
was performed. Results: In the presence of most of the examined 
concentrations, cells of both cell lines had a viability close to the 
negative control or slightly to moderately reduced. In this assay 
HeLa cells were more sensitive than MDCK cells which is especially 
pronounced at the highest concentration of both extracts. In the 
proliferation assay there are distinct differences in the effects of 
examined concentrations on this two cell types. All concentrations, 
except the lowest one, had antiproliferative activity on HeLa cells 
in a dose dependent manner. Only two of the highest examined 
concentrations of both extract types had an antiproliferative effect 
on MDCK cells in a dose dependent manner. Ultrasonic extract had 
a weaker antiproliferative effect on both cell lines than the extract 
prepared by Soxhlet apparatus. Conclusions: TBoth types of extract 
in examined concentrations markedly stronger act by reducing cell 
viability and proliferation of HeLa cancer cells compared to noncan-
cerous MDCK cells.
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PS 153 Vitamin C: a new use for a well-known compound?
Ribeiro AB1, Gonçalves AC1,2,4, Alves V3, Sarmento-Ribeiro 
AB1,2,4.
1 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
2 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra. 
3 Immunology Institute, Faculty of Medicine, University of Coimbra.
4 Center for Neuroscience and Cell Biology (CNC), University of Coimbra.
Aim: The main purpose of this study is to assess the potential of 
vitamin C as a new approach on cancer treatment. Introduction: 
The role of antioxidant vitamins, diet and lifestyle modifications in 
modulating human cancer incidence has drawn significant attention 
from basic and clinical scientists. Vitamin C has been long known 
for its anti-oxidant properties that may be related with is significant 
benefit on cancer, as a chemoprotective agent and/or as a thera-
peutic approach. Although the results are scattered, and no unifying 
hypotheses to explain the mechanisms of action of these vitamin in 
vitro or in vivo have been proposed. Vitamin C exists in two forms: 
ascorbate (AA) and dehydroascorbate (DHA). This water-soluble vita-
min is a potent antioxidant, but, depending on concentration, may 
also have pro-oxidant and even mutagenic effects in the presence of 
transition metals. Myelodysplastic syndromes (MDS) are a heteroge-
neous stem cell bone marrow disorders characterized by dysplasia, 
peripheral cytopenias, ineffective haematopoiesis due to excessive 
apoptosis and abnormal proliferation of blasts in bone marrow. The-
se diseases affects older adults and are associated with high risk 
of progression to acute leukaemia with a short overall survival and 
resistance to conventional therapies.. For most MDS patients the 
only potentially curative treatment is bone marrow transplant. On 
the other hand, Diffuse Large B Cell lymphoma (DLBCL) is the most 
common type of non-Hodgkin lymphoma (NHL) accounting for up 
to 40% of all NHL cases. It is a clinically aggressive disease with an 
incidence peak at around 60 years old with mean 5-year-survival of 
only up to 50%. Its current therapeutic approach is based in chemo-
therapy regimens that despite major advances are yet highly toxic 
and with a fairly reduced efficacy. Methods: To achieve our goal we 
used well-established MDS and DLBCL cell lines, the cells F36P and 
FARAGE , respectively. We incubated these cell lines in the absence 
and presence of AA and DHA, in single dose, in a daily dose adminis-
tration and in association with conventional anticarcinogenic agents 
(cytarabine, ARA-C; doxorubicin, DOXO). Cell viability and death was 
determined by the trypan blue assay, optical microscopy and by flow 
cytometry (FC) using annexin-V/propidium iodide stain and caspase 
3 expression levels. We also evaluated mitochondrial membrane 
potential, reactive oxygen species levels (hydrogen peroxide, H2O2; 
superoxide anion, O2•-) and the antioxidant defense, Reduced Gluta-
thione (GSH), by FC using JC1, 2,7-diclorofluorescein, dihidroetidium 
and mercury orange, respectively. Results: Our results show that both 
AA and DHA induce a decrease in cell viability and proliferation in a 
time, dose and cell type dependent manner with IC50 values ranging 
from 1,5 mM with AA and 1 mM for the FARAGE cells and values of 
2,5 mM (AA) and 1 mM (DHA) for the F36P cells. In the presence of 
AA and DHA, cells exhibited typical apoptotic morphology that may 
be related with the observed increase in caspase 3 expression levels. 
We also observed that Vitamin C induced apoptosis by increased ROS 
production and mitochondrial membrane potential depolarization. 
Conclusions: In conclusion, our results suggest that Vitamin C may 
be used as a new therapeutic approach on cancer treatment, namely 
in MDS and DLBCL in monotherapy or as adjuvant to conventional 
chemotherapy.
PS 156 Abnormalities lymphocyte populations in haematological 
malignancies.
Oliveira G1, Gonçalves AC2,3,4, Geraldes C4,6, Cortesão E4,6, 
Sousa I4,6, Carda JP4,6, Tavares P6, Teixeira A4,6, Santos M4,5, 
Alves V5, Sarmento-Ribeiro AB2,3,4
1 Medicine Student, Faculty of Medicine, University of Coimbra.
2 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
3 Center for Neuroscience and Cell Biology (CNC), University of Coimbra.
4 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra.
5 Immunology Institute, Faculty of Medicine, University of Coimbra. 
6 Clinical Hematology Department, University Hospital of Coimbra, Portu-
gal.
Aim: The aim of this study was evaluate the role of human lym-
phocytes subpopulations in evolution and prognosis of several hae-
matological malignancies, namely chronic lymphocytic leukaemia 
(CLL), multiple myeloma (MM), myelodisplastic syndromes (MDS) 
and chronic myelogenous leukaemia (CML). Introduction: For a long 
time, scientists believed that the immune system acted to fight 
cancer development. However, recent findings demonstrate that the 
immune system also acts to promote cancer progression. In fact, 
it has been proposed that when some types of immune cells en-
counter tumour cells, they can also cause inflammation. However, 
when compared to normal injury, these immune cells often do not 
withdraw, but rather generate an enduring chronic inflammation, 
stimulating cell proliferation and activating angiogenesis, invasion 
and metastization. Human lymphocytes are classified in three main 
populations according to their biological function and cell surface 
antigen expression: T lymphocytes, B lymphocytes and natural killer 
(NK) cells. T lymphocytes can be subdivided as well in functionally 
different populations. The most clearly defined of these are helper/
inducer T cells and suppressor/cytotoxic T cells. B lymphocytes are 
the producers of antibodies; they mediate humoral immunity parti-
cularly effective against toxins, whole bacteria, and free viruses. NK 
cells mediate cytotoxicity against certain tumors and virus-infected 
cells. Abnormalities in lymphocyte populations have been docu-
mented in patients with haematological malignancies. However, the 
role of these abnormalities is not clarified. Methods: To attaint this 
objectives we studied a total of 47 newly diagnosed patients (CLL=5 
pts; MM=18 pts; MDS=10 pts; CML= 11 pts) and 3 healthy donors. 
Using flow cytometry, we determined simultaneously in peripheral 
blood and/or bone marrow the major lymphocyte subpopulations, 
including the total number of T lymphocytes (CD3+), B lymphocytes 
(CD19+) and natural killer cells (CD3-/CD56+) as well as helper/
inducer (CD3+/CD4+) and suppressor/cytotoxic (CD3+/CD8+) T lym-
phocyte subsets. Results: Our results show that CLL patients have 
a significant increase of CD8+ T cells in peripheral blood compared 
to healthy controls. On the other hand, CD4+ T cells were decreased 
in CLL, MM and CML. In this context, CD4+/CD8+ ratio were decrease 
in CLL, MM and CML patients, while an increase were observed in 
MDS, suggesting that the abnormal lymphocytes distribution may 
contribute to the neoplastic process. Conclusions: Since haemato-
logical malignancies evolution may be associated with a number of 
phenotypic and functional alterations in lymphocytes populations, 
cellular immunity might influence patient outcome, response to an-
tineoplastic treatment and, consequently, the prognosis.
PS 161 The effect of chenodeoxycholic acid on butyrate uptake in 
non-tumoral and tumoral intestinal epithelial cell lines.
Telmo Catarino, Pedro Gonçalves, Inês Gregório, Fátima Mar-
tel.
Department of Biochemistry (U38-FCT), Faculty of Medicine, University of 
Porto, 4200 - 319 Porto, Portugal.
Aim: The aim of this study was to characterize the effect of the bile 
acid CDCA upon BT uptake and upon cellular viability, proliferation 
and differentiation, in non-tumoral (IEC-6) and tumoral (Caco-2) in-
testinal epithelial cell lines. Introduction: Colorectal cancer (CRC) is 
one of the most common solid tumours worldwide. Although the 
causes of CRC are multifactorial, a diet high in dietary fibre and 
low in saturated fats is associated with a reduced risk of this pa-
thology. Butyrate (BT), one of the main end products of dietary 
fibre bacterial fermentation in the human colon, is known to play 
an important role in colonic epithelium homeostasis, being able to 
prevent/inhibit colon carcinogenesis. BT is transported into colonic 
epithelial cells mainly by two carriermediated transport systems, 
the monocarboxylate transporter 1 (MCT1) and the sodium-coupled 
monocarboxylate transporter 1 (SMCT1), both being proposed to 
function as tumour suppressors. Epidemiological and experimental 
studies (both in vitro and in vivo) suggest that bile acids may play 
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a role in the aetiology of CRC. A significantly higher concentration of 
the primary bile acid chenodeoxycholic acid (CDCA) was observed in 
patients with CRC/adenoma, and CDCA was also shown to be tumour 
promoting in animal studies. Methods: 14C-BT uptake by Caco-2 and 
IEC-6 cell lines was quantified by liquid scintillometry, mRNA expres-
sion levels of MCT1 and of SMCT1 transporters were quantified by 
qRT-PCR and the effects of CDCA and BT on cell viability, proliferation 
and differentiation were quantified by the lactate dehydrogenase 
assay, sulforhodamine B assay and alkaline phosphatase activity 
assay, respectively. Results: Incubation with CDCA for 2 days did not 
affect 14C-BT uptake in Caco-2 cells while in IEC-6 cells resulted in 
a marked inhibition of 14C-BT uptake in a concentration-dependent 
manner (IC50=120 μM) and this effect was quantitatively similar from 
1 to 7 days of exposure. CDCA (100 μM) acted as a competitive inhi-
bitor of 14C-BT uptake for low concentrations of 14C-BT and showed 
no effect on cell viability (LDH and MTT assays) or proliferation (SRB 
assay). CDCA decreased both MCT1- and SMCT1-mediated 14C-BT 
transport and caused significantly increased SMCT1 mRNA expression 
levels. 14C-BT uptake was found to be stimulated by CaM, CaMKII 
and PKC and inhibitied by PKA. Inhibition of 14C-BT uptake by CDCA 
was dependent on CaM, MAP kinase (Erk 1/2 and p38 pathways) 
and PKC activation. Furthermore, CDCA was able to partially reduce 
the BT-mediated decrease in cell proliferation and the increase of 
differentiation of IEC-6 cells. Conclusions: In conclusion, our results 
suggest that inhibition of BT uptake in the intestinal epithelium may 
contribute to the procarcinogenic effect of the primary bile acid CDCA 
at this level.
PS 182 Clinical Relations of Methotrexate Pharmacokinetics in Pe-
diatric Osteosarcoma.
Gulacsi A, Z.Hegyi M, Kovacs G.
2nd Department of Pediatrics, Faculty of Medicine, Semmelweis Univer-
sity.
Aim: Our objectives were to analyze the relationship between ex-
posure to HD-MTX and toxicity, and to assess correlations between 
pharmacokinetic parameters and the survival of osteosarcoma. In-
troduction: High-dose methotrexate (HD-MTX) with leucovorin rescue 
is widely used to treat osteosarcoma, which predominantly occurs 
in children. Methotrexate efficiency and toxicity is unpredictable and 
shows large variability.Peak serum concentrations of methotrexate 
and the area under the concentration-time curve (AUC) have been 
reported to correlate with outcome, however, no such relations have 
been set up in the regard of toxicity. Methods: Pharmacokinetic data 
of 101 patients treated with 865 HD-MTX courses were evaluated. 
Pharmacokinetic parameters (MTX clearance and AUC) were calcula-
ted based on methotrexate serum levels measured at 6, 24, 36, 48 
hours after the initiation of the infusion by high pressure liquid chro-
matography (HPLC) technique. Clinical data were collected by retros-
pective chart review. Toxicity parameters were categorized according 
to Common Toxicity Criteria and MTX dose intensity was calculated. 
Data were analysed by Student’s t-test, Mann-Whitney U test and chi 
square test (StatSoft’s STATISTICA v8.0). Event-free survival (EFS) and 
overall survival (OS) were estimated according to the Kaplan-Meier 
method. All results with a p-value of less than 0.05 were considered 
statistically significant. Results: Patients with serious hepatotoxicity 
had significantly higher mean peak MTX concentrations, 24 h and 
48 h MTX serum levels and AUC(0-48h), and significantly lower MTX 
clearance. No significant association was found between toxicity and 
age, gender, presence of metastases or histologic tumor response. 
Patients with higher 24h and 48h methotrexate serum levels had 
significantly better overall and eventfree survival. Higher dose inten-
sity was associated with a greater probability of event-free survival. 
There was no association between presence of toxicity and survival. 
Conclusions: Higher MTX exposure leads to higher incidence of he-
patotoxicity. Higher serum concentrations at 24 and 48 hours result 
in a better 5-year OS and EFS. These results suggest that higher 
MTX exposure may lead to serious side effects, but it also improves 
treatment outcome.
PS 187 Establishment of direct bladder cancer xenografts in nude 
mice.
Bernardo C1, Gärtner F2, Amaro T3, Santos L4.
1 Health sciences department, University of Aveiro.
2 Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS 
- UP).
3 Department of Pathology, Portuguese Institute of Oncology - IPO, Porto.
4 Department of Surgical Oncology, Portuguese Institute of Oncology - IPO, 
Porto.
Aim: The aim of this project was to develop a direct xenografic model 
of invasive urothelial bladder carcinoma to study the tumoral res-
ponse to cisplatin and gemcitabine in vivo. To guarantee the utility 
and validity of this model, the reproducibility and maintenance of 
the phenotype of the original tumor were assessed through the com-
parison of the histologic type and grade and expression of several 
tumor markers (immunohistochemistry). With this model we will be 
able to select the best cancer treatment based on responsiveness 
of individual tumors and have the possibility of tailor treatment to 
individual patients—using effective agents while sparing unnecessary 
ones. Introduction: Transitional cell carcinomas (TCC) are the most 
common urothelial tumors in western countries and approximately 
25% of patients will, at the time of diagnosis or later, present with 
muscle invasive or locally advanced bladder cancer. The standard 
therapy for these patients is radical cistectomy and chemortherapy 
with therapeutic regimens containing cisplatin, MVAC (methotrexa-
te, vinblastine, dosurubicin and cisplatin) or GC (gencitabine and 
cisplatine). However both regimens carry risk of significant toxicity 
and toxic deaths and a substantial number of patients will suffer 
from adverse reactions without achieving any benefits. Unpredicta-
ble outcomes from empiric therapy in patients with the same tumor 
type and stage is a widely recognized and frustrating problem for 
patients, their caregivers, and medical professionals There has been 
a long-standing hope that new markers and approaches could be 
used to optimize therapy for each patient. Established human cancer 
cell lines, primary cultures of patient tumor specimens and animal 
models have been used to evaluate the activity of chemotherapeutic 
agents. However, these models showed some limitations in terms of 
correlation with clinical results and it’s predictive value The use of 
direct xenografting of human cancers allows the transplantation of 
all cellular fractions of the tumor, maintaining the original cell hete-
rogeneity, tumor phenotype and malignat potential. Methods: Tumor 
fragments of invasive bladder cancer obtained after patient cystec-
tomy were implanted subcutaneously into nude mice, and xenograft 
tumors were passed through 2 more mice generations before drug 
testing. At each passage, histopathology, CD147, TP5, P63, CD20, and 
Ki-67 molecules were examined by immunohistochemical analysis to 
evaluate the preservation of original features and tumor. Results: Tu-
mor growth was observed in 1 mice (11%, 1/9) after 13 weeks of lag 
period, and reached a volume of 1,5 cm3 at 18 weeks, when it was 
excised and implanted in new mice. Histological and immunohisto-
chemically, the tumor developed was similar to the original tumor. 
At the moment, this xenograft was passed from 2 generations. In the 
second generation, tumor growth was observed in 2 mice (66%, 2/3) 
at 5 and 9 weeks following transplantation. Conclusions: With these 
preliminary results we proved that it is possible growth urothelial 
bladder tumors in nude mice maintaining the original phenotype 
and immunohistochemical staining pattern. However more studies 
will be needed to understand the factors behind the low tumor take 
and eventually improve the success of xenotransplant. At the end of 
the project we hope to find some association between the molecular 
markers analyzed and the aggressiveness and chemo-resistance of 
the tumor.
PS 190 Expression of Metalloproteinases-2, -8 and -9 in Monoclonal 
Gammopathies.
Pais AS1, Gonçalves AC2,3,4, Geraldes C4,6, Cortesão E4,6, Sousa 
I4,6, Teixeira A4,6, Santos M4,5, Alves V5, Nascimento Costa J2,3,4, 
Sarmento-Ribeiro AB2,3,4.
1 Medicine Student, Faculty of Medicine, University of Coimbra.
2 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
3 Center for Neuroscience and Cell Biology (CNC), University of Coimbra.
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4 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra.
5 Immunology Institute, Faculty of Medicine, University of Coimbra. 
6 Clinical Hematology Department, University Hospital of Coimbra.
Aim: In the present study, we aimed to explore the role of MMPs, 
namely MMP-2, MMP-8 and MMP-9, in the pathogenesis of MGUS and 
progression to MM. Introduction: Matrix metalloproteinases (MMPs) 
are a family of structurally and functionally related proteinases cha-
racterized by the ability to degrade the extracellular matrix (ECM). 
Based on their substrate specificity and domain structure, MMPs 
were divided into subgroups. One of these subgroups is represented 
by gelatinases, which degrade gelatine and several types of colla-
gen, like gelatinase A (MMP-2) and gelatinase B (MMP-9). MMPs are 
known to play a role in cell growth, invasion, angiogenesis, metas-
tasis, and bone degradation, all important events in the pathoge-
nesis of cancer. Multiple myeloma is a B-cell cancer characterized 
by the proliferation of malignant plasma cells in the bone marrow, 
increased angiogenesis, and the development of osteolytic bone 
disease. The first pathogenic step is a premalignant monoclonal 
gamopathy of undetermined significance (MGUS). In the progression 
from MGUS to MM, complex genetic events occur in the neoplastic 
plasma cell (PC), and in the bone marrow (BM) microenvironment, 
including induction of angiogenesis, suppression of cell-mediated 
immunity, and development of paracrine signalling loops involving 
interleukin-6, insulin-like growth factor 1, interferon α and vascular 
endothelial growth factor. Furthermore, although tumour progression 
is observed mainly within the bone marrow during the early stages 
of the disease, extramedullary spreading occurs during the terminal 
stage of the disease. Moreover, malignant cells can be detected in 
peripheral blood of many patients with MM, suggesting migration of 
myeloma cells outside the bone marrow. However, the role of MMPs 
in the development of MM is poorly understood. Methods: A total of 
newly diagnosed 5 MGUS patients and 7 symptomatic MM patients 
were included in this study. Expression of MMP-2, MMP-8 and MMP-9 
was assessed on bone marrow plasma cells (PC) by flow cytometry 
using a four-color staining. Results: Our preliminary study, shows 
that MM patients have higher percentage of PC expressing MMPs 
when compared to MGUS patients. On the other hand, 60%, 80% and 
60% of MGUS patients and 50%, 100% and 88% of MM patients have 
positive staining for MMP-2, MMP-8 and MMP-9, respectively. In this 
subset of patients, 60% of MGUS and 100% of MM patients are at 
least positive for two MMPs. However, intracellular MMPs expression 
levels were higher in MGUS. Conclusions: Our findings suggest that 
PC MMP expression may be correlated with transition of MGUS to 
MM, promoting extramedullary spreading and disease evolution. 
Since MM remains incurable, confirmation of these results may con-
tribute to a better understanding of MM biology and can lead to new 
therapeutic approaches.
PS 191 The RAS/RAF and AKT/mTOR pathways as therapeutic targets 
in diffuse large b-cells lymphoma.
José Mendes1, Ana Ribeiro1, Ana Cristina Gonçalves2,3, Raquel 
Alves4, Vera Alves5, Ana Bela Sarmento-Ribeiro2,3,6.
1 Medical students of Faculty of Medicine, University of Coimbra (FMUC), 
Portugal.
2 Hematology and Applied Molecular Biology/Biochemistry Institute, 
FMUC, Portugal.
3 Center of Investigation on Environment Genetic and Oncobiology - CIMA-
GO, FMUC, Portugal.
4 Master student of Faculty of Science and Technology, University of Coim-
bra, Portugal.
5 Immunology Institute, Faculty of Medicine, University of Coimbra. 
6 Center for Neuroscience and Cell Biology, Coimbra, Portugal.
Aim: The aim of this study is to evaluate the potential therapeutic 
of an mTOR inhibitor (Everolimus) and a RAS/RAF pathway inhibitor 
(L744, 832) in DLBCL. Introduction: Diffuse large B-cell lymphoma 
(DLBCL) is a common type of non-Hodgkin lymphoma, accounting 
for about 25-30% of all cases in the western countries. It is a clini-
cally aggressive lymphoma in which the patients have a five-year 
survival rate of 50%. Several intracellular pathways are related to 
lymphomagenesis and two of the most frequently involved are the 
BCR/PI3K/AKT/mTOR pathway (B-Cell-Receptor/ Phosphatidylinositol-
3-kinase/AKT protein kinase B/Mammalian Target of Rapamicin) and 
RAS/MAPK pathway (MAPK, Mitogen Activated Protein Kinase, asso-
ciated with the RAS-RAF proteins). On the other hand, RAS proteins 
are activated by farnesylation mediated by the farnesyltranferase 
enzyme. Methods: For this purpose we used the a DLCL cell line, 
the Farage cells, cultured in the absence and presence of several 
concentrations of Everolimus and of L744,832, in monotherapy and 
in association with each other and with conventional chemotherapy 
drugs (Vincristine). Cell growth and viability were evaluated by the 
rezasurin assay. The effectiveness of the drugs was determined by 
dose-response curve and IC50. Cell death was investigated by optical 
microscopy using the May-Grunwald staining, and by flow cytometry, 
through the annexin-V and propidium iodide double staining. The 
mechanisms involved in the antiproliferative effect and in cell dead 
were analyzed by flow cytometry by the expression of Cyclin D1 
and proteins involved in apoptotic pathways, namely, Caspase 3, 
Cytochrome c, Lamin A/C, Bcl-2 and Bax. Results: Our preliminary 
results show that Everolimus and L744,832, induced cell death in a 
time- and dosedependent manner, with IC50 values of 500nM after 
48h for Everolimus and ranging from 50μM to 75μM after 24h for 
L744,832. These compounds induced cell dead mainly by apoptosis 
that may be mediated by caspase 3. Conclusions: In summary, our 
results suggest that Everolimus and L744 might be used as a new 
approach on DLCL treatment.
PS 204 Implication of mammalian target of rapamycin in children 
with Choroid Plexus Papilloma.
Beata Rak, Jaroslaw Józwiak, Wieslawa Grajkowska.
Medical University of Warsaw.
Aim: The main target of the Project was to confirm activation of kina-
ses belonging to extracellular signal -regulated kinase (Erk) pathway, 
e.g. pMEK, TRKA/B and mammalian target of rapamycin (mTOR) 
effectors: 4EBP1 and pS6K wchich are often found in brain tumors. 
Introduction: Choroid plexus papilloma (CPP) is a rare intracranial 
tumor located in the ventricular system of the choroid plexus, mostly 
in lateral ventricles. It may disrupt flow of cerebrospinal fluid and be 
the reason of increased intracranial pressure. CPP commonly affects 
young children under 5 years of age and accounts for 0.9-2 % of all 
brain neoplasms. At least 50% of cases are found in children under 2 
years. The tumor may be formed by epithelial cells of choroid plexus. 
So far, there were no reports on the activation of Erk (extraxellu-
lar signal -regulated kinase) in CPP, while this kinase triggers mTor 
signaling cascade and takes part in carcinogenesis in many types 
of brain tumors. Methods: We evaluated activation of kinases belon-
ging to Erk pathway as well as mTor signaling effectors: 4EBP1 and 
ribosomal protein S6 by Western Blot method, using phosphospecific 
antibodies, binding only phosphorylated, active protein forms. The 
research was performed on human choroid plexus papilloma tumors 
resected during elective surgery. Results: We demonstrated activa-
tion of mTOR kinase pathway and related Erk signaling pathway. 
Also, we confirmed increase of phosphorylation of 4EBP1 and pS6K 
responsible for protein translation. Excessive activation of mTOR 
downstream effectors may result in uncontrolled proliferation. Con-
clusions: mTOR kinase is a central regulator of cellular state and pro-
cesses like: autophagy, angiogenesis and proliferation. Erk pathway 
lays upstream of mTOR kinase. Excessive activation of this kinase 
may lead to uncontrolled proliferation and result in tumorgenesis. So 
far, there have been no data on mTor activation in CPC. In the current 
study we focused on confirmation of Erk pathway wchich may be a 
possible mechanism of tumorgenesis in CPP.
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PS 206 Epigenetic modifications in Hepatocellular carcinoma: The 
potential role of epigenetic modulators on HCC therapy.
Vieira L1, Silva P1, Neves S1,2, Sarmento-Ribeiro AB1,2, Nasci-
mento Costa JM1,2,3.
1 Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
2 Center of Investigation on Environment, Genetics and Oncobiology (CI-
MAGO), FMUC, Coimbra, Portugal.
3 Medicine Service and Hepatology Unit, University Hospital of Coimbra, 
Coimbra, Portugal.
Aim: The aims of this work are to study the epigenetic modifications 
in cell cycle regulators and apoptosis related genes in Hepatocellular 
carcinoma and the potential therapeutic role of epigenetic modula-
tors on this kind of solid tumor. Introduction: Hepatocellular carcino-
ma (HCC) is the third most frequent cause of cancer related deaths, 
with the heaviest burden on Southeast Asian and African countries, 
due to high rates of chronic Hepatitis B Virus (HBV) infection. The tu-
mor usually presents in an advanced stage, when surgical resection 
is non-curative. Thus, research on new, more effective chemothera-
peutic approaches is necessary. Besides the already known genetic 
mutations found on HCC cells, it has recently been accepted that 
epigenetic gene expression modifications may play a pivotal role 
on hepatocarcinogenesis. These mechanisms involve methylation 
of CpG islands and histone deacetylation, altering the expression 
of several genes, namely tumor suppressor genes and oncogenes. 
These mechanisms, opposite to genetic mutations, are reversible, 
so that they may be explored as new therapeutic approaches on 
hepatocellular carcinoma. In fact, drugs targeting these mechanisms 
are already available for the treatment of Myelodysplastic Syndro-
mes. Methods: By using a methylation-specific PCR protocol, we 
were able to find epigenetic alterations on some cell cycle regulator 
genes and apoptosis related genes on three different HCC cell lines, 
HUH-7, HEPG2 and HEP3B. Additionally, we proved the efficacy of 
trichostatin (a histone deacethylase inhibitor drug) and decitabine 
(a hypomethylating drug) on reducing cell viability on HCC cell lines 
by using the Alamar Blue reduction assay. Results: Our preliminary 
results show that the gene coding to the p16, DAPK and DKK family 
proteins are methylated in the different HCC cell lines and the epi-
genetic modulators, trichostatin and decitabine, induced a decrease 
in cell proliferation and viability in a dose and time dependent man-
ner. Conclusions: This study reinforces the theory that epigenetic 
modifications are involved in hepatocarcinogenesis and shows that 
epigenetic modulators (epidrugs) may be useful as new therapeutic 
approach in hepatocellular carcinoma.
PS 207 Nordihydroguaiaretic acid as a new therapeutic approach in 
cancer.
Barradas J1, Antunes da Silva P1, Neves S1,2, Sarmento-Ribeiro 
AB1,2, Nascimento Costa JM1,2,3.
1 Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
2 Center of Investigation on Environment, Genetics and Oncobiology (CI-
MAGO), FMUC, Coimbra, Portugal.
3 Medicine Service and Hepatology Unit, University Hospital of Coimbra, 
Coimbra, Portugal.
Aim: The aim of this study was to test the cytotoxic and antiprolifera-
tive effects of NGDA in different tumor cell lines namely in Hepatoce-
llular carcinoma (HCC) Acute Myeloid Leukemia (AML). Introduction: 
Nordihydroguaiaretic acid (NDGA) is a phenolic compound produced 
by Larrea tridentata, the creosote bush of Mexico and the American 
southwest. This compound is known for its anti-oxidant properties. 
NGDA eliminates reactive Oxygen Species (ROS) in vitro; inhibits 5-li-
poxygenase reducing the synthesis of leukotriens, leading to the 
reduction of the inflammatory pathways. It has also shown that this 
compound inhibits cell growth and induces apoptosis in different 
types of cancer, in both cell culture and animal models. However, 
the mechanism involved in its anti-tumorigenic and anti-proliferative 
effects are not clear. Methods: For this purpose, we used 3 HCC cell 
lines, Huh-7, Hepg-2 and Hep3b, and a AML cell line, HL-60. The 
antiproliferative effect was assessed by the Alamar Blue assay and 
cell death by optic microscopy and flow cytometry using Annexin V 
and Propidium iodide. We also assessed intracellular ROS levels by 
flow cytometry using specific fluorescent probes, DHE and DCF-DHA, 
respectively for superoxide anion and peroxides. Results: Our results 
showed that NGDA have antiproliferative and cytotoxic effects in a 
dose, cell and time dependent manner. The cell death occurred in 
all the cell lines, preferentially by apoptosis. An increasing of intra-
cellular levels of ROS was observed that may mediate cell death. 
Conclusions: Our results suggest that NGDA may constitute a new 
potential therapeutic approach in both HCC and ML treatment owing 
to its pro-oxidant properties when used in high concentrations.
PS 208 Suicide gene therapy in hepatocellular carcinoma - In vitro 
studies.
Marta Ribeiro1, Sílvia Neves1,2, Ana Bela Sarmento-Ribeiro1,2, 
José Manuel Nascimento Costa1,2,3.
1 Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
2 Center of Investigation on Environment, Genetics and Oncobiology (CI-
MAGO), FMUC, Coimbra, Portugal.
3 Medicine Service and Hepatology Unit, University Hospital of Coimbra, 
Coimbra, Portugal.
Aim: The aim of the present study is to test the therapeutic potential 
of gene therapy using suicide genes (HSV-TK/ GCV or CD/ 5-FC) in 
monotherapy and in combination with conventional anticarcinogenic 
agents (Doxorrubicin) and new targeted drugs (proteasome inhibitor 
MG-262) in the hepatocellular carcinoma cell lines, HUH-7 and HepG-
2. Introduction: Hepatocellular carcinoma (HCC) is the most frequent 
liver tumor in the world. It is often diagnosed in advanced stages of 
the disease and current treatments such as surgery, radiation and 
chemotherapy, have significant limitations in terms of efficacy and 
patients survival making HCC a disease without effective therapeutic 
options and poor prognosis. Although there are undergoing several 
preclinical studies and phase I/II/III clinical assays with drugs that 
target specific signaling pathways, growth factor receptors and/or 
tumoral microenvironment the results are not totally conclusive and 
the combination of gene therapy and conventional chemotherapy 
as been poorly studied in HCC. Suicide gene therapy involves the 
delivery of a suicide gene into target cells, making them sensitive to 
an appropriate prodrug. This delivery can be made by viral or non-
viral vectors, cationic liposome/DNA complexes (lipoplexes) emerged 
as promising systems due to their low toxicity and immunogenicity, 
lack of pathogenicity and versatility. Herpes Simplex Virus thymidine 
kinase (HSV-TK)/ ganciclovir (GCV) and the bacterial cytosine deami-
nase (CD)/ 5-fluorocytosine (5-FC) systems are the most commonly 
used. Methods: To attain this purpose, the HCC cell lines, HUH-7 
and Hepg-2, were submitted to suicide gene therapy (HSV-TK/GCV 
or CD/5-FC) mediated by the Tf-lipoplexes, using increasing concen-
trations of GCV and 5-FC both as single agents and in association 
with MG-262 and Doxorrubicin, during different periods of time. Cell 
viability was evaluated by the Alamar Blue assay. Results: Results 
show that the delivery of HSV-TK gene to the cells, mediated by 
the Tf-lipoplexes and followed by ganciclovir treatment, resulted in 
decreased viability in monotherapy, depending on GCV dose and in-
cubation time. A synergetic antiproliferative and cytotoxic effect was 
observed when used the combination of HSV-TK/GCV with MG-262 
or Doxorubicin Similar results were obtained when the suicide gene 
therapy approach CD/5-FC were used in both cell lines. Conclusions: 
These results suggest that suicide gene therapy HSV-TK/GCV or CD/5-
FC may constitute a new potential therapeutic approach in HCC not 
only in monotherapy, but also in association with conventional the-
rapies or new targeted drugs.
PS 209 The importance of signaling pathways in Chronic Myeloid 
Leukaemia: Ras/MAPK, PI3K/mTOR and Proteasome Pathways 
as therapeutic targets.
Alves R1,2, Fonseca AR1,2, Gonçalves AC2,3,4, Alves V5, Sarmento-
Ribeiro AB2,4,6.
1 Master Student, Faculty of Science and Technology, University of Coim-
bra.
2 Applied Molecular Biology and Hematology Group, Faculty of Medicine, 
University of Coimbra.
3 PhD. Student, Faculty of Medicine, University of Coimbra.
4 CIMAGO - Center of Investigation on Environment Genetics and Oncobio-
logy, Faculty of Medicine, University of Coimbra.
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6 Center for Neuroscience and Cell Biology (CNC), University of Coimbra.
Aim: The aim of this study was evaluated the potential therapeutic of 
the farnesiltransferase (L744832), mTOR (Everolimus) and proteaso-
me inhibitors (MG262) respectively, alone and in combination with 
Imatinib in Chronic Myeloid Leukemia. Introduction: Chronic myeloid 
leukaemia (CML) is a mieloproliferative disorder characterized by the 
presence of the BCR-ABL gene fusion that encodes an oncoprotein, 
with a deregulated tyrosine kinase activity. The first-line treatment 
is Imatinib, a specific tyrosine inhibitor that blocks BCR-ABL tyrosine 
kinase activity. This oncoprotein activates multiples pathways in 
cell, responsible for particularly tumor cells characteristic, namely 
the high cellular proliferation and resistance to apoptosis. One of 
these pathways is the RAS/MAPK pathway which is responsible 
for cell proliferation and survival. The activation of RAS proteins 
requires the attachment of a farnesyl group that is mediated by 
the farnesyltranferase enzyme. Other pathways include de activa-
tion of the PI3K/AKT/mTOR pathway (Phosphatidylinositol-3-kinase/
AKT protein kinase B/Mammalian Target of Rapamicin). On the other 
hand, the escape to apoptosis is also a problem. The proteasome 
inhibitor MG262, a bortezomib analogue, acts directly by blocking 
the proteasome 20s subunit triggering apoptotic mechanism. So, 
the knowledge of the cell signaling pathways involved in CML may 
contribute to the development of new therapeutic approachs in this 
kind of leukaemia. Methods: For this purpose, we used a CML cell 
line in blast crisis, the K562 cells. Cells were cultured in absence 
and presence of different concentrations of L744832, Everolimus and 
MG262 alone, and in association with Imatinib. To evaluate the effect 
of these inhibitors on cell viability we used the Resazurin Assay. 
Cell death was determined by optical microscopy (May-Grunwald 
staining), by flow cytometry (FC) using the Annexin V and Propidium 
Iodide double staining, and by the expression levels of the activated 
caspase 3. The effect of the drugs in cell cycle was determined by 
flow cytometry using Propidium Iodide incorporation. Results: We 
found that the half maximal inhibitory concentration (IC50) at 24 
hours of exposure to L744832 was 25μM. To Everolimus and MG262 
after 48 hours of treatment, the IC50 range between 15 to 25 μM and 
15 to 25 nM, respectively. The association of lower doses of these 
inhibitors with 1 nM of Imatinib, which IC50 value was 75 nM, shows 
an additive/synergist cytotoxic effect. Combined therapy reveals to 
be a more effective strategy since the effects are greater with the use 
of smaller doses. These compounds induced cell dead by apoptosis 
in a time- and dose- dependent manner. Conclusions: In conclusion, 
our results suggest that inhibition of others pathways beyond BCR-
ABL oncoprotein could be used as a new potential approach in the 
treatment of CML.
PS 94 AZFb microdeletions and oligozoospermia - How does it 
work?.
Rita Soares A1, Fernandes S1, Silva J2, Sousa M2,3, Barros A1,2.
1 Genetics Department, Faculty of Medicine, University of Porto.
2 Centre for Reproductive Genetics A Barros, 3 Laboratory of Cell Biology, 
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Por-
to; Porto, Portugal.
Aim: On this work, our aim was to identify the deletion patterns and 
its breakpoints in patients with “atypical” microdeletions in AZFb 
and AZFc and, when possible, to characterize the recombination 
mechanisms underlying these microdeletions. Introduction: Micro-
deletions in AZFa, AZFb and AZFc regions lead to different patterns 
of male infertility, from oligozoospermia to azoospermia. Intrachro-
mosomal recombination mechanisms were identified in patients 
with microdeletions in AZFb and AZFc. However, some AZFb deletions 
could not be explained through these mechanisms. Furthermore, 
severe oligozoospermia cases are normally associated to AZFc and 
not with AZFb deletions in the Y chromosome, as presented in this 
study. Methods: Two patients presenting severe oligozoospermia 
and two with azoospermia were identified as having atypical AZFb+c 
deletion patterns, after Y chromosome microdeletions analysis. The 
definition of those microdeletions and the fine characterization of 
the respective breakpoints were performed using STSs-PCR and DNA 
sequencing. Results: From the four patients studied, and according 
to Y chromosome structure and nomenclature, we identified three 
different deletion patterns: P5/P1 distal (50%; 2/4); P5/P1 proximal 
(25%; 1/4) and IR4/distal-P2 (25%; 1/4). Conclusions: Analysis of 
these patients allows us to present a putative region that should be 
involved in spermatogenesis conservation.
PS 216 NEW TARGETED THERAPIES IN DIFFUSE LARGE B-CELL LYMPHO-
MA - THE ROLE OF NF-KB PATHWAY.
Ana Ribeiro1, José Mendes1, Cristina Gonçalves2,3, Vera Alves4, 
Ana Bela Sarmento-Ribeiro2,3.
1 Medical students of Faculty of Medicine, University of Coimbra, Portu-
gal.
2 Applied Hematology and Applied Molecular Biology/Biochemistry Insti-
tute, Faculty of Medicine, University of Coimbra, Portugal.
3 Center of Investigation on Environment Genetics and Oncobiology (CI-
MAGO), Portugal.
4 Immunology Institute, Faculty of Medicine, University of Coimbra, Por-
tugal. 
Aim: The aim of this study was to evaluate the therapeutic potential 
of an IkB kinase inhibitor (Partenolide) and a proteasome inhibitor 
(MG262) in DLBCL. Introduction: Diffuse Large B-cell Lymphoma (DL-
BCL) is the most common type of non-Hodgkin lymphoma (NHL), 
accounting for about 30-40% of all cases. It is a clinically aggressive 
lymphoma with a five-year survival rate of 50%. The nuclear factor-kB 
(NF-kB) pathway is essential in lymphomagenesis, being active in 
several NHLs. The implication of this pathway confers cancer cells 
a survival advantage by inhibiting apoptosis. After activation, NF-kB 
translocates from the cell cytoplasm to the nucleus, where it parti-
cipates in gene transcription. On account of that, the deregulation 
of NF-kB pathway plays a role in the development of several NHLs, 
being critical for DLBCL, in particular to the activated B-cell-like (ABC) 
DLBCL subtype. The inhibition of the NF-kB through the introduction 
of an IkB-super-repressor or by inhibiting IkB proteasome degrada-
tion may be new therapeutic strategies in this kind of lymphomas. 
Methods: We used the DLBCL cell line Farage, tested in absence 
and presence of several concentrations of Partenolide and MG262, 
used in monotherapy and in association with each other and with 
conventional chemotherapy drugs (Vincristine). Cell viability was 
determined by the Alamar Blue® test and the efficacy of the drugs 
evaluated by dose-response curves and IC50. The type of cell death 
was investigated by flow cytometry (with Annexin-V and Propidium 
Iodide double staining) and optical microscopy (using May-Grünwald 
Giemsa staining). The mechanisms involved in drugs cytotoxicity 
were analyzed by flow cytometry through the expression of proteins 
involved in apoptosis, namely Caspase 3 and Cytochrome c. Results: 
Our preliminary results showed that Partenolide and MG262 induced 
cell death mainly by apoptosis in a time- and dose-dependent man-
ner, attaining the IC50 value of 10,0 μM after less than 24 hours for 
Partenolide and of 25 nM after 24 hours for MG262. Conclusions: Our 
investigation suggests that Partenolide and MG262 might be used 
as new therapeutic approaches in Diffuse Large B-Cell Lymphoma.
PS 226 Biophysical aspects of nucleolar-targeting peptides.
Penetra, AC1, Rodrigues, M2, Santos NC2, Gonçalves S2.
1 MFaculty of Medicine, University of Lisbon.
2 Institute of Biochemistry, Biomembranes Unit, Faculty of Medicine, 
University of Lisbon.
Aim: The main aim of this work is to unravel some of the impor-
tant features of nucleolar-targeting peptides (NrTPs) responsible for 
their efficient translocation. Introduction: Cell-penetrating peptides 
(CPPs) were first identified two decades ago and since then new 
classes and applications are constantly being discovered. CPPs are 
short cationic peptides that can serve as vehicles for the delivery 
of different molecules and particles into cells [1]. The efficiency and 
non-invasive nature of peptide-mediated cellular transport provides 
a promising tool for biomedical research. NrTPs are peptides derived 
from crotamine, the main compound of a South-American rattlesnake 
(Crotalus durissus terrificus) venom. These peptides have the ability 
to translocate into cells and exhibit preferential nucleolar localiza-
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tion [2]. Although NrTPs have already been classified as CPP, their 
mode of action at the molecular level is not, clear, yet. Methods: The 
work included the characterization in aqueous medium, quenching 
studies and quantification of partition into bilayers membranes. Re-
sults: This work allowed us to study the photophysical properties of 
peptides NrTP1, NrTP2, NrTP4 and crotamine. NrTP1, NrTP2 and NrTP4 
have essential the same spectral profile and molar absortivity as 
free tyrosine. Crotamine, on the other hand, reveals close proximity 
with tryptophan spectrum (twice the molar absorptivity due to the 
presence of two Trp residues). The quenching studies revealed a 
linear relation between acrylamide concentration and fluorescence, 
therefore indicating that there were no major peptide aggregates in 
solution. In the presence of lipid vesicles there was a decrease in 
the KSV. Conclusions: Results obtained suggest high affinity towards 
lipid bilayers, especially zwitterionic (POPC) and negative (POPG) 
charged ones, which is in agreement with the behaviour of most 
CPP. Moreover, quenching studies already predicted some degree of 
interaction, as KSV drops upon addition of lipid vesicles. Although 
these results only concern the basic and essential characterization 
of NrTP they are definitely the starting point for further studies that 
can ultimately lead to the production of a versatile therapeutic tool.
PS 240 The additional value of a family history of cancer in the de-
velopment of pelvic high grade serous carcinoma in BRCA1 
and BRCA2 mutation carriers.
Teixeira N1, Mourits MJE1, de Bock GH2.
1 Department of Obstetrics and Gynecology, University Medical Center 
Groningen.
2 Department of Epidemiology, University Medical Center Groningen.
Aim: The current study aims at evaluating the additional value of 
a family history on the development of pelvic serous carcinoma in 
BRCA1 and BRCA2 mutation carriers, regarding risk of developing the 
disease, as well as age of onset. Introduction: Approximately 5% 
to 10% of all ovarian cancer cases have a genetic predisposition. 
The BRCA1 and BRCA2 genes are tumor suppressor genes in which 
mutations can cause the hereditary breast-ovarian cancer syndro-
me, conferring a high risk of developing breast, ovarian, tubal and 
primary peritoneal cancer, especially at a young age. Family history 
is also known as a strong risk factor for developing ovarian cancer 
in the general population. However, the impact of a family history 
on the risk of ovarian cancer among carriers of a BRCA mutation is 
still unclear. Methods: Mutation carriers from families followed-up 
at the University Medical Center Groningen between 1996 and 2007 
were selected. The occurrence and age of onset of breast, contra 
lateral breast and ovarian cancer was recorded. The impact of family 
histories on the incidence and age of onset of breast and ovarian 
cancer was analyzed through Cox-regression. Results: 1018 patients 
from 201 different families were included. A total of 51 pelvic carci-
noma cases were diagnosed: 40 in BRCA1 and 11 in BRCA2 mutation 
carriers. The risk of developing the disease was significantly higher 
among patients who had first-degree relatives with ovarian cancer 
before the age of 50 (HR = 1.73, 95%CI = 1.17 - 2.56) and those who 
had first-degree relatives with ovarian cancer at any age (HR = 2.04, 
95%CI = 1.46 - 2.86). First or second-degree relatives with breast 
cancer did not significantly increase the risk of developing pelvic 
carcinoma. Conclusions: This is the first retrospective multicenter 
cohort study modeling the influence of a family history of cancer 
on the risk of developing pelvic carcinoma for women with a proven 
BRCA1 or BRCA2 mutation in a European population. Our findings 
demonstrate that ovarian cancer cases among first-degree relatives, 
at any age, do increase the risk of developing pelvic carcinoma in 
BRCA1 and BRCA2 mutation carriers substantially. This knowledge is 
important when counseling these patients.
PS 252 A drug Delivery system derived from Dengue Virus Structural 
proteins. A focus on siRNA Therapy.
Inês Rego de Figueiredo, João Miguel Freire and Miguel A. 
R. B. Castanho.
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade 
de Lisboa, Lisbon, Portugal.
Aim: Development of drug delivery system with clinical relevance for 
the therapy of pathologies at a molecular level using Dengue Virus 
(DENV) structural protein fragments. Specific objectives: 1. To eva-
luate the Lipid membrane partition and the translocation capability 
of Dengue Virus C protein derived peptides, pepM and pepR as well 
as ssDNA complexes, using Lipid vesicles as biomembrane models. 
2. To study the transfection capability of DENV derived peptides of 
a ssDNA or a plasmid in cell lines. 3. To study of the siRNA therapy 
approach using pepM and pepR as transfection agents using cell 
lines models for specific pathologies. Introduction: Due to the de-
mand on more specific and effective therapies for molecular based 
therapies, a plethora of drug delivery systems have been described 
and developed during the last years to improve the pharmacologi-
cal availability of the drug inside the cell. Cell Penetrating Peptides 
(CPP’s) are one of delivery systems for plenty of molecules, currently 
being used as novel therapeutic approaches for the treatment of 
numerous therapies. One of the first peptide described was the HIV 
Trans-Activator of Transcription protein (TAT). Our group evaluated 
the function of two conserved domains, one hydrophobic related 
to lipid membrane interactions (MBS) and other positively charged 
assigned to viral ssRNA binding of Dengue Virus Capsid Protein (DENV 
C protein)using synthetic peptides, pepM (MBS) and pepR (RBS), 
whose molecular features suggested new CPP system. Methods: In 
this work, fluorescence spectroscopy techniques together with the 
quantitative analysis using biophysical models were used, as well as 
confocal microscopy on cell lines (Baby Hamster Kidney, BHK, cells) 
and blood cells. The study was carried out using DENV C protein 
synthetic peptides, a ssDNA primer and Large Unilamelar Vesicles 
(LUV) as viral genome and cellular membrane models. For confocal 
microscopy, full lenght purified DENV C protein was also used. Re-
sults: Both pepM and pepR, and corresponding ssDNA complexes, 
revealed affinity for membranes. Partition constant showed that 
membrane affinity increases when the content in negatively charged 
lipids on membranes increases, a known feature during endosome 
maturation. PepM crosses lipid membranes and transporting ssDNA 
mainly due its high membrane affinity and hydrophobic profile. For 
pepR studies, no translocation profile using membrane models was 
observed, indicating that it is not by lipid membrane diffusion. Con-
focal microscopy correlates the affinity of DENV C protein peptides to 
cell membranes and ability to translocate along the lipid membrane 
delivering a cargo to the cytoplasm. PepR showed translocation ca-
pability alone and with ssDNA cargo. Together with the biophysical 
studies it may be dependent on an endocytosis mechanism. Con-
clusions: Both peptides have shown CPP capability by delivering a 
ssDNA molecule to the cell cytoplasm. Studies with different cargoes 
such as plasmids, antibodies, proteins or siRNA would evaluate the 
plethora of potentialities for these CPPs. In the future it may be used 
as a research tool as a transfection agent and/or in vivo imunohisto-
chesmistry techniques. Additionally, it may be a potential approach 
for breakthrough therapies for several molecular diseases by the 
delivery of pharmacological molecules such as siRNA.
PS 254 Characterization of Ceramide Kinase-Like (CERKL) in the Ma-
mmalian Retina.
Sharon Vekslin, Judith Nevet and Tamar Ben-Yosef.
Department of Genetics, Faculty of Medicine, Technion-Israel Institute of 
Technology, Haifa, Israel.
Aim: The CERKL gene encodes for ceramide kinase-like, a novel 
protein of unknown function. CERKL mutations are associated with 
a severe retinal phenotype. The purpose of this work is to charac-
terize CERKL’s retinal expression pattern and function. Introduction: 
Hereditary retinal degeneration (HRD) is a clinically and genetically 
heterogeneous group of diseases that cause visual loss due to pro-
gressive loss of rod and/ or cone photoreceptor cells in the retina. 
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The RP26 locus was originally mapped to human chromosome 2q31-
q33 in a large Spanish family. The underlying gene was identified and 
named ceramide kinase-like (CERKL). To date, nine CERKL mutations 
have been reported, all of which are responsible for a distinct form 
of HRD, characterized by early macular involvement with roughly 
parallel cone and rod loss, resulting in a deficit in both periphe-
ral and central vision. CERKL is a homolog of the ceramide kinase 
(CERK) protein, and both proteins harbor a kinase domain related 
to the diacylglycerol kinases (DAGK) and a pleckstrin homology (PH) 
domain. In addition, a CERK-specific region that is downstream from 
the catalytic core and bears a putative Ca2+/calmodulin binding mo-
tif is also present in CERKL. Several studies have been conducted 
to prove biochemical similarity between CERK and CERKL enzymatic 
activities. However, so far there has been no evidence that CERKL 
phosphorylates ceramide or any other lipid substrate in vitro or in 
vivo. Methods: RT -PCR analysis was conducted in order to asses the 
expression levels of Cerkl in the developing mouse eye as well as 
to reveal the unique splice variants of Cerkl in the mouse retina. A 
specific anti-CERKL antibody was used to study the localization of the 
endogenous CERKL protein in the mouse retina. A calcium-overlay 
assay was used to determine whether CERKL actually binds calcium. 
GST pull-down assay will be used to investigate a possible interaction 
between CERKL and calmodulin. To identify CERKL-binding proteins 
we used the Ras-Recruitment system. Results: RT -PCR analysis re-
vealed that in the mouse retina, Cerkl is highly expressed, while 
expression of its homolog, Cerk, is relatively low. The exon structure 
of human and mouse CERKL genes is highly conserved. Four different 
Cerkl splice-isoforms were identified in the adult retina (variants 
a’-d’). In the embryo, five different isoforms were detected (isoforms 
a’, d’-g’). One of the embryonic isoforms (isoform g’) included a 
novel exon of 156bp (exon 12). Therefore, the total number of exons 
in the mouse Cerkl gene is 14, as in the human ortholog. In the 
mouse retina CERKL is located in the ganglion cell layer, in amacrine 
cells of the inner nuclear layer, and in cone photoreceptors. Based 
on a calcium-overlay assay, CERKL does not appear to bind calcium 
directly. One of the identified CERKL-binding proteins is a ubiqui-
tously expressed calcium-binding protein. Interaction between CERKL 
and this protein was confirmed by a co-immunoprecipitation assay. 
Conclusions: The severe retinal phenotype associated with human 
CERKL mutations indicates that this gene plays a crucial role in re-
tinal activity. The high expression level of CERKL in cones correlates 
with the CERKL associated phenotype in humans, which involves 
severe cone degeneration. CERKL’s localization in the retina as well 
as the identified calcium-binding partner indicate that CERKL may 
require an interaction with one or several calcium-binding proteins, 
in order to sense changes in calcium concentration as part of the 
phototransduction cascade.
PS 258 POLYMOR PHISM OF GLUTAT HIONE S -TRANSFERASE M1 AND 
INDICATORS OF OXIDATIVE DNA DAMAGE IN PATIENTS WITH URI-
NARY BLADDER CARCINOMA.
Brankovic M, Cerovic I.
School of Medicine, University of Belgrade.
Aim: The aim of this study was to examine the role of GSTM1 po-
lymorphism in onset of urinary bladder carcinoma, through the asso-
ciation of polymorphism of GSTM1 and indicators of oxidative dama-
ge to DNA in patients with urinary bladder carcinoma. Introduction: 
Exposure to potential carcinogens is an etiological factor in 60-70% 
of patients with carcinoma of urinary bladder. Carcinogens in the or-
ganism are subject to biotransformation and detoxification reactions, 
in which the important role belongs to glutathione S-transferase M1 
(GSTM1). In addition, GSTM1 protects oxidatively damaged nitroge-
nous bases of nucleic acids by its selenium-independent glutathione 
peroxidase activity. Homozygous GSTM1*0 (frequently referred to 
as GSTM1-null genotype) individuals show loss of GSTM1 enzymatic 
activity, which may result in increased damage to DNA molecule. 
Methods: The case-control study had included 80 patients with uri-
nary bladder carcinoma, with additional 60 persons in the control 
group. GSTM1 polymorphism was determined using polymerase 
chain reaction (PCR). The degree of DNA damage was measured by 
the level of 8-hydroxydeoxyguanosine (8-OHdG), which was screened 
in urine samples using ELISA Kit (Competitive Enzyme-Linked Immu-
nosorbent Assay). The effect of smoking and occupational exposure 
on the level of DNA damage had also been evaluated. Results: In 
the control group, 53% of subjects had shown GSTM1-positive ge-
notype (homozygous and heterozygous for the GSTM1*1 allele), and 
47% of them had GSTM1-null genotype (homozygous for GSTM1*0 
allele). In 39% of patients with urinary bladder carcinoma, there is 
a GSTM1-positive genotype (homozygous and heterozygous for the 
GSTM1*1 allele), and in 61% GSTM1-null genotype (homozygous for 
GSTM1*0 allele) was confirmed. Statistical analysis has not shown 
the differences in concentrations of DNA damage marker (8-OHdG) 
between smokers and nonsmokers, neither in patients occupatio-
nally exposed to chemical carcinogens in relation to persons who 
were not exposed (p1 = 0.097, p2 = 0.446). In patients with GSTM1-
null genotype, obtained values of 8-OHdG were twice as high as in 
patients with GSTM1 positive genotype (7.52 ± 1.52 vs. 3.49 ± 0.93. Ng 
/ mg creatinine) and this difference is highly statistically significant 
(p = 0.002). Conclusions: The distribution of GSTM1-null genotype in 
the control group corresponds to the expected frequency of this gene 
in the Caucasian population. Although the distribution of GSTM1-null 
genotype among patients with urinary bladder carcinoma was higher 
than in control group, the difference was not statistically significant. 
There is a significant correlation between GSTM1-null genotype and 
the degree of DNA damage.
PS 268 Prolonged ingestion of epigallocatechin gallate prevents 
diabetes induced vascular modifications in the corpus ca-
vernosum of the rat. Immunofluorescence characterization 
of VEGF, VEGFR1 and VEGFR2 expression.
Catarina Lombo, Inês Tomada, Carla Morgado, Isaura Tavares, 
Delminda Neves.
Department of Experimental Biology, Faculty of Medicine of Universidade 
do Porto, 4200-319 Porto - Portugal.
Aim: To study whether the consumption of epigallocatechin ga-
llate (EGCG) solution during 10 weeks prevents diabetes induced 
structural and molecular changes in blood vessels of CC of rats. 
Introduction: Diabetes type 1 is a very common chronic disease that 
frequently initiates in youth. Patients suffering from this disease, 
have an increased risk of developing complications such as erectile 
dysfunction, which can have a great impact in sexual intercourse. 
This is due, in part, to marked oxidative stress in affected cells, in-
duced by the increasing production of ROS (reactive oxygen species) 
that causes damage in blood vessels of corpus cavernosum (CC), 
decreasing erectile capability of penis. Thus, we hypothesise that 
treatment with antioxidants in the initial phase of diabetes type 1 
may protect CC from structural and molecular changes induced by 
oxidative damage. In support of this hypothesis our previous study 
demonstrated that green tea long-term ingestion led to a decrea-
se of vascular endothelial growing factor (VEGF) and its receptor 
VEGFR2 expression in CC of aged rats. Methods: Wistar rats were 
divided into three groups (n=8): one control group of non-diabetic 
rats (C), one injected intraperitoneally with a streptozotocin solution 
(STZ) and another injected with STZ and treated with an antioxi-
dant present in green tea (EGCG- epigalocatequin galact) solution 
(2g/L) (STZ/EGCG). The rats were sacrificed 10 weeks after the STZ 
injection. The CC was removed and immediately fixed and processed 
for dual-labelling immunofluorescence detection of the endothelial 
protein PECAM (platelet/endothelial cell adhesion molecule) and 
α-actin, and VEGF and their respective receptors VEGFR1 and VE-
GFR2. All the sections were mounted and observed in an Apotome 
fluorescence microscope (Carl Zeiss MicroImaging GmbH). Besides 
that, we performed a morphometrical analysis of smooth muscle 
content in CC after imunohistochemical detection of α-actin (present 
in smooth muscle) employing the program ImageJ® (National Ins-
titutes of Health, Maryland, USA). Results: The expression of PECAM 
and VEGFR2 was restricted to the endothelium and of the α-actin to 
smooth muscle layer in corpus cavernosum’s blood vessels in all 
experimental groups. One the other hand, the expression of VEGF 
was observed both in the endothelium and on smooth muscle, often 
International Journal of Medical Students www.ijms.info   •   2013  |  Vol 1  |  Suppl 1 s30
IJMS
International Journal of 
Medical Students Abstracts
colocalizing with VEGFR1. Morphometrical study demonstrated that 
STZ rats presented a reduced layer of perivascular smooth muscle 
(12,8 +3,5) when compared with that observed in group C (26,2+3,5) 
or STZ/EGCG (23,8+5,5) animals. Conclusions: The data here reported 
suggest that EGCG consumption prevent structural diabetes-induced 
modifications of the blood vessels in the CC. The role of VEGF needs 
to be further evaluated namely in the perspective of a target to 
prevent erectile disfunction during diabetes.
PS 273 Effects of chronic ingestion of high-fat diet and energy res-
triction on the expression of VEGF, VEGFR1 and VEGFR2 in 
aged rat myocardium.
Dalila Fernandes, Inês Tomada, Henrique Almeida, Delminda 
Neves.
Department of Experimental Biology, Faculty of Medicine of Universidade 
do Porto, Porto, Portugal.
Aim: To analyse the effects of high-fat diet regular consumption and 
energetic restriction on the expression of VEGF and VEGFR1 and VE-
GFR2 in the myocardium of aged rat. Introduction: Cardiovascular 
diseases (CVD) are a leading cause of death in the aged population. 
Regular intake of hyperlipidic diet and obesity can induce endothe-
lial dysfunction that always precedes the onset of CVD and atheros-
clerosis. The heart is an organ where the damages caused by high fat 
diet lead to failure, that are due, in part, to structural modification, 
such as fibrosis, and to changes in the expression of angiogenic 
factors and their specific receptors. Herewith we characterize the 
expression of vascular endothelial growth factor (VEGF) and its 
membrane receptors VEGFR1 and 2 in the heart of young and aged 
rats treated with high-fat diet and energy restriction. Methods: Adult 
male Sprague-Dawley rats (8-wks old), individually housed in appro-
priated cages with free access to tap water and maintained under a 
12h light-dark cycle at standard temperature (20-22ºC) and humidity 
(40-60%), were divided into three groups (n=12): a control group of 
rats fed ad-libitum with a standard rodent chow with 7% of energy 
supplied from fat (C); a group of rats with free access to a rodent 
purified diet with 45% of energy supplied from fat (HF) and another 
subjected to energy restriction (75% of daily individual intake of C 
rats) (ER). In each group, 6 rats were sacrificed by decapitation when 
they reached the ages of 6 and 18 months. The heart was removed 
and divided in two fragments that were immediately fixed in 10% 
buffered formalin, or frozen at -80ºC until analysis. Dual-labelling 
immunofluorescence detection of the endothelial protein PECAM 
(platelet/endothelial cell adhesion molecule) and α-actin, VEGF and 
VEGFR1 or VEGFR2 was observed in an Apotome fluorescence micros-
cope (Carl Zeiss MicroImaging GmbH). Besides that, we performed 
to morphometrical analysis of smooth muscle content in the myo-
cardium after imunohistochemical detection of α-actin) employing 
the program ImageJ® (National Institutes of Health, Maryland, USA). 
Analysis of VEGF and VEGFR2 was also performed by Western blot-
ting followed by pixel computerized quantification (Scion Image®). 
Results: The expression of PECAM was restricted to the endothelium 
and of the α-actin to smooth muscle layer in myocardium’s blood 
vessels in all experimental groups. VEGF and its receptors were de-
tected in the cardiomyocytes, however no quantitative differences 
were detected neither with aging nor with consumption of high-fat 
diet or energetic restriction. Morphometrical study concerning the 
perivascular smooth muscle layer demonstrated a significant decrea-
se in the treated groups when compared with age-matched controls. 
Conclusions: The data suggest that aging and diet composition could 
modulate vascular mechanisms of the heart, nevertheless further 
molecular studies will be necessary to elucidate this hypothesis.
PS 277 The role of Pim1 in melanoma progression.
Hurlstone A, Hale AJ.
Faculty of Life Sciences, University of Manchester.
Aim: In order to identify the role that cytoplasmic serine/threonine 
kinase Pim1 has in promoting melanoma progression, regulation of 
melanoma cell proliferation by Pim1 was investigated using Pim1 
inhibitors. In addition, the regulation of Pim1 expression by PI3K 
signalling was investigated. To translate the findings into therapeutic 
potential, this study goes on to investigate whether Pim1 and SMI-4a 
can be combined with PI3K or MEK inhibitors to yield a synergistic in-
crease in the inhibition of melanoma cell proliferation. Introduction: 
Melanoma is the deadliest type of skin cancer with malignant (stage 
4) melanoma having a 5 year survival rate of less than 20%. Pim1 has 
recently been identified as a PI3K signalling dependent gene that is 
up regulated in melanoma cells but its role in melanoma progression 
has to date been only superficially characterized. Pim1 promotes 
cell proliferation and inhibits apoptosis by activating and inhibiting 
Cdc25a and Bad respectively. Pim1 has also been associated with re-
gulating Akt (PKB) and PRAS40 activity and inhibiting the expression 
of the cell cycle inhibitor p27Kip1 through directly promoting the sta-
bility of the substrate targeting subunit (p45Skp2) of the E3 ubiquitin 
ligase SCFSkp2 responsible for targeting p27Kip1 for degradation. The 
databases COSMICTM and CONANTM record that Pim1 over expres-
sion is in fact implicated in a variety of cancers. Methods: Human 
melanoma cell lines MV3, SKMEL28 and WM2664 were cultured in 
supplemented DMEM. Estimates of melanoma cell proliferation were 
obtained through absorbance measurements of melanoma cells 
treated with Pim1 inhibitors 4-[3-(4-Chlorophenyl)-2,1-benzisoxazol-
5-yl]-2-pyrimidinamine (Pim1) or [(5E/Z)-[[3-(Trifluoromethyl)phenyl]
methylene]-2,4-thiazolidinedione] (SMI-4a) and stained using crystal 
violet solution. Protein lysates, extracted using a NP40 lysis or RIPA 
buffer, were resolved in Bis-Tris Novex or SDS Acrylamide gels and 
estimates of protein expression were obtained using ECL or li-cor 
detection systems. RNA interference of Pim1 was carried out by 
transfection of ONTARGET plus Smart Pool Pim1. Results: The PI3K 
inhibitor reduced melanoma cell proliferation by ~75% but had 
no effect on Pim1, p45Skp2 or p27Kip1 expression. SMI-4a inhibits 
p45Skp2 expression and Akt and PRAS40 phosphorylation in a dose 
dependent manner. SMI-4a promotes p27Kip1 expression but has no 
effect on melanoma cell proliferation. Pim1 inhibits melanoma cell 
proliferation by ~30% and p27Kip1 expression but has no effect on 
p45Skp2 expression or Akt and PRAS40 phosphorylation. Attempted 
knock-down of Pim1 inhibited Pim1 expression by ~10% and had no 
effect on melanoma cell proliferation, p45Skp2 expression or PRAS40 
phosphorylation. The combinations of Pim1 inhibitors with PI3K or 
MEK inhibitors reduced melanoma cell proliferation by 55-70%. Con-
clusions: Pim1 and SMI-4a are less effective than the PI3K inhibitor 
at reducing melanoma cell proliferation. Pim1 is confirmed to regu-
late the expression of p45Skp2 and suppress p27Kip1 expression, 
suggesting Pim1 is able to promote melanoma progression. Pim1 is 
also confirmed to regulate Akt and PRAS40 phosphorylation but was 
not found to be regulated by PI3K signalling or to regulate its own 
expression in melanoma cells. Combinations of Pim1(2) or SMI-4a 
with PI3K or MEK inhibitors demonstrated no enhanced inhibition 
of melanoma cell proliferation compared to the effect of the PI3K or 
MEK inhibitor alone.
PS 280 Xanthohumol-supplemented beer affect skin wound-healing 
in diabetic rats.
Raquel Costa1, Rita Negrão1, Ângela Castela2, Delfim Duarte1, 
Pedro Gomes1, Raquel Soares1.
1 Department of Biochemistry (U38-FCT), Faculty of Medicine, University 
of Porto, Porto, Portugal.
2 Department of Epidemiology, University Medical Center Groningen.
Aim: This study aims to evaluate modulation of angiogenesis, in-
flammation and oxidative stress, after chronic consumption of a 
XN-supplemented beer, in diabetic rats. Introduction: In recent years 
there has been a growing interest in phenolic compounds as they 
seem to protect of the establishment of several highly prevalent 
pathologies, such as cancer, diabetes and cardiovascular diseases, 
having in common dysfunctional angiogenesis and inflammation. 
Special attention has been given to xanthohumol (XN), a polyphenol 
well-known for its anticancer and antioxidant potential, that has 
also demonstrated other interesting biological properties. Diabetes 
is responsible for metabolic dysfunction leading to inflammation and 
oxidative stress, resulting in deleterious actions on endothelium. 
Therefore, consumption of polyphenol-enriched food and beverage 
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could improve vascular dysfunction that occurs in diabetic tissues. 
Methods: This study aims to evaluate modulation of angiogenesis, 
inflammation and oxidative stress, after chronic consumption of 
a XN-supplemented beer, in diabetic rats. Healthy Wistar rats and 
streptozotocin (STZ)-induced diabetes mellitus type 1 Wistar rats 
consumed water (Control and STZ-Control, respectively), 5% ethanol 
(STZ-E), stout beer (STZ-Stout) or stout beer supplemented with 10 
mg/L XN (STZ-Stout XN), during 4 weeks. Then, skin wound-healing 
assay was performed, and animals continued the treatment for 7 
days. Wound tissue was collected to evaluate vessel number (vWF 
staining). Liver, kidney and muscle were removed to assess local 
oxidative stress by hydrogen peroxide (H2O2) production. VEGF, NO 
release and N-acetylglucosaminidase (NAG) content were measured 
systemically. Student’s t-test or ANOVA followed by the Bonferroni 
test were used for statistical analysis. Results: Results obtained de-
monstrated that in STZ-Stout XN the number of vessels decreased 
in the wound area. VEGF levels, NAG content and NO released were 
also reduced systemically when compared to STZ-Stout group. The 
same profile was noticed for local production of H2O2 that was redu-
ced in STZStout XN group. Conclusions: These findings suggest that 
consumption of a XN-supplemented beer decreased angiogenesis, 
inflammation and oxidative stress in diabetic animals. Based on the 
health-promoting properties of XN, the production of a beer enriched 
in this polyphenol would be of huge interest to the brewing industry, 
for the benefits this could bring to consumer’s health.
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PHYSIOLOGY & INMUNOLOGY Session
PS 18 POSTJUNCTIONAL α AND β-ADRENOCEPTOR-MEDIATED RESPON-
SES IN THE AORTA OF NEWBORN AND YOUNG RABBITS.
Graça AL1, Moreira-Rodrigues M1,2, Mendes P1, Moura D1,2.
1 Institute of Pharmacology and Therapeutics, Faculty of Medicine, Uni-
versity of Porto.
2 Neuropharmacology, IBMC, University of Porto, Portugal.
Aim: To evaluate α and b-adrenoceptor-mediated effects at the 
postjunctional level in the aorta of newborn and young rabbits. In-
troduction: Postjunctional α-adrenoceptors are innervated receptors 
responsive to the neurotransmitter noradrenaline, whereas b2-adre-
noceptors function as hormone receptors responsive to adrenaline 
from the adrenals. Canine and ovine blood vessels express fully 
developed α-adrenoceptor-mediated responses at birth. In 1-week 
old rabbits, b-adrenoceptor-mediated responses are fully functioning 
and b-adrenoceptor-coupled intracellular responses are present in 
newborn rats. In canine saphenous vein, at birth, there is a lack of 
b-adrenoceptor mediated responses. α and β -adrenoceptormediated 
effects were never evaluated in newborn rabbits. Methods: Aortas 
of anesthetized newborn (postnatal day 1) and young (3 to 4 mon-
ths old) rabbits were dissected, removed, transversely sectioned, 
mounted in isolated-organ baths and connected to isometric force 
transducers. Dose-response curves to isoprenaline and phenyle-
phrine were determined. Data was fitted to sigmoid curves by non-
linear regression (GraphPad Software, La Jolla, CA, USA). Statistical 
analysis was performed by Student’s t-test. The F-test was used to 
analyze the statistical significance of differences in the values of 
Hill slope. P<0.05 was the chosen level of significance. Results: The 
maximal contraction to phenylephrine was lower in neonates than 
in young rabbits (0.54±0.12 mN/mg, n=12 vs 1.00±0.16 mN/mg, n=18. 
P<0.05) but the potency of phenylephrine was higher in neonates 
(EC50=0.38±0.05 μM, n=12) than in young rabbits (1.11±0.17 μM, 
n=18). Complete relaxation to isoprenaline of phenylephrine-con-
tracted aortic rings occurred only in newborn rabbits. The maximal 
relaxation in young rabbits was 21±4 %. Isoprenaline potency was 
higher in neonates (EC50=15.0±2.8 nM, n=10) than in young rabbits 
(EC50=190±42 nM, n=8). In young rabbits, the Hill slope was not 
different from unit (0.98±0.02, n=8). In newborn rabbits, the Hill slo-
pe was significantly higher than 1 (1.64±0.23, n=10). Conclusions: 
Postjunctional α-adrenoceptor-mediated responses in rabbit aorta 
are already developed at birth, similarly to other species. In rabbits, 
β-adrenoceptor-mediated responses are present at birth and develop 
earlier than in dogs. α-adrenoceptor-mediated responses seem to co-
rrelate with the release of noradrenaline, present at birth in all spe-
cies. The maturation of β2-adrenoceptor-mediated responses seem 
to correlate with the adrenaline secretion which is developed in all 
species except for the dog Since in newborn rabbits the Hill slope for 
the β-adrenoceptor-mediated dose-response curve is different from 
unit we hypothesize that a different population of β-adrenoceptors 
is present at birth to disappear later during postnatal maturation.
PS 53 Neuregulin attenuat es right ventricular hypertrophy and 
dysfunction in an experimental model of pulmonary hyper-
tension.
Mendes–Ferreira P1, Maia -Rocha C1, Adão R1, Silva M1, Men-
des MJ1, Lourenço AP1, Cerqueira RJ1, Castro-Chaves P1, De 
Keulenaer GW2, Leite-Moreira AF1, Brás-Silva C1,3. 
1 Department of Physiology, Faculty of Medicine, University of Porto , 
Portugal.
2 Laboratory of Physiology, University of Antwerp, Belgium.
2 Faculty of Nutrition and Food Sciences, University of Porto, Portugal.
Aim: This study analysed the effects of NRG-1 chronic treatment in 
an animal model of PAH and HF. Introduction: Neuregulin (NRG)-1 is 
implicated in the preservation of left ventricular (LV) performance 
in pathophysiological conditions [1]. Nevertheless, the role of NRG-
1 in right ventricular (RV ) failure secondary to pulmonary arterial 
hypertension (PAH) is still unknown. This study analysed the effects 
of NRG-1 chronic treatment in an animal model of PAH and HF. Me-
thods: Male Wistar rats (180-200g) randomly received monocrotaline 
(MCT, 60mg/Kg, sc) or vehicle. After 14 days, animals from these 
groups were randomly assigned to receive treatment with either 
NRG-1 (4ug/Kg/day, ip) or vehicle. The study resulted in 4 groups: 
control (n=10); control+NRG (n=10); MCT (n=10); MCT+NRG (n=10). 
Echocardiography, RV invasive hemodynamic evaluation and sam-
ple collection for vascular, morphometric, histologic and molecular 
studies were performed 25 to 28 days after MCT administration. 
Results: MCT group developed PAH, as shown by the increase in RV 
maximum pressure (MCT vs control: 63±3 vs 34±3mmHg) and by the 
decrease in cardiac output (MCT vs control: 34.4±4.4 vs 64.6±3.4mL/
min) which were both attenuated in the MCT+NRG group (53±3mmHg 
and 52.2±1.6mL/min). Ecocardiographic data confirmed these results 
and showed a marked dilatation of the RV , and a decrease in the 
pulmonary artery acceleration time in the MCT group, changes that 
were also reduced by NRG-1 treatment. Animals from the MCT group 
developed RV hypertrophy (RV weight/tibia length ratio MCT vs con-
trol: 0.08±0.002 vs 0.05±0.003 g/cm) and pulmonary congestion (lung 
weight/tibia length ratio MCT vs control: 0.7±0.03 vs 0.4±0.03g/cm), 
both changes were minimized by the NRG-1 treatment (0.06±0.002 g/ 
cm and 0.6±0.03 g/cm, respectively). Histological analysis also revea-
led a decrease of RV cardiomyocyte hypertrophy and fibrosis in the 
MCT+NRG group in comparison with MCT group. The RV of MCT group 
animals presented an increased expression of brain natriuretic pepti-
de and endothelin(ET)-1 (17.5 and 5.0 times vs control, respectively). 
These changes were attenuated or reversed in the MCT-NRG group 
(brain natriuretic peptide expression increased only 5.6 times vs con-
trol, and ET-1expression did not change). The MCT group presented 
endothelial pulmonary vascular dysfunction (38.2±5.4% vs control 
86.3±1.8%) of relaxation of a phenylephrine contracted arterial ring 
in response to acetylcholine), effect that was also attenuated in the 
MCT+NRG group  51.0±5.7%). Conclusions: NRG-1 chronic treatment 
significantly reduced the severity of PAH and RV hypertrophy, as well 
as the expression of genes associated with overload and ventricular 
hypertrophy. These findings suggest that the NRG-1 pathway has a 
relevant role on the pathophysiology of PAH and right ventricular HF, 
representing a potential therapeutically target.
PS 100 The effect of oxidati ve stress upon the absorption of folic 
acid in Caco-2 cells.
Couto M, Araújo JR, Gonçalves P, Correia-Branco A, Gregório 
I, Martel F.
Department of Biochemistry (U38-FCT), Faculty of Medicine, University of 
Porto, Portugal.
Aim: The aim of this study was to investigate the effect of oxidative 
stress upon the uptake of FA by human intestinal epithelial cells 
(Caco-2 cells). Introduction: Excessive reactive oxygen species (RO 
S) in the cells, either because they are formed in excess or be-
cause they are not adequately removed by the antioxidant defense 
machinery, cause oxidative stress, leading to cellular damage. In 
agreement with this, RO S have been implicated in the initiation and 
progression of a number of pathologies, including some conditions 
that affect the intestine. Folic acid (FA) plays a fundamental physio-
logical role in one-carbon metabolism. An adequate supply of FA is 
therefore necessary for normal human health. Humans cannot syn-
thesize FA and thus depend on dietary sources of this vitamin, and 
so any impairment in the process of intestinal absorption of FA may 
induce a whole-body deficiency state. Methods: For this purpose, we 
investigated the effect of a 1h incubation with increasing concentra-
tions of tert-butylhydroperoxide (TBH) upon oxidative stress markers 
and upon viability and proliferation. Induction of oxidative stress 
was evaluated by measuring lipid peroxidation (TBARS assay) and 
total (GSx), oxidized (GSSG) and reduced (GSH) glutathione levels. 
Cellular viability and proliferation was measured by quantification 
of extracellular lactate dehydrogenase activity and sulforhodamine 
B assay, respectively. Results: TBH (3000 μM) induced a decrease in 
total and reduced gluthatione levels and an increase in lipid peroxi-
dation products, while maintaining cell viability and proliferation. 
Based on these results, TBH 3000 μM was chosen for the following 
experiments. Analysis of time-course of 3H-FA (10 nM) uptake by 
Caco-2 cells showed a reduced intracellular maximal accumulation 
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(Amax) and a reduced rate constant for outward transport (kout) of 
3H-FA over time in TBH-treated cells. Analysis of saturation curves at 
4°C shows that TBH did not affect non-carrier mediated 3H-FA uptake. 
Analysis of saturation curves at 37ºC shows that uptake of 100 μM 
3H-FA was significantly increased in TBH-treated cells. For concen-
trations of 3H-FA up to 10 μM, we observed no differences between 
the two groups in carrier-mediated 3H-FA uptake. 3H-FA uptake was 
strongly pH-dependent, being acidic pH-stimulated, both in control 
and TBH-treated cells. Finally, 3H-FA uptake was similarly reduced by 
DIDS (100 μM), 5-metyltetrahydrofolate (1 μM), pemetrexed (0.2 μM) 
and methotrexate (1 μM) in control and TBH-treated cells. Conclu-
sions: Based on our results, we conclude that Caco-2 cells submitted 
to treatment with 3000 μM TBH for 1 h constitutes a good cellular 
model to study the effects of oxidative stress. We also conclude 
that TBH (3000 μM) distinctly modulates the membrane transport 
of low (10 nM) and high concentrations (100 μM) of 3H-FA. Namely, 
oxidative stress (a) increases the efflux of low concentrations of 
3H-FA, probably by affecting the activity of the efflux transporters 
multidrug resistance protein (MRP) and/or breast cancer resistance 
protein (BCRP), and (b) increases uptake of high concentrations of 
3H-FA, by increasing the activity of a transport mechanism with an 
unknown identity at present.
PS 159 The role of polymorphisms in cytokine encoding genes as 
risk factors for autoimmune thyroiditis.
Moreira C1, Durães C2, Alvelos I2, Mendes A2, Santos L2,3, Ne-
ves C1,4, Soares P1,2,5.
1 Faculty of Medicine, University of Porto, Portugal.
2 Institute of Molecular Pathology and Immunology of University of Porto 
(IPATIMUP), Portugal.
3 Medical Faculty of Coimbra.
4 Service of Endocrinology, Hospital S João, Portugal.
5 Department of Pathology, Medical Faculty, University of Porto, Portugal.
Aim: The general aim is to go further in the understanding of AT 
at the genetic level and use this knowledge to achieve a better 
management of the patients. We will evaluate the role of genetic 
polymorphisms in IL6, TNFA, IL1B and IFNGR1 as risk factors for the 
development of Graves disease and Hashimoto’s thyroiditis. Intro-
duction: Autoimmune thyroiditis (AT) comprises a set of diseases 
including Hashimoto’s disease and Graves disease. Hashimoto’s 
thyroiditis and Graves’ disease are characterised by the reactivity 
of autoantigens, causing, respectively, inflammatory destruction or 
autoimmune stimulation of the TSH (thyroidstimulating hormone) 
receptor. AT (and particularly Hashimoto’s thyroiditis) is the most 
common thyroid disease and is the leading form of autoimmune 
disease in women. Cytokines are crucial in the regulation of immune 
and inflammatory responses and therefore are potential candidate 
genes as risk factors in the development of autoimmune thyroiditis. 
Methods: Our project is a case-control study comprising 1075 sub-
jects. The control group included 667 DNA samples obtained from 
Portuguese healthy blood donors. The case group included 408 sub-
jects, of which 79 were diagnosed with Graves disease and 329 with 
Hashimoto’s thyroiditis. Cytokine gene polymorphisms were analy-
sed by real time polymerase chain reaction using TaqMan genotyping 
assays. Results: A significant association was found between the A 
allele in TNFA-308G>A (OR =1.69, CI 1.27-2.27, p=0.0004), the allele C 
in IL6-174G>C (OR =1.33, CI 1.01-1.75, p=0.04) and risk for Hashimoto’s 
thyroiditis. The homozygous genotype CC of IFNGR1-56T>C was also 
significantly associated with Hashimoto’s thyroiditis (OR =0.67, CI 
0.47-0.95, p=0.02), but in this case exerting a protective effect. Signi-
ficant associations were also observed for the risk to develop Graves 
disease: TNFA-308G>A (OR =1.70, CI 1.03-2.81, p=0.04), the allele C in 
IL6-174G>C (OR =1.84, CI 1.11-3.05, p=0.02). The individuals carrying 
the homozygous genotype CC of IFNGR1-56T>C (OR =0.48, CI 0.24-0.99, 
p=0.03) have a lower risk to develop Graves disease . We did not 
observe any significant associations between the IL1B-511C>T and 
any type of autoimmune thyroiditis. Conclusions: This study reports 
significant associations of genetic variants in TNFA, IL6 and IFNGR1 
with the risk to develop Hashimoto’s thyroiditis and Graves disease, 
highlighting the relevance of polymorphisms in inflammation-related 
genes as molecular markers for autoimmune thyroiditis.
PS 177 The role of motivational component in energy provision of 
mental activity.
Mitina Y1, Trutneva E2.
1 Faculty of Medicine, Ryazan I. P. Pavlov State Medical University.
2 Department of Normal Physiology, Ryazan, I. P. Pavlov State Medical 
University.
Aim: Evaluation of changes of brain haemodynamics and metabo-
lism of an organism at rest and at mental activity, and revealing of 
interrelation between various productivity of carrying-out of the task 
and haemodynamic and metabolic characteristics both at students 
with various structure of motivation and a functional condition. In-
troduction: The main indicator of any activity is its success. There 
are many features and reasons which provide on success of activity. 
One of the main factors is motivation to carrying-out of activity and 
to success achievement. It`s known that any activity is impossible 
without energy expenditure. We hypothesize that motivational com-
ponent as the mechanism which provides on high results of any 
activity participates in forming of definitive level of energy expendi-
ture. In additional we hypothesize that successful and unsuccessful 
persons have different final energy expenditure according to their 
structure of motivation. Methods: We used following methods in our 
research: the metabolography, based on incomplete gas analysis, the 
rheoencephalography for evaluation of a brain blood supply level as 
obligatory parameter of mental work carrying-out, the method of the 
heart rhythm mathematical analysis, the Gerbachevsky`s multifacto-
rial psychodiagnostic motivational test, test “Quantitative relations” 
(D.Y. Raygorodsky). Our research was involved 23 students, including 
12 women and 11 men from 19 to 20 years old. Data are expres-
sed as median and range. Data were analysed by Mann-Whitney 
U test, Student t-criteria, Wilcoxon T-criteria. A p-value <0.05 was 
considered statistically significant. Results: We have allocated 11 
successful and 12 unsuccessful students according to the data of 
the test “Quantitative relations”. We observed increase of resting 
metabolic rate at 6 persons from group of successful students, at 10 
studets from group of unsuccessful students. We also registered de-
crease of resting metabolic rate at 5 persons in successful group, at 
2 persons in unsuccessful group (p<0,05) The rheographic index, the 
characteristic of blood supply, received by means of a rheoencepha-
lography method, has increased in both cases. Parameter ascending 
statistically significantly for pools of the left internal somnolent and 
vertebral arteries in case of successful students and for pools of both 
hemispheres in case of unsuccessful students (p<0,01). Motives of 
achievement prevail at successful persons, motives of an avoidan-
ce prevail at unsuccessful persons (p <0,05 concerning motive of 
competition, motive of an avoidance). Conclusions: We assume that 
decrease of resting metabolic rate at successful students is possible 
due to redistribution of energy supply towards working structures 
of a brain. This kind of expenditure is essentially less in comparison 
with expenditure at physical activity. The rheographic index is an 
astable indicator at unsuccessful students. Parameters of functioning 
of an organism are more optimum for achievement of concrete result 
at successful persons.
PS 18 Functional ontogenesis of postjunctional angiotensin II re-
ceptors in the rabbit aorta.
Coutinho L1, César E1, Moreira-Rodrigues M1,2, Graça L1, Men-
des P1, Moura D1,2.
1 Institute of Pharmacology and Therapeutics, Faculty of Medicine, Uni-
versity of Porto.
2 Neuropharmacology, IBMC, University of Porto, Portugal.
Aim: The aim of the present study was to evaluate aorta angiotensin 
II-mediated responses at postjunctional level of newborn and young 
rabbits. Introduction: In the aorta of newborn sheep, angiotensin II-
mediated contraction (postjunctional response) is absent or diminis-
hed compared to adult animals(1).In contrast, the aorta of near-term 
mice already contracts to angiotensin II in a concentration-depen-
dent way(2). However the maturation of postjunctional angiotensin 
II-mediated vasoconstriction at birth is unknown in rabbits. Methods: 
Aortas of anesthetized (xylazine 3 mg/kg and ketamine 22 mg/kg) 
male New Zealand newborn (postnatal day 1), young (3 to 5 months 
International Journal of Medical Students www.ijms.info   •   2013  |  Vol 1  |  Suppl 1 s34
IJMS
International Journal of 
Medical Students Abstracts
old) and adult (14-16 months old) rabbits were dissected, removed 
and cut in rings which were mounted in isolated-organ baths and 
connected to isometric transducers. Non-cumulative dose-response 
curves for angiotensin II were determined. Concentration-response 
results were plotted and fitted to a sigmoid curve by non-linear 
regression (GraphPad Software, La Jolla, CA USA). Statistical analy-
sis was performed by Student’s t-test and by F-test (for Hill slope). 
P<0.05 was assumed to denote a significant difference. Results: 
Angiotensin II (1-300 nM) caused a dose-dependent contraction of 
the aorta in all groups. Angiotensin II potency was lower in adults 
(EC50 = 9.66×10-8 ± 1.32×10-8 M, n=4) than in young rabbits (EC50 
= 1.48×10-8 ± 3.67×10-9 M, n=6). This loss of potency in adult rab-
bits suggests that young rabbits are the best control for this study. 
Maximal contraction to angiotensin II was lower in neonates than in 
young rabbits (neonates: Emax = 0.23 ± 0.07 N/g, n=5; young: Emax = 
0.67 ± 0.12 N/g, n = 6). The potency of angiotensin II (neonate: EC50 
= 1.01x10-8 ± 2.77×10-9 M, n=5; young: EC50 = 1.48×10-8 ± 3.67×10-
9 M, n=6) and the Hill slope of the concentration-response curve 
(neonate: Hill slope 1.07± 0.19; young: Hill slope 0.94±0.08) were not 
significantly different between neonatal and young rabbits. Conclu-
sions: Postjunctional angiotensin II-mediated responses in aorta are 
already expressed in neonates when compared to young rabbits. As 
the potency of angiotensin II and the slope of the concentrationres-
ponse curve were similar in neonates and young rabbits, it is sugges-
ted that the response is mediated by the same receptor, namely AT1, 
in both groups. The lower efficacy of angiotensin II at birth suggests 
that either the maturation of the excitation-contraction coupling or 
the receptor density is still incomplete. These results differ from 
those observed in sheep(1), but are in agreement with the results 
obtained in near-term mice(2), showing that the maturation of aorta 
postjunctional angiotensin II-mediated responses at birth are species 
dependent.
PS 198 Research of splenic lymphocyt e homing using in vivo cell 
competition method.
Donát Péter Sarlós.
Faculty of Medicine , University of Pécs.
Aim: We aimed to study the effect of cell immobilization and surface 
carbohydrate chain modulation on the splenic homing of lympho-
cytes in mice. Introduction: The spleen is the largest peripheral 
solitary lymphoid organ with a major lymphocyte homing activity. In 
contrast to lymph nodes and Peyer’s patches, the spleen lacks high 
endothelial venules (HEV), and the exact details of lymphocyte recir-
culation both in humans and mice are not yet known. According to 
data from literature carbohydrate components are presumably pla-
ying a key role in the early adhesion of lymphocytes to the vascular 
endothelium. Our goal was to develop a method in which we could 
compare the migratory behaviour of two sets of lymphocytes within 
one organism. Methods: In our research we obtained lymphocytes 
from donor mice, and made them distinguishable with two different 
methods. One part of the cells were reacted with intracellular dye 
carboxy-fluorescein diacetate succinimidyl ester (CFSE), the other 
part was marked by non-specific biotinylation of their cell surface 
proteins. With flow cytometry and multicolour labelling microscopy 
we have verified that the labelling procedures have not influenced 
the adhesion and tissue specific localization of the cells. To justify 
the method’s concept, we have studied the effect of different cell 
modifying substances: ConA lectin, binding to cell surface carbo-
hydrate chains and colcemid (similar to colchicin) inhibiting micro-
tubule polymerization, thus immobilizing cells. Results: We found 
that ConA lectin strongly inhibited CFSE-labeled lymphocyte entry 
into the spleen and almost completely prevented their migration to 
the white pulp compared to competitor cells. Colcemid treatment 
did not alter the number of CFSE-labeled lymphocytes entering the 
spleen significantly; however their migration in splenic tissues was 
greatly inhibited. Conclusions: According to our results, this method 
could be suitable for further research of splenic lymphocyte homing 
details.
PS 200 Ghrelin and obestatin decrease the IOP in a acute glaucoma 
model.
Azevedo-Pinto S1, Tavares Silva M1, Pereira-Silva P1, Araújo 
J1,2, Rocha-Sousa A1,2.
1 Physiology Department, Faculty of Medicine, University of Porto.
2 Ophthalmology Department, Faculty of Medicine, University of Porto.
Aim: The aim of this study is to evaluate the effect of the pro-ghrelin 
derived peptides in the intra-ocular pressure in animal models of 
acute glaucoma. Introduction: Ghrelin, des-acyl-ghrelin and obestatin 
are peptides derived from the pro-ghrelin. Ghrelin, an acylated 28 
aminoacid peptide, is the endogenous ligand of the growth hormone 
secretagogues receptor-type 1a (GHSR-1a). Des-acyl-ghrelin lacks the 
acyl group and does not bind GHSR-1a. Obestatin is a 23 aminoacid 
peptide generated by an alternative splicing mechanism. These pep-
tides act on many organ systems. In the eye, ghrelin promotes the 
relaxation of the iris’ sphincter muscle independently from GHSR-1a 
and from nitric oxide (NO) and dependently on prostaglandins, while 
obestatin potentiates its cholinergic contraction. On the iris’ dilator 
muscle ghrelin promotes relaxation, mediated by the GHSR-1a, and 
obestatin leads to a decrease in the basal tension. Ghrelin’s aqueous 
humour levels were studied in patients with glaucoma. Glaucoma 
consists on an optic nerve damage and is the second cause of blind-
ness all over the world, appearing subsequently to an increased in-
tra-ocular pressure (IOP) in the majority of cases. Ghrelin’s aqueous 
humour levels were significantly decreased in glaucoma. Methods: 
The first part of the experimental protocol was the calibration of the 
Tonovet® tonometer, used to measure the IOP, to the rabbit. The 
external calibration involved the cannulation of the eye’s anterior 
segment with a 25G needle, connected to a pressure transducer and 
to a 0,9% NaCl reservoir, which enabled us to alter the IOP. Real IOP 
values varied from 5 to 60 mmHg and in each level IOP was measured 
with the tonometer. Afterwards, the real IOP was compared to the 
the tonometer measurements. In the second part of the protocol we 
generated acute glaucoma models in rabbits and studied the effects 
of ghrelin (10-4M, n=6), des-acyl-ghrelin (10-4M, n=7) and obestatin 
(10-4M, n=7) in the IOP, as well as the subcellular pathways involved. 
An intra-vitreal injection of 20% NaCl (50μL) was made in both eyes, 
in order to raise the IOP, being this an adapted glaucoma model. 
Then, one of the three peptides was sub-conjunctivally injected. 
Concerning the subcellular pathways, keterolac (a COX inhibitor; 30 
mg/mL; 500μL; n=7) or L-NAME (a NO synthase inhibitor; 150mg/Kg; 
500 μL; n=11) were sub-conjunctivally injected previously to both 
NaCl and ghrelin injection. All the results were compared to a control 
group which did not receive ghrelin, des-acyl-ghrelin or obestatin. 
Results: There is a linear correlation between the IOP measured by 
the Tonovet (Y) and its real value (X), being that the tonometer 
underestimated the real value (Y= -0,331 + 0,750X). Our results show 
that the NaCl injection increases the IOP from 9.9 ± 1.9 to 44.9 ± 4.1 
mmHg. After that ghrelin promotes a decrease of 20,8 ± 5,0 mmHg 
(47,9 ± 11,6%); des-acyl-ghrelin does not significantly change IOP; 
and obestatin promotes a decrease of 15,8 ± 3,9 mmHg (37,5 ± 9,4%). 
When keterolac or L-NAME are added, ghrelin’s effect is completely 
blunted. Conclusions: It is of major importance to calibrate the 
tonometer, in order to obtain real measurements. Concerning the 
experimental protocol, ghrelin leads to a decrease in the intra-ocular 
pressure, dependently on GHSR-1a and on NO and prostaglandins 
synthesis. Obestatin also promotes a decrease in the IOP.
PS 231 A Combined Cell Therapy and In-Situ Tissue-Engineering.
Habib M1, Shapira-Schweitzer K2, Caspi O1, Gepstein A1, Arbel 
G1, Aronson D1, Seliktar D2, Gepstein L1.
1 The Bruce Rappaport Faculty of Medicine & 2 Faculty of Biomedical Engi-
neering, Technion-Israel Institute of Technology, Haifa, Israel.
Aim: To test the hypothesis that combined delivery of a novel in-situ 
polymerizable-hydrogel and cardiomyocytes into the rat myocardial 
infarction model will result in superior functional outcome than 
each intervention alone. Introduction: Myocardial cell-replacement 
strategies are emerging as novel therapies but are hahmpered by li-
mited sources for human cardiomyocytes and by significant cell loss 
following transplantation. Methods: A photopolymerizable, biodegra-
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dable, PEGylated-fibrinogen hydrogel was shown to be an effective 
carrier for cardiomyocytes [neonatal rat ventricular cardiomyocytes 
(NRV CMs) or human embryonic stem cell-derived cardiomyocytes 
(hESC-CMs)] both in-vitro and in-vivo. To determine the functional 
impact of this combined in-situ cell-delivery/tissue-engineering stra-
tegy, infarcted rat hearts were randomized to injection of saline, 
NRV CMs, biopolymer, or combined delivery of the biopolymer and 
NRV CMs. Results: Echocardiography revealed typical post-infarction 
remodeling in the saline-injected control group [deterioration of 
fractional shortening (FS) by 31.0±3.6%]. Injection of NRV CMs or bio-
polymer alone significantly (p<0.01) altered this remodeling process 
(manifested by a slight increase in FS (3.1±6.6% and 0.5±5.3%, res-
pectively). Co-injection of the biopolymer and NRV CMs resulted in a 
significant increase in the cell-graft area (by 144%) and eventually to 
the best functional outcome, with FS improving by 26.3±6.6%. Fina-
lly, feasibility studies demonstrated the ability of the biopolymer to 
act as an effective cell-carrier of hESC-CMs and to significantly alter 
the remodeling process (FS improved from 18.9±1.7% to 20.0±1.5%, 
p<0.05). Conclusions: We describe a novel injectable in-situ-forming 
hydrogel that functions as an effective cardiomyocyte carrier and 
adds to the effect of the grafted cells to prevent unfavorable post-
infarction cardiac remodeling.
PS 234 A Combined Gene and Cell Therapy Approach for Restoration 
of Cardiac Conduction.
Anat H, Ilanit I, Amira G, Irit H, Lior G.
Faculty of Medicine, Technion-Israel Institute of Technology.
Aim: To test the feasibility of a novel strategy for cardiac conduc-
tion repair utilizing genetically engineered cells designed to form 
biological “conducting-cables”. Introduction: Abnormal cardiac elec-
trical conduction may underlie both bradyarrhythmias and reentrant 
tachyarrhythmias. However, no practical way exist for restoring or 
improving conduction in areas of conduction slowing or block. The-
refore, restoration of conduction may represent an important antiarr-
hythmic target. Methods: An in-vitro model of conduction block was 
established using spatially-separated, spontaneouslycontracting, 
non-synchronized, human embryonic stem cell-derived cardiomyo-
cyte - clusters. Immunostaining, dye-transfer, intracellular recordings 
(patch clamp), and multielectrode array (MEA) studies were perfor-
med to evaluate the ability of genetically-engineered HEK293 cells, 
expressing the SCN5A-encoded Na+ channel, to couple with cultured 
cardiomyocytes and to synchronize their electrical activity. Further 
studies were focused on extending the maximal coupling distance 
and on enhancing conduction velocity along the “conducting-cables” 
by co-expressing the inward-rectifier potassium channel (Kir 2.1 
channel) in the SCN5A- HEK293 cells. A unique MEA plate consisting 
of larger recording area (256 electrodes) was utilized for testing this 
concept. Results: Connexin-43 immunostaining and Calcein dye-trans-
fer experiments confirmed the formation of functional gap junctions 
between the engineered cells and neighboring cardiomyocytes. MEA 
and intracellular recordings were performed to assess the ability of 
the engineered cells to restore conduction in the co-cultures and 
to synchronize contractions among the beating clusters. Synchroni-
zation was defined by establishment of fixed local activation time 
differences between the cardiomyocyte-clusters and convergence of 
their spontaneous activation cycle-lengths. Non-transfected control 
cells were able to induce synchronization between cardiomyocyte-
clusters separated by distances up to 300μm. In contrast, the Na+ 
channel-expressing cells synchronized contractions between clusters 
separated by up to 1000μm. Finally, we demonstrated that enginee-
red cells expressing both Na+ and K+ channels extended the maxi-
mal coupling distance up to 5.5mm (the longest distance studied), 
which is 5.5 fold more distant than the maximal coupling distance 
facilitated by the cells expressing only the sodium channels. The 
synchronization occurred immediately after establishing co-culture 
between the engineered cells and the hESC-CMS- clusters and the 
conduction along the “cables” improved considerably. Conclusions: 
Genetically-engineered nonmyocytes, transfected to express Na+ and 
K+ channels, can form biological “conducting-cables” bridging and 
coupling spatially-separated cardiomyocyte-clusters in an in vitro 
model of conduction block. This proof-of-concept study describes 
a novel combined cell and gene therapy approach for restoration 
of cardiac conduction and might be useful for the development of 
therapeutic strategies for both brady- and tachy-arrhythmias.
PS 238 THE EFFECTS OF PROTAMINE SULPHATE ON THE DIFFERENT TY-
PES OF ACTIVATION OF THE ISOLATED RAT UTERUS.
Sipovac M, Sofrenovic M, Milovanovic S, Stankovic D, Joka-
novic D.
University of East Sarajevo, Faculty of Medicine, Departm ent of Pharma-
cology.
Aim: The aim of this experiment was to examine the relaxing effect 
of Protamine sulphate (PS) on the isolated uteri of rats and we 
tried to determine how this process developed, in spontaneous and 
calcium-induced activity, and also acetylcholine-induced activity, as 
well as the role of glibenclamide in antagonizing the effect of PS in 
spontaneous and calcium-induced activity. Introduction: Protamine 
sulphate is a mixture of polyamins, and it is used to counteract 
the anticoagulant effect of heparin. It has been found that PS has a 
relaxing effect in rats’ uteri with spontaneous and calciuminduced 
activity as well as it decreases contractility induced by acetylcho-
line. There are several possible mechanisms that could cause the 
relaxation of muscle of uterus via the action of different types of 
receptors and signaling processes. They can involve K+ channels, 
a Ca2+-mediated effect, or some other receptor-mediated proces-
ses, but it has not proved any of these mechanisms yet. Methods: 
In our experiment we used uteri isolated by normotensive female 
Wister rats. The uteri were incubated for about 30 minutes in water-
bath in De Jalon’s solution at 37°C and aerated with 95% O2 and 5% 
CO2. Isometric contractions were recorded using an isometric force 
transducer. The preload of the preparation was approximately 1 g. 
In these conditions, some uteri immediately showed spontaneous 
contractions. Some uteri did not show spontaneous contractions, so 
they had to be stimulated by calcium or acetylcholine. When uteri 
achieved stable contractions, we put increasing doses of PS into the 
water bath. We examined the relaxing effects of protamine sulphate 
on the isolated rats uteri. We also used glibencamide 10mM because 
of its characteristics. Glibencamide is known as one of the most 
selective blockers of KATP channel, but it can also block voltage-
sensitive pottassium (Kv) channels in concentrations higher than 10 
mM. We used it in order to analyse its role as pottassium channels 
blocker in inhibiting effects of protamine sulphate. Results: We found 
out that increasing doses of PS (μg/ml: 10, 20, 50, 100, 150, 200, 300, 
600) had a relaxing effect on uteri muscles in rats. Lower doses (μg/
ml: 10, 20) caused no effect, but higher doses (μg/ml: 150, 200, 300, 
600) were more effective than the lower ones, causing the comple-
te relaxation. That effect was more expressed in spontaneous and 
calcium-induced contractions than in acetylcholineinduced activity. 
We also found out that glibencamide did not show any inhibiting 
effect on PS, both in spontaneous and calcium-induced activity. Con-
clusions: Our results showed that PS had a dose-dependent relaxing 
effect on uteri muscles. Mechanism of action is likely to be realized 
in KATP channel independent way.
PS 247 Different mechanism for diastolic dysfunction in diabetes 
and chronic pressure-overload.
Miranda-Silva D, Falcão-Pires I, Gonçalves N, Moreira-Gonçal-
ves D, Leite-Moreira AF.
Medicines’ Faculty, University of Porto.
Aim: To study the myocardial morphological and functional changes 
induced by diabetes mellitus (DM) and/or pressure-overload (PO). 
Introduction: Diastolic heart failure (DHF) accounts for ~50% of heart 
failure cases and represents a growing problem in industrialized 
nations. Its pathophysiology is ascribed to impaired relaxation or 
increased myocardial stiffness. Often, chronic PO and DM lead to DHF. 
Moreover, hypertension is more prevalent among the diabetic popu-
lation and exacerbates the extent of diabetic cardiomyopathy. Even 
so, functional and structural cardiac consequences of combined PO 
and DM are still unclear. Methods: Pressure-overload was performed 
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in Wistar-male rats by supra-renal aortic banding. After six-weeks, 
diabetes was induced by streptozotocin (65 mg/kg, ip) resulting in 
four groups: SHAM, banding (BA), diabetic (DM) and diabetic-banding 
(DB). Six weeks later, hemodynamic study was performed to evaluate 
cardiac performance. Samples were collected for histology, molecular 
studies and force measurement in isolated skinned cardiomyocytes. 
Results: Chronic PO increased LV hypertrophy (cardiomyocyte dia-
meter: BA 22.0±0.4μm, SHAM 18.2±0.3μm), myofilament active force 
(Factive: BA 25.7±3.6kN/m2, SHAM 18.6±1.4kN/m2) and Ca2+ sen-
sitivity (BA 5.56±0.02, SHAM 5.50±0.02) as well as phosphorylation 
of myofilamentary protein (MLC-2, MyBP-C) and insulin signaling 
pathways (Erk, Akt). At the extracellular matrix level, interstitial 
fibrosis (BA 10.8±0.9%, SHAM 5.3±0.6%) and pro-MMP-2 e MMP-9 ac-
tivity were increased. In vivo, contractility (LV peak systolic pressure 
(LV-PES) and maximal LV wall stress (LV-Wstress)) was increased and 
both LV-PES and LV-Wstress correlated positively with Factive, while 
relaxation was impaired (τ; BA 14.0±0.9ms, SHAM 12.9±0.4ms). DM 
increased cardiomyocyte diameter (DM 21.4±0.4μm, DB 20.6±0.4μm), 
the expression of inflammatory (TNF-α) and apoptosis markers (Bax/
Bcl-2). At the extracellular matrix level, diabetic animals displayed 
augmented myocardial fibrosis (DM 13.9±1.8%, DB 13.8±0.8%) and 
advanced glycation end-products (AGEs) deposition: 4.9±0.6score/
mm2, 5.1±0.4score/mm2. In vivo, these abnormalities resulted in 
increased stiffness confirmed by the higher values of LV end dias-
tolic pressure (LV-PED, DM 7.0±1.2mmHg, DB 6.7±0.7mmHg, SHAM 
5.3±0.4mmHg) and end-diastolic pressure-volume relation (EDPVR, 
DM 0.59±0.18, DB 0.83±0.17, SHAM 0.41±0.10). Furthermore, diabetic 
animals displayed lower contractility (end-systolic pressure-volume 
relation (ESPVR), expression of MHC-α/MHCbeta and, as expected, 
lower activation of insulin signaling pathways (Akt phosphorylation 
levels). The association of DM and PO induced further pulmonary 
congestion (Lungs/body-weight: DB 5.23±0.21g/kg, SHAM 3.80±0.14g/
kg) as this group combined overload-induced relaxation abnormali-
ties and diabetes-induced stiffness. Conclusions: DM and PO led to 
distinct diastolic dysfunction phenotypes: while diabetes promoted 
myocardial stiffening, pressure overload impaired relaxation. The 
association of these damages accelerates the progression of DHF 
progression in diabetic-banded animals.
PS 255 Mycobacterial Thymic Immune Response.
Rodrigues B, Correia-Neves M, Nóbrega C.
Life and Health Sciences Research Institute (ICVS), School of Health Scien-
ces, University of Minho, Braga, Portugal.
ICVS/3B’s-PT Government Associate Laboratory, Braga/Guimarães, Portu-
gal.
Aim: Investigate the characteristics of the immune response against 
mycobacteria within the thymus: Characterize the cytokine and che-
mokine profiles of infected thymi compared to those established in 
peripheral infected organs like the spleen and lung; Evaluate to what 
extent recent thymic emigrants and/or re-circulating mature T cells 
are responsible for the immune response against mycobateria within 
infected thymi. Introduction: Our laboratory has recently shown that, 
in the mouse model, mycobacteria are able to infect the thymus, 
the organ responsible for T lymphocyte differentiation, rendering 
newly differentiated T cells tolerant in responding to mycobacterial 
antigens. The bacterial load in the thymus slowly progresses, rea-
ching a stagnation at more advanced periods of infection [16weeks 
post-infection (wpi)], while in the spleen it occurs after 4weeks. In 
the spleen, this stagnation is clearly associated to the appearance 
of IFN-γ secreting T cells, and so we suspected the involvement of 
these cells in the thymus as well. Knowing that newly generated T 
cells in the adult mice are not fully differentiated and that T cells that 
differentiate within an M. avium-infected thymus are tolerant to the 
invading pathogen, we suspected the involvement of mature T cells 
which are re-circulating from peripheral organs back to the thymus, in 
the thymic mycobacterial infection. Methods: Wild type and RAG-GFP 
mice were infected i.v. with 106 CFU M. avium. Expression of specific 
genes was assessed through qRT-PCR. Using the transgenic RAG-GFP 
mice, that allow the discrimination of newly generated T cells (GFP+) 
from re-circulating T cells (GFP-), we assessed the number, specificity 
and IFN-γ secreting ability of both these populations in the thymus. 
To analyze the specificity of re-circulating T cells in the thymus, cells 
were incubated with tetramers for the mycobacterial epitope antigen 
85 (Ag85). Results: Coinciding with the stabilization of the bacterial 
load in the thymus is an increased expression of IFN-γ at 16wpi, in 
infected mice in comparison to uninfected, followed by an increase 
in iNOS expression, a marker of macrophagic activation, at 24wpi. 
Increased levels of the Th1 recruiting chemokines IP-10, MIG and 
MIP-1beta was detected in the thymus from 16wpi in comparison 
to non-infected mice. Although the number of re-circulating cells 
was not increased by infection, this pool was enriched with specific 
mycobacterial T cells. We were able to detect an increased number 
of Ag85-specific T cells within the pool of re-circulating T cells from 
16wpi on. Conclusions: The data from this work presents evidence 
of an ongoing immune response in the thymus, which occurs at 
later time points and with a distinct activation profile from that in 
the spleen. The thymus recruits mycobacterial-specific T cells from 
the periphery, which appear to be major producers of IFN-γ upon 
stimulation with mycobacterial antigens. Consequently, this work 
suggests a role for re-circulation: cells that re-circulate back to the 
thymus might be part of a simple surveillance routine.
PS 256 A role for regulatory CD4+ T cells in the immune system 
reconstitution of HIV-infected patients under anti-retroviral 
therapy.
Pedro Amorim-Machado1, Palmira Barreiro-Silva1, Claúdia 
Nóbrega1, Ana Aboim Horta1,2, Rui Sarmento e Castro1,2, Mar-
garida Correia-Neves1, António Gil Castro1.
1 Life and Health Sciences Research Institute (ICVS), School of Health 
Sciences, University of Minho, Braga, Portugal.
2 Infectious Diseases Department, Hospital Joaquim Urbano, Porto, Portu-
gal.
Aim: The present work aims at understanding if the number or cha-
racteristics of the Treg cells are associated with the quality of the im-
mune system reconstitution in a transversal study with HIV+ patients 
under HAART. Specifically, we aim to investigate how the proportion 
of Treg correlates with * the level of CD4+ T cell reconstitution; * 
the activation status of CD4+ T cells; * other characteristics of the 
patients like Nadir, age, duration of therapy. Introduction: Protection 
against infection is fundamental which is mostly mediated by the 
immune system. However, this system is subject to failure that might 
result in immunodeficiency. HIV infection is characterized by a pro-
gressive loss of CD4+ T cells, which has a significant impact on the 
efficiency of the immune /response. The highly active antiretroviral 
therapy (HAART) has reduced the morbidity and mortality associated 
with HIV infection by decreasing the viral load and increasing CD4+ T 
cell counts. Regulatory T (Treg) cells play a very important role in the 
immune system homeostasis, avoiding excessive activation during 
certain immune responses to infection and reducing the activation 
of auto-reactive T cells. These cells express the HIV co-receptor CCR5 
and are highly susceptible to HIV infection and replication. Since 
Treg cells are crucial for the homeostasis of the immune system, the 
correct recovery of these cells during immune reconstitution due to 
HAART might have an important impact on this process. Methods: 
The aim of this work is to evaluate 60 HIV-infected adult individuals 
that are currently under HAART. Any patient interrupting therapy is 
excluded from the study. The clinicians collect all relevant infor-
mation for each patient, namely age, sex, the latest CD4+ counts 
and HIV viral load, years in treatment, other existing pathologies 
and clinical signs of health/disease. Different blood cell populations 
are analyzed according to specific markers for each population by 
flow cytometry analysis: neutrophils (CD15), TCRαbeta lymphocytes 
(TCRαbeta), T cells (CD3), B cells (CD19), CD4+ versus CD8+ T cells, 
naïve (CD45RA) versus memory (CD45RO ) cells, activated cells (CD69 
and HLA-DR), recent thymic emigrants (CD31 and PTK7) and Treg 
cells (CD127lowCD25high-Foxp3+). Results: Our preliminary results 
suggest that an increased proportion of Treg cells is associated with 
a poor  recovery of CD4+ effector T cells, and these Treg levels are 
negatively related to the Nadir value. Conclusions: Our results show 
a possible role for Treg cells in the maintenance of the homeostasis 
of the immune system by regulating the expansion and proliferation 
of CD4+ T cells.
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PS 257 Function muscular evaluation in response to α-adrenergic 
stimulation in Diabetes and/or pressure Overload.
Patrícia Rodrigues, Carla Barros, Daniela Miranda-Silva, Inês 
Falcão-Pires, Adelino F. Leite-Moreira.
Serviço de Fisiologia e Cirurgia Cardiotorácica, Faculdade de Medicina da 
Universidade do Porto.
Introduction: Both Diabetes mellitus (DM) and chronic pressure-over-
load due to hypertension are major causes of heart failure. Several 
studies suggest that the association of diabetes and hypertension 
results in more pronounced myocardial histological, ultrastructural 
and mechanical damages than each condition per se. Under cardiac 
stress conditions, such as hypertension or DM, the increased sympa-
thetic activity and subsequent α-adrenergic (α-AR) stimulation is an 
important physiologic mechanism to enhance cardiac performance 
during augmented circulatory demands. The aim of this study was to 
investigate the role of myocardial α-adrenergic stimulation in pressu-
re overload, diabetes mellitus and their association. Methods: Pres-
sure-overload was established by suprarenal aortic banding in male 
Wistar rats. Six weeks later, diabetes was induced by streptozotocin 
(STZ, 65mg/kg, intraperitoneally), resulting in four groups: SHAM, ban-
ded (BA), diabetic (DM), and diabetic-banded (DM-BA). On the 12th 
week, left ventricular (LV) function was assessed in vitro by papillary 
muscle’s performance at baseline and in response to increasing con-
centrations of phenylephrine (PHE; Dose A: 100mM; Dose B: 30mM; 
Dose C: 10mM; Dose DEF: 3mM) in the presence of a beta-adrenergic 
antagonist (nadolol, 0,01mM). Results: After 12 weeks, increasing 
concentrations of PHE decreased contractility in SHAM, BA, DM-BA 
groups (PS: Sham:-32,6±5,96%; BA:-17,7±8,07%; DM-BA:5,45±5,30%; 
dL/dtmax: Sham:-26,2±5,90%; BA:-15,0±8,34%; DM-BA:-5,6±5,02%; 
AT: Sham:-34,4±5,95%; BA:-18,9±7,80%; DM-BA:-9,3±5,92%; dT/dtmax: 
Sham:-31,7±6,48%; BA:-14,7±8,62%; DM-BA:-7,4±5,53%). Moreover, 
PHE showed a negative lusitropism as observed by the analyzed re-
laxation parameters (dL/dtmin: Sham:-37,1±9,87%; BA:-17,7±10,52%; 
DM-BA:-9,5±6,88%; dT/dtmin: Sham:-23,7±10,42%; BA:-17,3±8,30%; 
DMBA:-11,5±6,13%) (Table 1). Interestingly, only DM group displa-
yed an increased in contractility and relaxation (PS: 17,3±10,52%; 
dL/dtmax: 13,3±8,70%; AT: 18,7±13,35%; dT/dtmax: 17,7±10,95%; dL/
dtmin: 35,1±20,31%; dT/dtmin: 7,0±23,83%). Conclusions: Myocardial 
α-adrenergic stimulation with PHE improved contractility and relaxa-
tion only in diabetic animals. We conclude that this effect represent a 
compensatory response to the decreased betaadrenergic stimulation.
PS 261 IL-10 plays a role in the several behavioral dimension of 
depression.
Diogo Teles, Susana Monteiro, Filipe Quintas, Bruno Rodri-
gues, Daniela Calçada, Nuno Sousa, Joana A. Palha, Margari-
da Correia-Neves, Susana Roque.
Life and Health Sciences Research Institute (ICVS), School of Health Scien-
ces, University of Minho, Braga, Portugal.
ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portu-
gal.
Aim: Study anxious-like, hedonic and cognitive behavior in mice 
lacking IL-10 expression (IL-10-/-) known to present depressive-like 
behavior. Evaluate the cytokine profile, in the periphery and brain 
regions, of these mice and correlate with behavioral alterations. In-
troduction: The role of pro-inflammatory cytokines in depression has 
been addressed by the scientific community during the last decades. 
In fact, patients with depression present increased serum levels of 
a sub-set of those cytokines. However, recent studies demonstrate 
that anti-inflammatory cytokines, namely IL-10, also play a role in 
this pathology. In fact, some studies show that depressed patients 
presented decreased IL-10 levels in the serum, while antidepressant 
treatment led to their increase. Accordingly, mice lacking IL-10 ex-
pression present depressive-like behavior that can be reversed with 
IL-10 administration. Symptoms like anxiety, anhedonia and cogni-
tive impairment are usually present in depressed patients. Thus in 
this study we evaluated if these behavioral alterations were also 
present in mice lacking IL-10 expression. Moreover the mechanisms 
underlying the behavioral alterations present in IL10-/- mice are 
unknown. Since alterations in cytokine milieu are associated with 
depressive-like behavior we studied the cytokine profile of IL-10-/- 
in the periphery and also in the central nervous system. Methods: 
Females Balb/c IL10-/- and wild-type (WT), 3 months old, were use to 
study the behavior phenotype and the cytokine profile. Anxious-like 
behavior was evaluated in the Novelty-Suppressed Feeding (NSF). 
Hedonic behavior was studied in the burrowing test. To assess cog-
nitive performance mice were submitted to Barnes Maze (BM) and 
Novel object Recognition (NOR) tests. The expression levels of several 
pro and anti-inflammatory cytokines were quantified by qPCR in the 
spleen (periphery) and several brain regions. Results: We observed 
that female IL-10-/- mice present an increased latency time in the 
NSF when compared to WT animals. The burrowing behavior was de-
creased in IL-10-/-. Furthermore, a decreased recognition index in the 
NOR and an increased latency time on the BM were observed in IL10-
/- mice in comparison to controls. The study of cytokine profile in 
brain regions and periphery showed that IL10-/- mice present some 
alterations in the cytokine milieu. Conclusions: In addition to de-
pressive-like behavior, female IL-10-/- mice also present anxious-like 
behavior, anhedonia and cognitive impairment, the same behavioral 
dimensions frequently altered in depressed patients. Interestingly 
all this behavioral alterations are associated with an imbalance in 
the cytokine expression in the brain and also in the periphery. These 
findings suggest that IL-10 could be a target molecule for the develo-
pment of new antidepressant therapies.
PS 271 Ghrelin expression in the rat’s eye.
Pereira-Silva P1, Azevedo-Pinto S1, Pinho S1, Rocha-Sousa 
AD1,2.
1 Faculty of Medicine, University of Porto.
2 Ophthalmology department, Faculty of Medicine, University of Porto.
Aim: The purpose of this study was to evaluate ghrelin’s ocular tissue 
distribution in the adult rat’s eye and to confirm previously reported 
data, describing the identification of ghrelin’s mRNA in the iris pos-
terior epithelium and in the ciliary body non pigmented epithelium. 
Introduction: Ghrelin is an acylated 28 aminoacid peptide that was 
first discovered in the rat’s gastric mucosa in 1999 by Kojima et al.. 
This peptide is the endogenous ligand of the somatosecretagogue’s 
receptor (GHSR-1a), promoting growth hormone’s release from the 
hypothalamus. Recently, it has been described that ghrelin induces 
the relaxation of iris’s sphincter muscle independently from GHSR-1a, 
nitric oxide and calcium dependent potassium channels and depen-
dently on prostaglandins release. Ghrelin also relaxes the iris’ dilator 
muscle, being this process mediated by the GHSR-1a. Ghrelin’s mRNA 
was also identified in the iris posterior epithelium and in the ciliary 
body non pigmented epithelium. Methods: Adult Wistar rats were 
sacrificed through an intraperitoneal injection of sodium pentobar-
bital and both eyes were immediately enucleated and processed for 
cryostat sections and indirect immunofluorescence protocol. Slides 
were incubated with anti-ghrelin, anti-histone H3 (positive control) 
and with 2% NGS (negative control) at 4ºC for 48 hours and then with 
secondary antibody containing a fluorescent tag during 1 hour. After 
incubation slides were examined under a fluorescence microscope. 
Results: We observed immunolocalization of ghrelin in the rat’s ci-
liary body epithelium. Its major label appeared in the inner part 
of that epithelium facing the stroma of the ciliary processes. This 
peptide showed no expression in the posterior segment, namely 
in the retinal pigmented epithelium. Conclusions: Ghrelin is locally 
produced in the eye, mainly in the ciliary processes. Based on these 
findings, we can conclude that this peptide may play a role as a 
local regulator of the aqueous humor dynamics and ciliary muscle 
kinetics.
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PS 115 Simultaneous pancreas-kidney transplantation vs. kidney 
transplantation in type 1 diabetic patients: which one provi-
des a better quality of life?.
Costa R, Dias J, Almeida F, Correia J, Lima F, Miguel R, Pinto F, 
Reinas R, Santos G, Torres S.
Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, 
Portugal.
Aim: The goal of this study was to compare quality of life between si-
multaneous pancreas-kidney transplant (SPKT) and kidney transplant 
(KT) among type 1 diabetic patients. Introduction: Long-term compli-
cations of Diabetes Mellitus (DM) are responsible for the majority 
of all morbidity and mortality associated with the disease. Terminal 
diabetic nephropathy is more and more dealt with a simultaneous 
pancreas-kidney transplant (SPKT) in type 1 DM patients instead of 
kidney transplant (KT), with a reduction in morbidity and mortali-
ty. Methods: A cross-sectional study was carried out in 49 patients 
in the SPKT group and 33 patients in the KT group. Quality of life 
was assessed with the validated SF-36 questionnaire. Results: The 
SPKT group presented better values in all domains, though only the 
Physical Function (80,17% vs. 68,33%, p=0,027) and General Health 
(43,88% vs. 32,58%, p=0,009) variables have yielded statistically sig-
nificant results. Conclusions: The SPKT group presented statistically 
superior results in some domains of quality of life when compared to 
KT. Larger studies are needed in order to confirm this trend.
PS 132 The influence of gender and body mass index on eruption 
time of permanent teeth in children aged 6.
Davidovac S1, Babic M1, Vujkov S2.
1 Faculty of Medicine, University of Novi Sad.
2 Clinic for dentistry of Vojvodina.
Aim: The aim of this study is to determine the time of eruption of 
permanent teeth, if there is a change in the time of eruption and if it 
depends on gender and body mass index (BMI). Introduction: Tooth 
eruption is the developmental process responsible for moving teeth 
from its crypt position through the alveolar process into the oral 
cavity to its final position of occlusion with antagonist. The factors 
which affect the organism as a whole are reflected also on the growth 
and eruption of teeth. Overweight children have low growth hormon 
serum levels, but they have high leptin levels which may play role in 
earlier onset of puberty and development in girls or later in boys. Fat 
tissue has aromatase enzymes that convert testosterone to estrogen 
which slows down boys development. Reduced energy and protein 
intake can delay eruption. Methods: The research included 126 chil-
dren, 65 girls and 61 boys, aged 6, in the city of Novi Sad and its 
surroundings. To evaluate nutritional status, weight and hight were 
measured, the BMI was calculated and percentile distribution was 
performed using the percentile curve. Dental examination was per-
formed. The statistical significance was determined with statistical 
methods of descriptive and comparative analysis. Results: The mean 
value of existing permanent teeth for the entire group is 5,03 while 
by gender is significantly higher (p<0.05) for females. Underweight 
girls have significantly fewer teeth than overweight girls (p<0.05) 
and boys with normal weight have significantly more teeth than 
overweight boys (p <0.05). Children with low BMI have significantly 
fewer permanent teeth (p<0.05). Conclusions: Based on these results 
it can be concluded that dental age in 6 years old children is 5,03 
teeth, that there is a change in the time of eruption of permanent 
teeth and that it depends on gender and BMI.
PS 152 THE EFFICIENCY OF LOW LEVEL LASER THERAPY IN THE 
TREATMENT OF THE MOUTH BURNING SYNDROME IN DIABETICS.
Karuovic K, Jordacevic N, Conic S.
Faculty of Medicine, University of Nis.
Aim: To analyse the efficiency of low level laser treatment in diabe-
tics burning mouth syndrome. Introduction: Low-power lasers are 
used in dentistry for treatment numerous oral painfull conditions 
and diseases. The biostimulative effects, especially analgesic, anti-
inflammatory and antiedemous effect are confirmed. The numerous 
changes in the oral cavity such as dry mucous membranes, burning 
mouth and tongue, decreased saliva flow rate, Candidiasis are diag-
nosed in diabetic patients. Methods: The study was conducted on 20 
patients diagnosed as diabetes mellitus as well as Burning mouth 
syndrome. Patients were divided into two groups: Group I consisted 
of 10 patients who were treated with low-power laser and the group 
II consisted of 10 patients who were treated with therapeutic prepa-
rations (Dactanol Gel + Amp Lemod). LLLT was applied, with a Scor-
pion Dental Optima apparatus (wavelength 635 nm, strength 25mV, 
exposure time 120 s), in 5 daily sessions. Visual-Analogue Scale for 
pain was used for measuring oral discomforts in diabetics. Results: 
After the first session the statistically significant difference between 
the average value of pain between the groups was established. Na-
mely, the patients treated by LLLT had significantly lower mean value 
of pain than those treated by Dactanol gelom+Amp Lemod (p<0,05). 
After II, and III sessions, the average value of pain decreased in both 
groups, but the decrease was more pronounced in patients treated 
with laser. In the end, the level of statistical significance of differen-
ces in mean of pain between the groups was (p <0.001). Conclusions: 
LLLT is beneficial as an adjunctive treatment modality for treating 
symptoms of mouth burning syndrome in diabetic patients.
PS 157 Automatic pre-bended customized bars for Nuss operation 
using chest CTscan.
Direito-Santos B1, Vilaça JL1,2, Henriques-Coelho T3, Soares TR1, 
Madureira A4, Fonseca J5, Pinho ACM6, Rodrigues PL1, Correia-
Pinto JD1,3.
1 Life and Health Sciences Research Institute (ICVS), School of Health 
Sciences, University of Minho.
2 DIGARC - Polytechnic Institute of Cávado and Ave.
3 Pediatric Surgery Department, Hospital São João, Porto.
4 Radiology Department, Hospital São João, Porto.
5 Industrial Electronics Department, University of Minho.
6 Mechanical Department, University of Minho.
Aim: Study all patients that underwent Pectus Excavatum (PE) correc-
tive surgery at the Pediatric Surgery department in Hospital de São 
João-Porto between 2000 and 2010 and evaluate the modifiable varia-
bles that affect the surgical results in which integrates i3DExcavatum 
System. Introduction: PE is the most common thoracic malformation 
occurring between 1:400 and 1:1000 births and more frequently in 
males. The surgical repair has progressed over the past 20 years due 
to improvements of the Nuss technique that aims to place a metal 
bar in the retrosternal space where it remains 2-3 years. We deve-
loped a new technology - i3DExcavatum System - that complements 
the surgical procedure allowing the automatic and personalized bar 
bending based in 3D CT scan previously to surgery. Methods: Through 
clinical process consultation, data regarding the surgical correction 
of PE between 2000 and 2010 was collected. To compare the internal 
references used for automatic bending with the external costal grade 
references used for manual-bending process, the distance between 
the skin and costal margin in the CT horizontal plan was measured 
including the deepest point of the sternum at midaxillaries lines and 
under the nipples. The lengths over the skin and above the external 
surface of the costal grade in this plan and the plan for insertion 
of the prosthesis were measured. To study the evolution of surgical 
correction influence area, the anterior chest surface pre-surgical 
and post-surgical 3D reconstructions were comparatively analyzed. 
Results: There were significant decreases (p<0.001) of 33 minutes in 
duration of surgery, 22 minutes in duration of anesthesia and 2.5 
days in length of postsurgical stay in automatic modelling group. 
The complication rate is lower in the group of automatic modelling 
(31.6% vs. 8.3%, p<0.05). The skin-to-costal distances reached values 
over 20 mm at mid-axillaries lines and under the breasts mainly 
in females. Significant differences were detected between the skin 
and the costal lines in both genders. Despite deformity correction 
occurs similarly in all directions of the anterior chest wall, diverging 
measures and outliers were found. Conclusions: These results are 
encouraging and confirm the advantages of metal bar automatic mo-
delling. i3DExcavatum System overcomes the time consuming and 
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boring step of manual bending, allowing creation of a smooth bar 
completely adapted to the patients characteristics and minimizing 
the errors induced by a manual bending process based in the skin 
surface.
PS 160 Treatment of femoral head osteonecrosis following IV drug: 
total hip arthroplasty versus core decompression.
Niloufar A, Pardis N, Ali N.
Faculty of Medicine, Shahid Beheshti University.
Aim: The main purpose of current study was to compare the functio-
nal outcomes after THA and CD in patients with femoral head osteo-
necrosis following long-term Tamjizak and Norjizak usage. Introduc-
tion: Femoral head osteonecrosis is a common problem following 
long-term corticosteroid usage. Tamjizak and Norjizak are two forms 
of IV drugs in Iran which contain corticosteroids. Currently, total hip 
arthroplasty (THA) and core decompression (CD) are two methods for 
treating femoral head osteonecrosis. Methods: The population in this 
clinical trial study consisted of 30 patients with femoral head osteo-
necrosis following-term Tamjizak and Norjizak usage aged 35.53±9.42 
years (17-55). There were 25 males and 5 females. Mean time of IV 
drug injection was 3.2±1.6 years (1-5 years). Patients were divided 
into 2 groups: 15 underwent THA and 15 CD. The mean follow up was 
14 months (6 months to 2 years). Functional hip score was used to 
assess the functional status of the patients Pre- and postoperatively. 
The score questions pain, mobility, and ability to walk. Each of these 
has 6 points. The greater the score the outcome will be better. Outco-
mes can be classified as very good, good, medium, fair, and poor. 
Finally, data were analyzed using paired and independent samples 
t-test. Results: The mean score was 7.8±1.9 preoperatively and 15.7±1 
postoperatively in THA group and 7.4±1.6 and 14.33±1.2 in CD group. 
Paired t-test showed that there was a statistically meaningful diffe-
rence between pre- and postoperative scores in 2 groups (p=0.00). 
The postoperative score of the THA group was significantly greater 
than the other (p=0.002). Conclusions: Compared to CD, current stu-
dy showed superior functional outcomes with THA in the treatment 
of patients suffered from femoral head osteonecrosis following long-
term corticosteroid usage.
PS 174 THE USE OF MODERN METHODS OF ENTEROSCOPY IN PREOPERA-
TIVE DIAGNOSIS AND TREATMENT OF SMALL BOWEL TUMORS.
Ivanova EV1, Timofeev ME1, Yudin OI1, Kouznetsov DA2, Fe-
dorov ED1.
1 Moscow University Hospital â31, Russian Federation.
2 Faculty of fundamental medicine, Lomonosov Moscow State University, 
Russian Federation.
Aim: To estimate the possibilities of videocapsule endoscopy (VCE) 
and balloon-assisted enteroscopy in preoperative diagnosis and mi-
nimally invasive treatment of the small bowel tumors. Introduction: 
From V.2003 to V.2011 we observed 56 pts. with definitely establis-
hed or strongly suspected diagnosis of SBT. Small bowel tumors 
were diagnosed in 28 (50,0%) pts. (m-16, f-12, ranged from 18 to 
76 years, mean age 54,7±13,9 years) by using VCE (Given Imaging, 
Olympus, OMOM) and flexible enteroscopy (FE) (single- and double 
balloon, push enteroscopy or laparoscopically-assisted balloon 
enteroscopy). At this period 12 (21,4%) pts. were admitted to the 
hospital and operated urgently (without previous examination) for 
small bowel obstruction/peritonitis or intestinal bleeding caused by 
angioleiomyoma (1), malignant carcinoid (4), adenocarcinoma (2), 
lymphoma (1), sarcoma (2) and melanoma metastasis (2). During 
complex examination in 16 (28,1%) pts. the diagnosis of SBT wasn`t 
confirmed. Methods: From V.2003 to V.2011 we observed 56 pts. with 
definitely established or strongly suspected diagnosis of SBT. Small 
bowel tumors were diagnosed in 28 (50,0%) pts. (m-16, f-12, ranged 
from 18 to 76 years, mean age 54,7±13,9 years) by using VCE (Given 
Imaging, Olympus, OMOM) and flexible enteroscopy (FE) (single- and 
double balloon, push enteroscopy or laparoscopically-assisted ba-
lloon enteroscopy). At this period 12 (21,4%) pts. were admitted to 
the hospital and operated urgently (without previous examination) 
for small bowel obstruction/peritonitis or intestinal bleeding caused 
by angioleiomyoma (1), malignant carcinoid (4), adenocarcinoma (2), 
lymphoma (1), sarcoma (2) and melanoma metastasis (2). During 
complex examination in 16 (28,1%) pts. the diagnosis of SBT wasn`t 
confirmed. Results: From 28 pts with SBT in 15 pts we performed 
VCE which defined indications to FE and radiological methods (in 
some cases) for diagnosis improvement in 13 pts (with subsequent 
surgery in 6) and directly to surgery in 2 pts. During FE in 19 pts. we 
were able to evaluate the tumor, to provide biopsy or to perform SBT 
removal. Histologically there were: hyperplastic polyp - 5, tubular 
adenoma - 3, Peutz-Jegher’s hamartoma - 5, leomyoma - 2, carcinoid 
- 2, adenocarcinoma - 4, GIST - 4, undifferentiated carcinoma - 1, 
B-cell lymphoma -1, metastatic lesion -1. Conservative treatment 
(including chemotherapy) have been applied in 6 (21,4%) pts. En-
doscopic interventions were performed in 10 (35,7%) pts.: polypec-
tomy by electroexcision (9) - 19 tumors were removed, the biggest 
one - 60mm; mucosal resection (1) - in FA P case, 3 adenomas were 
removed, carcinoid was removed by a polypectomy snare. There 
were three complications - small bowel intussusception in a patient 
with Peutz-Jegher’s syndrome during VCE, the patient was urgently 
operated; capsule retention in a patient with adenocarcinoma, that 
was solved by resection of the affected bowel; bleeding in 1 patient 
after polypectomy in ileum that was stopped using argon plasma 
coagulation. Surgical operations were performed in 12 (42,9%) pts.: 
partial small bowel resection of tumor via mini-laparotomy access 
after previous laparoscopy (3) and conventional laparotomy (9) for 
adenocarcinoma - 4, GIST - 4, leomyoma - 2, large Peutz-Jegher’s 
polyp complicated by acute intussusception during VCE - 1, mela-
noma metastasis - 1. Nor intra- neither postoperative complications 
or deaths have been revealed in all these patients. Conclusions: 
Diagnostic possibilities of VCE and balloon-assisted enteroscopy 
along with biopsy helps to select the right treatment policy: 57,1% 
pts with SBT needs conservative treatment (with endoscopic removal 
in 35,7% of cases) while surgery is necessary in 42,9% mainly malig-
nant cases. Due to the novel methods of deep enteroscopy (VCE and 
balloon assisted enteroscopy) SBT are being diagnosed more often 
at the earlier stages with greater accuracy while no complications 
are developed.
PS 176 Improvement of cardiovascular markers after Roux-en-Y gas-
tric bypass in female patients.
Janik M, Rutkowski M, Sujecki D, Janik PD.
Department of General, Transplant and Liver Surgery.
Aim: The purpose of our study was to estimate the influence of 
Roux-en-Y gastric bypass on markers of cardiovascular events in 
female patients. Introduction: Obesity is strongly linked to cardio-
vascular diseases, the leading cause of mortality in Poland. Bariatric 
operations significatly reduce weight and treat obesity. We assume 
that in addition to weight reduction, bariatric surgery affects several 
cardiovascular markers. Methods: We retrospectively analysed the 
data of 22 female patients operated on from 2008 to 2009 (Roux-
en-Y gastric bypass) . Patients were evaluated before operation and 
in 3, 6, 12 months. We measured biochemical cardiovascular risk 
biomarkers: total cholesterol, high-density lipoprotein (HDL), low-
denisty lipoprotein (LDL), trigliceryde, total cholesterol/HDL ratio and 
fibrinogen. The data were analysed using Statistica 9.0PL. Results: 
The mean age of the 22 patients was 41 years, the mean BMI was 
49 (±6) kg/m2, 32% were diabetic and 59% were hypertensive. Sig-
nificant improvement occurred in the cardiovascular biomarkers: TC, 
HDL, LDL, HDL/TC ratio, fibrinogen and trigliceryde level (p<0.05). Total 
cholesterol decreased from 171,1 (±28,4) mg/dL to 137,4 (±27,1) mg/
dL at 12 months (p<0,05) ; HDL level increased from 43,1 (±10,8) mg/
dL to 53,6 (±11,2) mg/dL at 12 months (p<0,05) ; LDL level decreased 
from 98,3 (±21,6) mg/dL to 66,9 (±23,6) mg/dL at 12 months (p<0,05). 
; Total cholesterol/HDL ratio decreased from 4,1 (±0,9) to 2,6 (±0,7) 
at 12 months(p<0,05); fibrinogen level decreased from 469,2 (±112,7) 
mg/dL to 383,6 (±85,3) mg/dL at 12 months(p<0,05); trigliceryde le-
vel decreased from 151,3 (±37,6) mg/dL to 83,1 (±30,6) mg/dL at 12 
months (p<0,05). Conclusions: The findings of the study have proved 
the influence of bariatric operations on cardiovascular markers in 
female patients. The improvment of all investigated factors has been 
shown after bariatric operation with statistic significance in total 
cholesterol, HDL, LDL,fibrinogen level and TC/HDL ratio.
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PS 222 Improvement in Type 2 Diabetes Mellitus after Roux-en-Y 
Gastric Bypass in Morbidly Obese Patients.
Sujecki D, Janik M, Rutkowski M, Janik P, Piotr Kalinowski MD.
Department of General, Transplant and Liver Surgery Medical University 
of Warsaw.
Aim: The aim of this study was to assess the influence of Roux-en-Y 
gastric bypass on diabetic parameters in diabetic morbidly obese 
patients. Introduction: Obesity is a problem closely related to type 2 
diabetes mellitus. There are growing evidences that bariatric proce-
dures such as Roux-en-Y Gastric Bypass (RYGB) lead to improvement 
or even complete resolution of type 2 diabetes mellitus (T2DM) in 
morbidly obese patients. Methods: Forty one patients underwent 
RYGB from 2008 to 2009, nine of them were diabetic (22%). Data of 
diabetic patients were analyzed retrospectively. Body mass index 
(BMI), fasting plasma glucose level, fasting insulin level and HbA1c 
were measured before and 12 months after surgery. HbA1c level 
lover than < 6.5% was defined as well controlled diabetes. Results: 
Mean BMI changed from 46.3±6.4kg/m2 to 31.4±7.9 kg/m2 in 0, 12 
months period (p<0,05). Mean fasting plasma glucose level decrea-
sed from 124,3 ±34.8mg/dl before operation to 84.9 ±9.9 mg/dl after 
operation (p<0,05). Mean HbA1c level decreased from 7.1 ±0.8mg/dl 
before operation to 5.61 ±0.72mg/dl after operation (p<0,05). Mean 
fasting insulin level decreased from 15.3±10.9 uIU/ml before opera-
tion to 4.49±4.13 uIU/ml after operation (p<0.05). Before operation 2 
of 9(22.2%) patients had HbA1c level lover than 6.5%. Twelve months 
after surgery 8 of 9 (88.9%) patients had HbA1c level lover than 
6.5%. Conclusions: Diabetic parameters were improved 12 months 
after RYGB operation in morbid obese patients with type 2 diabetes. 
Percentage of patients with well controlled diabetes increased after 
operation.
PS 246 Fetal Middle Cerebral and umbilical arteries blood flow velo-
cities in normal and diabetic associated pregnancies.
Mehrpour M1, Fereshtehnezhad SM1, Nasirzadeh R2, Askari S3, 
Alemzadeh SAP3, Younesi L2, Zanjani M2, Alirezaee M2.
1 Tehran University of Medical Sciences, FCRDC.
2 Tehran University of Medical Sciences.
2 Tehran University of Medical Sciences, SSRC.
Aim: To assess the Doppler parameters in the umbilical and fetal 
Middle Cerebral arteries in women with Gestational diabetes mellitus 
(GDM) and normal pregnancies. Introduction: Gestational diabetes 
mellitus (GDM) is one of the most current complications in preg-
nancies; which has an incidence as high as 13% in high-risk ethnic 
groups.GDM associated gestations may be susceptible for both ma-
ternal and fetal complications, which is approved by some studies. 
Several studies showed that maternal-placental blood flow might 
have changes caused by hyperglycemia during the pregnancy; As a 
compensatory mechanism to the decrease of placental blood flow, 
redistribution of blood flow from peripheral vessels to the brain was 
occurred,which can be well defined by Doppler Ultrasound measu-
rements of Umbilical artery(UA) and Middle cerebral arteries(MCA) 
of the fetuses. Nowadays fetal cerebral blood flow  velocities as-
sessment has become a suggested way of evaluation of high-risk 
pregnancies. Although some studies have been done on evaluating 
the pregnancy complications such as Intra Uterine Growth Restriction 
(IUGR) and pre-eclampsia, and they have shown significant changes 
in the Doppler parameters of the fetal MCA; there isn’t sufficient 
evidence about the effect of GDM on the fetuses. Methods: A cross-
sectional study was performed on 66 pregnant women, including 
33 women with GDM and the others without it, in Akbar-Abadi 
University Hospital in Tehran, Iran during 2010-2011. Peak systolic 
and diastolic velocities, pulsatiliy index(PI), resistance index(RI) and 
systolic/diastolic ratio(S/D) were recorded in Umbilical artery(UA) as 
well as both right and left Fetal Middle Cerebral Arteries(MCAs) for 
every recruited pregnant women by means of Doppler ultrasonogra-
phy. Results: The mean gestational age at the time of examination 
was 34.45(SD=2.62) weeks in GDM-positives and 34.63(SD=3.23) in 
GDM-negatives (P=0.218). Although all of the measured Doppler pa-
rameters had higher values in GDM-positives, but the differences 
were not significant between two groups of study; except for the 
left fetal MCA-PI which was significantly higher in GDM associated 
group [2.07(SD=0.07) vs. 1.85(SD=0.74), P=0.03]. Conclusions: Evalua-
ting other pregnancy complications including Intra Uterine Growth 
Restriction (IUGR) and preeclampsia, some studies have shown signi-
ficant changes in the blood flow velocity of the fetal MCA. Our study 
is one of the first to confirm that gestational diabetes could also 
correlate with the increased pulsatility index of the fetal MCA. This 
result could be due to the brain-sparing phenomenon; and as it was 
demonstrated that hyperglycemia affect the diabetic adult vessels, 
it might also involve fetal vessels in GDM associated pregnancies.
PS 249 MINIMALLY INVASIVE SURGERY IN THE TREATMENT OF BILIARY 
TRACT LITHIASIS.
Kosjer J1, Sarcev K2, Pjevalica J1, Jovanovic G1.
1 Faculty of Medicine, University of Novi Sad.
2 Clinic for Abdominal, Endocrine and Transplantation Surgery, Clinical 
Center of Vojvodina.
Aim: Evaluation the frequency of laparoscopic cholecystectomy (LC) 
compared to conventional (OC), length of hospital stay and cost-
benefit procedures, as well as the distribution of patients according 
to sex and age structure, in our material. Introduction: Minimally 
invasive surgery in the treatment of biliary tract lithiasis, or lapa-
roscopic cholecystectomy, based on the classic surgical principles 
with new technology solutions, includes planned and emergency 
surgery. Methods: This retrospective analysis included 618 patients, 
with the diagnosis of biliary tract lithiasis, male and female, age 
over 18 years old, who were hospitalized and treated at the Cli-
nics for Abdominal, Endocrine and Transplantation Surgery at the 
Clinical Center of Vojvodina, in the period from 01.01. to 31.12.2010. 
Laparoscopic cholecystectomy was performed in all patients who 
were scheduled for elective surgery, unless they didn`t want this 
approach. In emergency operations, the selection of approach was 
on the treating surgeon, with the consent of the patient. Results: 
Results show a higher frequency of LC-367 (59%) compared to OC-251 
(41%). Length of hospital stay for patients operated LC is significantly 
shorter and is 2 days, while the OC is 7days, which is statistically 
significant (p <0.05). Cost-benefit procedures LC compared to OC, 
shows a high level of statistical significance (p <0.005). LC frequency 
is higher in women 71%, and represents a statistically significant 
difference (p <0.05). The patients are from the same age group, which 
means that there are no restrictions on the age structure of patients. 
Conclusions: Length of hospital stay LC is significantly shorter and 
allows faster return normal life activities, average of 7 days. Laparos-
copic cholecystectomy represents effective and economical way to 
treatment of biliary tract lithiasis.
